Household air pollution and adult pneumonia in Malawi by Jary, HR & mortimer,
  
 
HOUSEHOLD AIR POLLUTION AND 
ADULT PNEUMONIA IN MALAWI 
 
 
 
Thesis submitted in accordance with the requirements of the University of 
Liverpool for the degree of Doctor of Philosophy by 
 
Hannah Rose Jary 
MBChB, MClinRes, MRes, MRCP(2011), DTM&H 
 
 
 
 
November 2017  
i 
 
Declaration 
 
I declare this thesis to be the result of my own work, except where explicitly stated below. The 
contributions of others are listed here and described in more detail at the beginning of relevant 
chapters. The work was conducted at the Liverpool School of Tropical Medicine (LSTM), UK and the 
Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW), UK. My supervisors Dr Kevin 
Mortimer (LSTM, UK), Dr Ingrid Peterson (MLW, Malawi) and Professor Stephen Gordon (MLW, 
Malawi) advised on design, conduct, analysis and reporting for all research presented here.  The 
work within this thesis reflects work completed during my Wellcome Trust Clinical PhD Fellowship. 
 
Individuals  Contribution Chapter 
Dr Deborah Havens (LSTM, UK) and Dr 
Daniel Pope (University of Liverpool, UK) 
Systematic review: protocol design input,  
title/abstract/paper searching 
3 
Professor Nigel Bruce (University of 
Liverpool, UK) 
Systematic review: protocol design input 3 
Hope Simpson (London School of Hygiene 
and Tropical Medicine, UK) and Dr 
Geoffrey Manda (University of Malawi) 
Systematic review: title/abstract/paper 
searching 
3 
Dr Jamie Rylance (LSTM, UK) Airway macrophage particulate load study: 
study conception and design 
4 
Dr Latifa Patel (formerly Aintree 
University Hospitals, UK) 
Airway macrophage particulate load study: 
assistance with participant recruitment 
4 
Dr Andy Cross (University of Liverpool Airway macrophage particulate load study: 
assistance with sputum processing and 
analysis 
4 
Vincent Doyle (Concern Universal, 
Malawi), Conor Fox (Clioma Ltd, Malawi), 
Elizabeth Banda (Clioma Ltd, Malawi), 
Christa Roth (Fuel and Food Consultants, 
Germany) and Dr Sean Semple (University 
of Aberdeen, UK). 
Cookstove randomised controlled trial 
pilot: input into study design 
5 
ii 
 
James Kachidihu, Howard Bandah and 
Macfary Kapanga (all Concern Universal, 
Malawi) 
Cookstove randomised controlled trial 
pilot: data collection 
5 
Professor Robert Heyderman (formerly 
MLW, Malawi) 
Acute Infection of the Respiratory tract 
(AIR) Study: input into study design  
6 
Professor Brian Faragher (LSTM, UK) AIR study: statistical advice 6 
Dr Stephen Aston (Principal Investigator 
of the MARISO study, MLW, Malawi) and 
Dr Antonia Ho (Principal Investigator of 
the BASH-FLU Study) 
AIR study: input into study set up and 
execution, team supervision, data 
collection and management 
6 
AIR, BASH-FLU, MARISO and Influenza 
Surveillance Study teams (all MLW, 
Malawi) 
AIR study: data collection and management 6 
Lindsay Zurba (Spirometry Training 
Services Africa CC, South Africa) 
Air study: spirometry interpretation and 
quality assurance 
6 
Brigitte Denis, George Selemani, Aaron 
Mdolo and MLW laboratory staff (all 
MLW, Malawi) 
AIR study: clinical sample analysis 6 
Rachel Lloyd (LSTM, UK) AIR study: data management assistance 6 
Dr Nico Nagelkerke (formerly MLW, 
Malawi) 
AIR study: interim analysis 6 
Dr Ingrid Peterson (MLW, Malawi) AIR study: construct of principal 
components analysis 
6 
Dr Emanuele Giorgi (Lancaster University, 
UK) 
AIR study: geospatial analysis, data 
imputation using spatial interpolation and 
support of multivariate logistic regression 
analysis 
6 
 
  
iii 
 
Acknowledgements 
 
This work would not have been possible without the hard work, dedication and support of many 
people. There are too many people to mention everyone by name, but I am very grateful for the 
invaluable contribution than many of my colleagues, collaborators, friends and family have made.  
I am extremely thankful to the volunteers involved, both in the UK and Malawi, who put their trust 
in our study teams, and without whom this research would not have been possible. 
The research was generously funded by the Wellcome Trust (Grant number 099929/B/12/Z) and I 
am grateful for the commitment they have made to supporting clinical research in resource poor 
settings. My supervisors have each made their own invaluable contributions to the work, bringing 
different skills and attributes to the projects. I am grateful to Professor Stephen Gordon not only for 
the wisdom and guidance he had brought to my doctoral studies, but also for offering me 
mentorship many years ago and opening the door for me to work at LSTM. Dr Ingrid Peterson has 
provided invaluable epidemiological input, helping me to understand the implications of my study 
design and statistics, for which I’m very appreciative. There are many things I would like to thank Dr 
Kevin Mortimer - my primary supervisor - for, including inspiring me to study household air 
pollution, teaching me to always do things for the right reasons, keeping it all in perspective, but 
especially for always, without fail, having my back.  
Clinical and laboratory staff at Aintree University Hospital supported me to conduct a study of 
induced sputum, with guidance from Dr Jamie Rylance. Professor Nigel Bruce, Dr Daniel Pope, Dr 
Deborah Havens and other colleagues demonstrated great tenacity and goodwill during our efforts 
to conduct a systematic review. Professor Neil French and Dr Henry Mwandumba (my advisory 
panel) along with Professor David Lalloo provided sage advice and guidance throughout my doctoral 
studies. 
I would also like to thank the team at the Wellcome Trust Liverpool Glasgow Centre for Global 
Health Research, UK, particularly Carolyn O’Leary, Matt Hanlon and Kate Jones, for their hard work 
and logistical support. Working at MLW was a wonderful experience and I’d like to thank the wider 
team there, particularly the operations staff, for making it so. Clemens Masesa (Senior Data Systems 
Manager, MLW) and Owen Mwenefumbo (Information Technology Manager, MLW) deserve special 
mention for their time, efforts and good humour when helping me on many occasions.   
iv 
 
It was a privilege to work amongst many intelligent, ambitious and inspiring colleagues in the Junior 
Researchers Room at MLW, who have taught me so much and many of whom will be life-long 
friends. I am particularly thankful for the collaboration of Dr Stephen Aston and Dr Antonia Ho 
(Principal Investigators of the MARISO and BASH-FLU studies, respectively), whose concurrent 
studies were closely interlinked with the AIR study. I learnt a great deal from their expertise and 
knowledge, and their hard work and generosity benefited me greatly. Our studies were also 
supported by the Influenza Surveillance Study (Principal Investigators Dr Dean Everett and Dr Ingrid 
Peterson) for which I am very grateful. 
The AIR Study Team (Beatrice Chinoko, Chimwemwe Kambudzi, Collins Chiliwawa, Malumbo 
Ng’oma, Patrick Munthali, Gift Sagawa, Stain Nkata and Dr Newton Kalata) worked tirelessly to 
collect data and facilitate the study, and I am grateful for their dedication, enthusiasm and hard 
graft. Members of the BASH-FLU, MARISO and Influenza Surveillance study teams also played an 
important role in the running of the AIR Study. Many colleagues at Queen Elizabeth Central Hospital 
(QECH), Malawi, kindly facilitated the AIR Study, including Rose Malamba, Dr Jane Mallewa and Dr 
Mulinda Nyirenda.  
My deepest gratitude goes to my parents, Maggie and Chris, for their endless encouragement and a 
lifetime of emotional, intellectual and practical support. It is thanks to them that I am where I am 
today. More recently, they have literally been left “holding the baby”, and were not for that, this 
thesis would never have been written. The most important thank you is to my loving husband, 
Aylwin, who has put up with so much and supported me in so ways, from keeping me fed during 
long hours of work to making me smile when all seemed too difficult, from cleaning dirt out of 
pollution monitors to moving to a different continent – I could never have done this alone. Our 
wonderful daughter, Alba, has not provided much intellectual input, but gives reason to striving for a 
more equitable world.  
  
v 
 
Publications related to work presented in this thesis 
 
Jary H, Simpson H, Havens D, Manda G, Pope D, Bruce N, et al. Household Air Pollution and Acute 
Lower Respiratory Infections in Adults: A Systematic Review. PloS one. 2016;11(12):e0167656.  
 
Jary H, Rylance J, Patel L, Gordon SB, Mortimer K. Comparison of methods for the analysis of airway 
macrophage particulate load from induced sputum, a potential biomarker of air pollution exposure. 
BMC Pulmonary Medicine. 2015;15:137.  
 
Jary H, Kachidiku J, Banda H, Kapanga M, Doyle JV, Banda E, et al. Feasibility of conducting a 
randomised controlled trial of a cookstove intervention in rural Malawi. The international journal of 
tuberculosis and lung disease : the official journal of the International Union against Tuberculosis 
and Lung Disease. 2014;18(2):240-7.  
 
Jary H, Mallewa J, Nyirenda M, Faragher B, Heyderman R, Peterson I, et al. Study protocol: the 
effects of air pollution exposure and chronic respiratory disease on pneumonia risk in urban 
Malawian adults--the Acute Infection of the Respiratory Tract Study (The AIR Study). BMC Pulmonary 
Medicine. 2015;15:96.  
 
Jary H, Aston S, Ho A, Giorgi E, Kalata N, Nyirenda M, et al. Household air pollution, chronic 
respiratory disease and pneumonia in Malawian adults: A case-control study [version 1; referees: 
2 approved]. Wellcome Open Research. 2017;2:103.  
 
  
  
 
  
vi 
 
Abstract 
Household air pollution and adult pneumonia in Malawi 
Hannah Jary 
 
Background: Three billion people worldwide use solid fuels for cooking and heating their homes. The 
World Health Organization estimates that the resultant household air pollution causes 6.5 million 
deaths per year, predominantly in low- and middle-income countries. Despite causing half a million 
deaths per year from childhood pneumonia, the association between household air pollution and 
pneumonia in adults - a common cause of morbidity and mortality in sub-Saharan Africa – is not 
established. Studies of household air pollution are limited by difficulties in quantifying exposure 
levels, contributing to the relative scarcity of evidence. Addressing these methodological challenges 
would facilitate efforts to obtain the evidence required to reduce this health burden for the world’s 
poorest populations. Focussing particularly in the sub-Saharan country of Malawi, this thesis aims to 
explore the challenges regarding exposure measurements in resource poor settings, and to provide 
evidence regarding the role of household air pollution in pneumonia in adults.  
Methods: The literature was systematically reviewed to establish the current evidence base for an 
association between household air pollution and pneumonia in adults. Two prospective studies 
examining the suitability of potential biomarkers of household air pollution exposure were 
undertaken: firstly, to establish the feasibility of using airway macrophage particulate load obtained 
from induced sputum samples as a biomarker; and secondly, to explore whether exhaled carbon 
monoxide is a suitable biomarker for use in field studies. Finally, a case-control study of HIV-positive 
and HIV-negative Malawian adults was undertaken to establish the role of household air pollution, 
and other potential risk factors, in pneumonia.  
Results: Eight studies regarding household air pollution and acute lower respiratory tract infection 
were identified, reporting conflicting data and with limited study quality. The two methods used to 
calculate airway macrophage particulate load were lengthy, complex and unreliable. Exhaled carbon 
monoxide tests were easy to use and acceptable to participants in Malawi, but were subsequently 
found to not correlate with measured air pollution exposures.  145 (117 HIV-positive; 28 HIV-
negative) cases and 253 (169 HIV-positive; 84 HIV-negative) controls completed follow up in the 
case-control study. Household air pollution was not associated with pneumonia in HIV-positive (e.g. 
ambulatory particulate matter adjusted odds ratio [aOR] 1.00 [95% CI 1.00–1.01, p=0.141]) or HIV-
negative (e.g. aOR 1.00 [95% CI 0.99–1.01, p=0.872]) participants. Chronic respiratory disease was 
associated with pneumonia in HIV-positive (aOR 28.07 [95% CI 9.29–84.83, p<0.001]) and HIV-
negative (aOR 104.27 [95% CI 12.86–852.35, p<0.001]) participants. 
Conclusions: There is insufficient evidence in the existing literature to confirm an association 
between household air pollution and pneumonia in adults. Previous studies have been limited by 
methodological issues. To address these challenges, this thesis has added to the growing body of 
literature regarding biomarkers of household air pollution exposure. However, our finding suggest 
that neither airway macrophage particulate load nor exhaled carbon monoxide are well suited for 
use at scale in resource poor settings. This thesis reports the largest study of household air pollution 
and adult pneumonia to date, with detailed exposure and outcome assessments. Although the case-
control study sample size was not met, we found no evidence for an association between household 
air pollution and pneumonia in Malawian adults; further studies should be conducted to ensure that 
future public health resources are appropriately targeted. Broader solutions, including tackling 
poverty, malnutrition and chronic respiratory disease, will likely be required to reduce the burden of 
pneumonia in resource poor settings.   
vii 
 
List of abbreviations 
 
8-oxodG 8-oxo-7,8-dihydro-2’-deoxyguanosine 
AIDS Acquired Immunodeficiency Syndrome 
AIR Acute Infection of the Respiratory Tract Study 
ALRI Acute Lower Respiratory Tract Infection 
AM Airway Macrophages 
AMPL Airway Macrophage Particulate Load 
aOR Adjusted Odds Ratio 
ATS American Thoracic Society 
BAL Bronchoalveolar Lavage 
BASH-FLU Burden and Severity of HIV-associated Influenza Study 
BMI Body Mass Index 
BOLD Burden of Obstructive Lung Disease Study 
bpm beats/breaths per minute 
CI Confidence Interval 
CO Carbon Monoxide 
COPD Chronic Obstructive Pulmonary Disease 
CRD Chronic Respiratory Disease 
CURB Pneumonia severity score based on confusion, urea, respiratory rate and blood 
pressure 
viii 
 
CURB65 Pneumonia severity score based on confusion, urea, respiratory rate, blood 
pressure and age over 65 years 
DALYs Disability Adjusted Life Years 
DEP Diesel Exhaust Particles 
DNA Deoxyribonucleic Acid 
eCO Exhaled carbon monoxide 
ELISA Enzyme-linked Immunosorbent Assay 
EMAP II Endothelial Monocyte-activating Polypeptide-II 
FEV1 Forced Expiratory Volume in 1 second 
FVC Forced Vital Capacity 
HIV Human Immunodeficiency Virus 
HR Hazard Ratio 
IDSA Infectious Diseases Society of America 
Image SXM Digital image analysis software 
ImageJ Digital image analysis software 
IQR Interquartile Range 
ISAAC International Study of Asthma and Allergies in Children  
LSTM Liverpool School of Tropical Medicine 
MARISO Malawian Adult Lower Respiratory Tract Infection Severity, Aetiology and 
Outcome Study 
MDA Malondialdehyde 
ix 
 
MLW Malawi-Liverpool-Wellcome Trust Clinical Research Programme 
MOST Pneumonia severity score based on based on male sex, oxygenation, inability 
to stand and tachycardia. 
N/A Not applicable 
NHANES III The Third National Health and Nutrition Examination Survey  
OR Odds Ratio 
PCR Polymerase chain reaction 
PGP Proline-glycine-proline peptide 
PM Particulate Matter 
PM<0.1 Particulate Matter less than 0.1µm diameter 
PM10 Particulate Matter less than 10µm diameter 
PM2.5 Particulate Matter less than 2.5µm diameter 
ppm parts per million 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
QECH Queen Elizabeth Central Hospital 
RAGE Receptor for Advanced Glycation End products 
RCT Randomised Controlled Trial 
REC Research Ethics Committee  
RESPIRE Randomized Exposure Study of Pollution Indoors and Respiratory Effects Trial 
rpm revolutions per minute 
x 
 
SMRT-CO Pneumonia severity score based on systolic blood pressure, multilobar chest 
radiography involvement, respiratory rate, tachycardia, confusion, and 
oxygenation 
SOB Shortness of Breath 
SpO2 Peripheral capillary oxygen saturation 
SPSS Statistical software 
STD Standard Deviation 
TB Tuberculosis 
UCB-PATS University of California, Berkeley - Particle and Temperature Sensor  
UK United Kingdom 
USA United States of America 
USD United States Dollar 
WHO World Health Organization 
   
xi 
 
Table of contents 
 
HOUSEHOLD AIR POLLUTION AND ADULT PNEUMONIA IN MALAWI............................................... i 
Declaration ................................................................................................................................. i 
Acknowledgements ................................................................................................................. iii 
Publications related to work presented in this thesis ........................................................... v 
Abstract .................................................................................................................................... vi 
List of abbreviations ............................................................................................................... vii 
Table of contents...................................................................................................................... xi 
List of figures ......................................................................................................................... xviii 
List of tables ............................................................................................................................xix 
1. General Introduction ............................................................................................................ 1 
1.1. Chapter Preface ...................................................................................................................... 1 
1.2. Household air pollution .......................................................................................................... 1 
1.3. Pneumonia .............................................................................................................................. 5 
1.4. Study setting ........................................................................................................................... 6 
1.4.1. Malawi ............................................................................................................................. 6 
1.4.1.1. Blantyre ................................................................................................................... 7 
1.4.1.2. Ntcheu district ......................................................................................................... 7 
1.4.2. Queen Elizabeth Central Hospital ................................................................................... 8 
1.5. Thesis overview ....................................................................................................................... 9 
1.5.1. Thesis hypothesis ............................................................................................................ 9 
1.5.2. Key research questions ................................................................................................... 9 
1.5.3. Thesis Outline .................................................................................................................. 9 
2. Literature Reviews: Air Pollution and Pneumonia ................................................................ 11 
2.1. Chapter overview .................................................................................................................. 11 
2.2. Literature Review: Air Pollution ............................................................................................ 11 
xii 
 
2.2.1. Ambient air pollution .................................................................................................... 11 
2.2.1.1. Sources of ambient air pollution ........................................................................... 12 
2.2.1.2. Exposure to ambient air pollution ........................................................................ 12 
2.2.1.3. Constituents of ambient air pollution ................................................................... 12 
2.2.2. Occupational air pollution ............................................................................................. 13 
2.2.3. Household air pollution................................................................................................. 13 
2.2.3.1. Sources of household air pollution ....................................................................... 14 
2.2.3.2. Exposure to household air pollution ..................................................................... 15 
2.2.3.3. Constituents of household air pollution ............................................................... 16 
2.2.4. Tobacco smoke ............................................................................................................. 18 
2.2.5. Health effects of air pollution exposure ....................................................................... 19 
2.2.5.1. Health effects of ambient air pollution ................................................................. 20 
2.2.5.2. Health effects of occupational air pollution ......................................................... 22 
2.2.5.3. Health effects of household air pollution ............................................................. 23 
2.2.6. Measuring air pollution exposure ................................................................................. 28 
2.2.6.1. Particulate matter monitoring .............................................................................. 28 
2.2.6.2. Carbon Monoxide monitoring ............................................................................... 30 
2.2.6.3. Placement of air pollution monitors ..................................................................... 31 
2.2.6.4. Biomarkers of air pollution exposure.................................................................... 32 
2.2.7. Reducing exposure to air pollution ............................................................................... 35 
2.2.7.1. Reducing ambient air pollution exposure ............................................................. 35 
2.2.7.2. Reducing household air pollution exposure ......................................................... 35 
2.2.8. Household air pollution in Malawi ................................................................................ 38 
2.3. Literature review: Risk factors for pneumonia ..................................................................... 39 
2.3.1. Pneumonia .................................................................................................................... 39 
2.3.1.1. Definition and classification .................................................................................. 39 
2.3.1.2. Pathogenesis ......................................................................................................... 40 
2.3.1.3. Diagnosis .................................................................. Error! Bookmark not defined. 
xiii 
 
2.3.1.4. Management and prognosis ................................................................................. 42 
2.3.2. Risk factors for pneumonia ........................................................................................... 42 
2.3.2.1. HIV ......................................................................................................................... 43 
2.3.2.2. Tobacco smoke exposure ...................................................................................... 43 
2.3.3. Pneumonia in African adults ......................................................................................... 44 
2.3.3.1. Aetiology and prognosis of pneumonia in African adults ..................................... 44 
2.3.3.2. Risk factors for pneumonia in African adults ........................................................ 46 
2.3.4. Conclusion ..................................................................................................................... 46 
3. Systematic Review – Is household air pollution a risk factor for Acute Lower Respiratory Tract 
Infections in adults? ................................................................................................................... 47 
3.1. Introduction .......................................................................................................................... 47 
3.1.1. Objectives ...................................................................................................................... 47 
3.1.2. Contributors to this chapter ......................................................................................... 47 
3.2. Methods ................................................................................................................................ 48 
3.2.1. Eligibility criteria ............................................................................................................ 48 
3.2.1.1. Participants ........................................................................................................... 48 
3.2.1.2. Exposure ................................................................................................................ 48 
3.2.1.3. Outcomes .............................................................................................................. 49 
3.2.2. Search strategy.............................................................................................................. 49 
3.2.3. Data extraction.............................................................................................................. 51 
3.2.4. Quality assessment ....................................................................................................... 52 
3.2.5. Risk of bias assessment ................................................................................................. 52 
3.2.6. Data analysis ................................................................................................................. 52 
3.3. Results ................................................................................................................................... 52 
3.3.1. Summary of literature search ....................................................................................... 52 
3.3.2. Study designs ................................................................................................................ 53 
3.3.3. Study settings ................................................................................................................ 54 
3.3.4. Study participants ......................................................................................................... 54 
xiv 
 
3.3.5. Exposure assessments .................................................................................................. 54 
3.3.6. Outcome assessments .................................................................................................. 59 
3.3.7. Adjustment for confounders ......................................................................................... 59 
3.3.8. Effect estimates ............................................................................................................ 59 
3.3.9. Quality and Risk of Bias assessment ............................................................................. 60 
3.4. Discussion .............................................................................................................................. 61 
4. Exploring airway macrophage particulate load from induced sputum as a potential biomarker 
of air pollution exposure ............................................................................................................ 64 
4.1. Introduction .......................................................................................................................... 64 
4.1.1. Objectives ...................................................................................................................... 65 
4.1.2. Contributors to the chapter .......................................................................................... 65 
4.2. Methods ................................................................................................................................ 66 
4.2.1. Participant involvement ................................................................................................ 66 
4.2.2. Sputum induction .......................................................................................................... 66 
4.2.3. Sputum processing ........................................................................................................ 67 
4.2.4. Digital image acquisition ............................................................................................... 67 
4.2.5. Image SXM analysis ....................................................................................................... 68 
4.2.6. ImageJ analysis .............................................................................................................. 69 
4.2.7. Feasibility comparison of methods ............................................................................... 71 
4.2.8. Statistical analysis ......................................................................................................... 71 
4.2.9. Ethical approval ............................................................................................................. 71 
4.3. Results ................................................................................................................................... 71 
4.3.1. Sputum induction .......................................................................................................... 71 
4.3.2. Feasibility of methodology ............................................................................................ 72 
4.3.3. Airway macrophage particulate load ............................................................................ 75 
4.4. Discussion .............................................................................................................................. 77 
5. Exploring exhaled carbon monoxide as a potential biomarker of air pollution exposure: a 
feasibility study for a randomised controlled trial of a cookstove intervention in Malawi ............ 81 
xv 
 
5.1. Introduction .......................................................................................................................... 81 
5.1.1. Objectives ...................................................................................................................... 81 
5.1.2. Contributors to this chapter ......................................................................................... 81 
5.2. Methods ................................................................................................................................ 82 
5.2.1. Participants and setting ................................................................................................ 82 
5.2.2. Intervention .................................................................................................................. 82 
5.2.3. Randomisation .............................................................................................................. 83 
5.2.4. Blinding ......................................................................................................................... 83 
5.2.4.1. Primary outcome................................................................................................... 83 
5.2.4.2. Secondary outcomes ............................................................................................. 84 
5.2.5. Data collection .............................................................................................................. 84 
5.2.5.1. Household air pollution exposure assessments .................................................... 84 
5.2.5.2. Health assessments ............................................................................................... 84 
5.2.6. Sample Size ................................................................................................................... 84 
5.2.7. Compensation ............................................................................................................... 84 
5.2.8. Statistical Methods and Analysis .................................................................................. 85 
5.2.9. Ethical Approval ............................................................................................................ 85 
5.3. Results ................................................................................................................................... 85 
5.3.1. Recruitment .................................................................................................................. 85 
5.3.2. Randomisation .............................................................................................................. 85 
5.3.3. Retention....................................................................................................................... 86 
5.3.4. Baseline data ................................................................................................................. 86 
5.3.5. Exposure measurements .............................................................................................. 89 
5.3.6. Symptom Burden and Oxygen Saturations ................................................................... 90 
5.4. Discussion .............................................................................................................................. 90 
6. Household air pollution, chronic respiratory disease and pneumonia in Malawian adults: a 
case-control study ...................................................................................................................... 94 
6.1. Introduction .......................................................................................................................... 94 
xvi 
 
6.1.1. Objectives ...................................................................................................................... 94 
6.1.2. Integration with concurrent studies ............................................................................. 94 
6.1.3. Contributors to this chapter ......................................................................................... 95 
6.2. Methods ................................................................................................................................ 96 
6.2.1. Study design and setting ............................................................................................... 96 
6.2.2. Participants ................................................................................................................... 96 
6.2.2.1. Cases ..................................................................................................................... 96 
6.2.2.2. Controls ................................................................................................................. 98 
6.2.3. Study procedures .......................................................................................................... 99 
6.2.3.1. In-patient case assessment ................................................................................... 99 
6.2.3.2. Follow-up assessments ......................................................................................... 99 
6.2.4. Exposures of interest .................................................................................................. 100 
6.2.4.1. Primary exposures of interest ............................................................................. 100 
6.2.4.2. Secondary exposures of interest ......................................................................... 101 
6.2.5. Sample size .................................................................................................................. 102 
6.2.5.1. Recruitment targets ............................................................................................ 102 
6.2.6. Statistical considerations ............................................................................................ 102 
6.2.6.1. Interim analysis ................................................................................................... 104 
6.2.7. Ethical considerations ................................................................................................. 104 
6.3. Results ................................................................................................................................. 104 
6.3.1. Participant recruitment ............................................................................................... 104 
6.3.2. Hospital admission details for cases ........................................................................... 107 
6.3.2.1. Characteristics of confirmed pneumonia cases .................................................. 110 
6.3.2.2. Comparison of cases who completed follow up and those who did not ............ 111 
6.3.3. Characteristics of cases and controls .......................................................................... 111 
6.3.4. Air pollution exposure ................................................................................................. 122 
6.3.4.1. Air pollution monitoring ...................................................................................... 122 
6.3.4.2. Measured air pollution exposures ...................................................................... 122 
xvii 
 
6.3.4.3. Self-reported air pollution exposures ................................................................. 126 
6.3.4.4. Exhaled carbon monoxide ................................................................................... 132 
6.3.5. Chronic respiratory disease ........................................................................................ 132 
6.3.5.1. Spirometry........................................................................................................... 135 
6.3.6. Univariate analysis of potential risk factors ................................................................ 137 
6.3.7. Multivariate analysis of potential risk factors ............................................................. 138 
6.4. Discussion ............................................................................................................................ 139 
6.4.1. Recruitment and participant characteristics ............................................................... 139 
6.4.2. Pneumonia patient characteristics ............................................................................. 141 
6.4.3. Air pollution exposure ................................................................................................. 143 
6.4.4. Exhaled carbon monoxide ........................................................................................... 144 
6.4.5. Chronic respiratory disease ........................................................................................ 145 
6.4.6. Risk factors for pneumonia ......................................................................................... 147 
6.4.7. Strengths and weaknesses .......................................................................................... 148 
6.4.8. Conclusions ................................................................................................................. 150 
7. Discussion ........................................................................................................................ 152 
7.1. Thesis summary .................................................................................................................. 152 
7.2. Conclusions ......................................................................................................................... 154 
7.3. Future research priorities ................................................................................................... 155 
7.3.1. What is the burden of disease in adults caused by household air pollution exposure, 
and how can this be reduced? .................................................................................................... 155 
7.3.2. How can the burden of pneumonia in sub-Saharan Africa be reduced? .................... 156 
7.3.3. What is the impact of chronic respiratory disease in sub-Saharan Africa? ................ 156 
7.4. Public health and policy implications .................................................................................. 157 
8. References ....................................................................................................................... 158 
9. Appendix 1 – Liverpool Quality Assessment Tool ............................................................... 177 
 
xviii 
 
List of figures  
 
Figure 1-1: WHO map of deaths attributable to household air pollution from solid fuel use................................. 3 
Figure 1-2: World Bank map of global income. ...................................................................................................... 4 
Figure 2-1: The energy ladder: household energy and development are inextricably linked. .............................. 15 
Figure 2-2: Devices used for particulate matter air pollution monitoring. ........................................................... 30 
Figure 2-3: Devices used for carbon monoxide air pollution monitoring. ............................................................. 31 
Figure 2-4: Examples of types of improved cookstoves ........................................................................................ 36 
Figure 3-1: Systematic review PRISMA flow chart. ............................................................................................... 53 
Figure 4-1: Systematic digital image acquisition. ................................................................................................. 68 
Figure 4-2: Image SXM methodology. .................................................................................................................. 69 
Figure 4-3: ImageJ methodology. ......................................................................................................................... 70 
Figure 4-4: Participants and samples.................................................................................................................... 72 
Figure 4-5: An example of inaccurate Image SXM analysis. ................................................................................. 74 
Figure 4-6: An example of inconsistent SXM analysis. .......................................................................................... 75 
Figure 4-7: Airway macrophage heterogeneity. ................................................................................................... 76 
Figure 5-1: Cooking practices in rural Malawi ...................................................................................................... 83 
Figure 5-2: Consort flow diagram showing recruitment to the study, randomisation and loss to follow up. ...... 86 
Figure 5-3: Personal exposures to CO at baseline and at follow-up in four participants. ..................................... 89 
Figure 6-1: Participant flow chart showing the number of cases and controls screened, recruited, and followed 
up in the HIV–positive and HIV–negative sub-groups. ....................................................................................... 106 
Figure 6-2: Participant household locations. ...................................................................................................... 107 
Figure 6-3: Symptoms at presentation for all recruited cases ............................................................................ 109 
 
  
xix 
 
List of tables 
 
Table 2-1: Constituents of household air pollution and their mechanisms of actions and health effects (not 
exhaustive). ........................................................................................................................................................... 17 
Table 2-2: Pathophysiological molecules – potential biomarkers of household air pollution exposure. .............. 34 
Table 2-3: Definitions of pneumonia..................................................................................................................... 41 
Table 3-1: Summary of findings table for four studies investigating the effects of household air pollution on 
adult acute lower respiratory tract infections. ..................................................................................................... 55 
Table 3-2: Assessment of risk of bias, by four domains of methodology, using the Liverpool Quality Assessment 
Tool. ...................................................................................................................................................................... 60 
Table 4-1: Characteristics of 13 participants. ....................................................................................................... 73 
Table 4-2: Differential cell counts. ........................................................................................................................ 73 
Table 4-3: Comparison of resource requirements for methods. ........................................................................... 76 
Table 4-4: Airway macrophage particulate load results using Image SXM and ImageJ methodology. ................ 77 
Table 5-1: Baseline characteristics of study participants. ..................................................................................... 87 
Table 5-2: Participant household air pollution exposure at baseline. ................................................................... 88 
Table 5-3: Symptoms reported at baseline and follow-up. ................................................................................... 91 
Table 6-1: A priori potential confounders included in the multivariate logistic regression model. .................... 103 
Table 6-2: Reasons for ineligibility for potential cases and controls................................................................... 108 
Table 6-3: Baseline hospital data for all recruited cases. ................................................................................... 112 
Table 6-4: Participant characteristics for HIV-positive and HIV-negative cases and controls, and univariate 
analysis of the association between exposures and pneumonia. ....................................................................... 114 
Table 6-5: Measured ambulatory and household air pollution exposures in HIV-positive and HIV-negative cases 
and controls, and univariate analysis of the association between measured air pollution exposures and 
pneumonia. ......................................................................................................................................................... 123 
Table 6-6: Self-reported exposure to air pollutants in HIV-positive and HIV-negative cases and controls, and 
univariate analysis of the association between self-reported air pollution exposures and pneumonia. ............ 127 
Table 6-7: Chronic respiratory diagnoses, medications and symptoms in HIV-positive and HIV-negative cases 
and controls, and univariate analysis of the association between past respiratory health and pneumonia. .... 133 
Table 6-8: Spirometry findings in HIV-positive and HIV-negative cases and controls, and univariate analysis of 
the association between spirometry findings and pneumonia. .......................................................................... 136 
Table 6-9: Multivariate analysis of the effects of household air pollution exposure and chronic respiratory 
disease on pneumonia risk for HIV-positive and HIV-negative sub-groups. ....................................................... 139 
   
1 
 
1. General Introduction 
 
1.1. Chapter Preface 
The World Health Organization (WHO) estimates that 11.6% of all global deaths - 6.5 million deaths - 
in 2012 were associated with indoor or outdoor air pollution (1). The majority (92%) of people 
worldwide are exposed to levels of air pollution that exceed recommended limits, according to 
estimates by WHO generated using data from over 3000 locations around the world (1). Almost 90% 
of these deaths occur in low- and middle-income countries, and are the result of non-communicable 
diseases, such as chronic obstructive pulmonary disease (COPD), cardiovascular diseases and lung 
cancer, as well as infectious diseases, such as respiratory infections (1, 2). This thesis explores air 
pollution exposures and their adverse health effects, with a particular focus on pneumonia in the 
sub-Saharan African country of Malawi, where indoor air pollution from household solid fuel burning 
is high (3). In low-income countries like Malawi, pneumonia has high incidence and mortality rates 
(4-6). Identification of preventable risk factors for pneumonia, such as air pollution exposure, may 
help to alleviate this public health burden in the future.  
1.2. Household air pollution 
Three billion people worldwide are exposed to household air pollution each day due to a reliance on 
burning solid fuels for domestic energy purposes (2). Essential everyday activities, such as cooking, 
lead to toxic exposures for individuals – especially women in developing countries – who rely on 
polluting solid fuels due to poverty. It is women - who traditionally have responsibility for cooking - 
and the children they care for who are at most risk of the harmful effects of household air pollution.  
Deaths from household air pollution affect individuals living in poverty, as highlighted by the similar 
distributions shown for household air pollution deaths and low income in Figure 1-1 and Figure 1-2. 
According to the Global Burden of Disease study, household air pollution caused 2.9 million deaths 
in 2015 and is the eighth most important risk factor for disability adjusted life years (DALYs) 
worldwide, although this may be an underestimate due to lack of available data on the contribution 
of household air pollution to ambient air pollution (7). Household air pollution is thought to account 
for 12% of ambient particulate matter (PM) pollution (8). Globally, the number of deaths and DALYs 
caused by household air pollution are similar to that caused by ambient air pollution, but in sub-
Saharan Africa household air pollution is the major risk factor (9). In Malawi, household air pollution 
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is the fourth most important risk factor for DALYs, following unsafe sex, childhood undernutrition 
and unsafe water (7).  
These Global Burden of Disease study death and DALY estimates are based on models for the effects 
of household air pollution on stroke, ischaemic heart disease, COPD, lower respiratory tract 
infections and cataracts (10). Since the Global Burden of Disease study 2013, lower respiratory tract 
infections have been incorporated as an outcome for adults as well as children, although due to a 
paucity of data, the estimates for adults have been based on an integrated exposure-response curve 
using data for ambient air pollution and tobacco smoke (9, 11). An association between household 
air pollution and pneumonia in adults is biologically plausible given the known risk in children (12), 
and the known risk of adult pneumonia associated with ambient air pollution and tobacco smoke 
exposure (13, 14). However, the extrapolation of data by Global Burden of Disease study has 
limitations, as discussed below, and direct evidence for the effects of household air pollution would 
improve these estimates.  
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Figure 1-1: WHO map of deaths attributable to household air pollution from solid fuel use. 
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Figure 1-2: World Bank map of global income. 
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1.3. Pneumonia 
With an estimated 291 million incident cases per year (15), acute lower respiratory tract infections 
(ALRI) cause 2.7 million deaths (16) and the loss of 103 million DALYs per year (17). ALRI are the 
second leading cause of death worldwide for children under the age of 5, after pre-term birth 
complications (18). Although DALYs attributed to ALRI have fallen in the past decade, ALRI are the 
third leading cause of DALYs in all ages (17). Total mortality from ALRI has fallen slightly over the 
past decade (2.8 million in 2005 to 2.7 million in 2015) (16). Many ALRI deaths are attributable to 
pneumococcal and Haemophilus influenzae type B pneumonia, with 1.5 million and 60 thousand 
deaths per year in all age groups, respectively (16). Pneumonia is a disease that disproportionately 
affects people living in poverty, with the highest burden of disease seen in sub-Saharan Africa, South 
Asia and parts of Latin America.  
Data regarding the incidence of adult pneumonia are scarce for sub-Saharan Africa, but estimates of 
4 million adult ALRI episodes per year have been made using epidemiological models (19). 
Pneumonia is a common cause of adult admissions to hospital in Malawi: 17% and 16% of all adult 
medical admissions to Queen Elizabeth Central Hospital (QECH), Blantyre in 1973 (pre-Human 
Immunodeficiency Virus (HIV) era) and 2013 (in-patient HIV prevalence 26%) respectively (5, 20). 
Adult pneumonia mortality in sub-Saharan Africa varies between 6-14.5% (6, 21, 22). Although this 
figure is comparable to that seen in many European studies, a noticeably younger population is 
affected in sub-Saharan Africa with over 50% of adult deaths seen in under 35 year olds (6). ALRI are 
the third leading cause of DALYs in Malawi, following HIV infection and malaria (17). 
Pneumonia risk is increased up to 25-fold in individuals with HIV infection in the absence of 
antiretroviral therapy (23-26), and the risk of invasive pneumococcal disease is increased up to 100-
fold (27). Even with established ART, there is 35 times the risk of invasive pneumococcal disease in 
individuals with HIV compared to those without (28). In settings like Malawi, high HIV prevalence has 
a major impact on pneumonia incidence, management and treatment (29). Pneumonia in adults who 
are HIV-seropositive can commonly be complicated by HIV associated coinfections, in particular, 
tuberculosis. 
There are complex relationships between poverty, household air pollution, HIV infection and 
pneumonia risk. In Malawi - where all of these factors are highly prevalent - if an association 
between pneumonia and household air pollution is established, then the attributable risk of 
household air pollution for pneumonia is potentially high. If this is the case, reductions in household 
air pollution may provide an opportunity to address this preventable health burden in a vulnerable 
population. 
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1.4. Study setting 
1.4.1. Malawi 
Much of the work presented in this thesis was conducted in Malawi, in particular the studies 
described in Chapters 5 and 6. In this section, I describe some of the characteristics of Malawi and 
some of the issues faced by the country which have impacted on the research presented in this 
thesis. 
Malawi is a landlocked country situated in southern central Africa, a member of the Southern African 
Development Community. The country spans 118,484km2 along the Great Rift Valley, including 
Africa’s third largest lake – Lake Malawi. With an estimated population of 16.3 million people in 
2015 (30, 31), Malawi has a population density of 173 persons/km2(30). This is set to increase 
further, with an annual live birth rate of 651700 per year and an annual death rate of 147600 per 
year (32); the population is predicted to reach 37 million by 2050 (33). The majority (84%) of 
Malawi’s population live in rural areas, predominantly in the densely populated Southern Region.  
Life expectancy in Malawi has improved dramatically in recent years, mainly a result of 
improvements in child and maternal health, as well as the introduction of antiretroviral treatments 
for HIV infection. However, healthy life expectancy at birth is only 50 years and the under-five 
mortality rate is 68 per 1000 live births (32). Improvements in mortality from infectious causes have 
been made – although HIV/Acquired Immunodeficiency Syndrome (AIDS) and lower respiratory 
infections remain the two leading causes of death – but recent years have seen an increase in the 
number of deaths resulting from non-communicable diseases, including stroke and cardiovascular 
disease (32). National HIV prevalence is estimated to be 10.8% but this is as high as 17.4% in urban 
areas (34). Of those with HIV infection eligible to be on antiretroviral therapy in 2012, 69% were 
receiving treatment (35).  
Having fallen sharply in recent years, Malawi’s gross domestic product per capita in 2015 was $372, 
making Malawi the fourth lowest ranking country worldwide according to World Bank estimates 
(36). Of this gross domestic product, 8.3% is spent on health (35). Malawi’s national budget is heavily 
dependent on foreign aid, which is contingent on political stability: the consequences of this became 
apparent when aid was withdrawn following the “Cashgate” corruption scandal in 20131 (37). With 
61.6% of the population living below the poverty line (2007-2011, (34)) and the majority of 
                                                          
1 “Cashgate” was Malawi’s biggest financial scandal, with an estimated $250 million USD lost through allegedly 
fraudulent payments to businessmen. 
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individuals dependent on subsistence farming, families have little resilience when faced with 
additional challenges. This economic instability can have consequences such as national fuel 
shortages, which impacted on research activities for the pilot study described in Chapter 5.  Poor 
national infrastructure, particularly in rural areas, means that the country is especially vulnerable in 
the event of natural disasters. Two national emergencies have been declared in Malawi during the 
course of this PhD: the first following devastating flooding in 2015, which affected an estimated 1.1 
million people, displaced 230,000 people and destroyed much of the country’s harvest (38); the 
second following widespread drought in 2016, which resulted in a 96% reduction in maize 
production in the worst affected districts of the country (39), leaving 6.5 million people food 
insecure (40). These natural disasters impacted on the case-control study described in Chapter 6, by 
affecting participant recruitment rates. 
Given the lack of national infrastructure for providing energy solutions, and the lack of personal 
finances, 95% of Malawians depend on cheap solid fuels, such as wood and charcoal, for their 
domestic energy sources (3, 41). With rapidly increasing population growth, this puts Malawi’s 
natural resources under significant demand with deforestation already widespread across the 
country: solid fuels are not a sustainable solution for Malawi’s energy requirements. Solid fuel use, 
and the resultant air pollution exposure and health implications, are the focus of this thesis and will 
be discussed in more detail below.  
1.4.1.1. Blantyre 
The case-control study presented in Chapter 6 was conducted in Blantyre, Malawi’s second city. 
Whilst Lilongwe in the Central Region is the country’s political capital, Blantyre is the financial, 
commercial and manufacturing centre of Malawi and is located in the Southern Region. Blantyre City 
Council estimates a population of 884,000 overnight, rising to over 1 million during the day time as a 
result of a daily influx of workers (30). Between 60-75% of Blantyre’s population are estimated to 
live in informal settlements. The rainy season is from October to April and the dry season is from 
May to October, although “chiperoni” rains (light drizzle) occur from May to July (30). The Southern 
Region, including Blantyre, is mainly inhabited by people from the Chewa ethnic group, of the Bantu 
people. 
1.4.1.2. Ntcheu district 
130km north of Blantyre, along the border with Mozambique and halfway to Lilongwe, lies the rural 
district of Ntcheu in the Central Region of Malawi. Ntcheu town, where the pilot study described in 
Chapter 5 was conducted, is the administrative capital of the district and where Ntcheu District 
Hospital is located. The district has a population of approximately 475,000 in an area of 3,424km2 
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according to the 2008 Malawi population census. The inhabitants of Ntcheu are predominantly 
Ngoni people. The region is known for vegetable production.  
1.4.2. Queen Elizabeth Central Hospital 
QECH, Blantyre is a government-funded tertiary-referral hospital, the largest in Malawi with 
approximately 1200 beds. It is adjoined by a large medical school campus for the College of 
Medicine, University of Malawi. QECH provides healthcare free at the point-of-care to the 
population of greater Blantyre (population 1.3 million) and the surrounding districts, receiving 
referrals from community health centres and district hospitals.   
Adult patients are initially assessed by medical or clinical officer staff in the Adult Emergency and 
Trauma Centre. Patients requiring admission to the medical department will usually be assessed by 
the on-call medical team (intern or registrar, with possible review by the consultant) before transfer 
to one of two general medical wards (single-sex) or the tuberculosis ward. The general medical 
wards each have approximately 60 beds (although patient numbers frequently exceed 100, with 
mattresses on the floor provided for those without beds) in addition to a 6-bed high dependency 
unit, where increased nursing-ratios and supplementary oxygen via oxygen concentrators are 
available.  
Nurse staffing levels on the wards are generally low, with all of the patient’s personal care being 
provided by their ‘guardian’ (usually a friend or relative who has been appointed to care for the 
patient for the duration of their inpatient stay). General hygiene on the wards is poor, with frequent 
water shortages, broken lavatories, and lack of soap or disinfectant. Consultant-led ward rounds are 
conducted twice a week on all medical wards, with interim care provided by junior doctors, clinical 
officers or medical students. Basic radiological (x-rays, ultrasounds and limited magnetic resonance 
imaging) and laboratory (basic haematological and biochemistry blood tests, and tuberculosis 
screening) diagnostics are provided by the hospital or College of Medicine, but it is not uncommon 
for these to be unavailable due to broken equipment or lack of reagents. Routine microbiological 
diagnostics (including blood cultures and cerebrospinal fluid culture and analysis) are provided by 
the Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW) laboratories, which are 
located on the QECH site. Therapeutic options are limited to a relatively small number of essential 
medicines, which are in theory provided free of charge to the patient, but are frequently unavailable 
at the hospital pharmacy (including antibiotics, analgesia, cardiovascular medications and insulin). If 
the patient can afford to, they may be able to pay for diagnostic tests or medicines elsewhere in 
Blantyre, but for the majority of patients this is not an option. 
9 
 
1.5. Thesis overview 
1.5.1. Thesis hypothesis 
The aim of this thesis is to explore the respiratory health effects of household air pollution on adults 
– with a particular focus on pneumonia in Malawi – and some of the methodological issues 
surrounding research of household air pollution in a sub-Saharan African setting. The overarching 
hypothesis is that household air pollution is a preventable risk factor for pneumonia, which if 
confirmed, provides an opportunity to reduce the burden of disease in sub-Saharan Africa using 
interventions to reduce household air pollution exposure. This thesis also aims to evaluate the use of 
field biomarkers for household air pollution exposure which will improve capacity to conduct future 
exposure and intervention studies. 
1.5.2. Key research questions 
This thesis addresses the following key research questions: 
 Is research of household air pollution and its’s health effects feasible in Malawi, and what 
lessons can we learn to improve research implementation? 
 Is there a biomarker of household air pollution that is practically useful in a sub-Saharan 
African setting? 
 What is the existing evidence of an association between household air pollution and 
pneumonia in adults? 
 What are the levels of exposure to air pollution in urban Malawi? 
 Is household air pollution a risk factor for pneumonia in adults in Malawi, and what are the 
other potentially avoidable risk factors? 
1.5.3. Thesis Outline 
The global burden of pneumonia and of air pollution exposures have been outlined in this 
introductory chapter; this thesis focuses on these two important issues by exploring the relationship 
between pneumonia in adults and their exposure to household air pollution. Chapter 2 provides a 
review of the existing evidence for the health effects of air pollution and of current understanding 
regarding the risk factors for pneumonia. This is followed by a more detailed systematic review 
focusing on the evidence of an association between household air pollution and ALRI in adults in 
Chapter 3. Chapters 4 and 5 explore some of the issues regarding conducting research on this topic: 
firstly, reporting on the findings of a feasibility study regarding the implementation of a household 
air pollution intervention trial, and secondly, regarding the challenges of developing field-usable 
biomarkers of exposure with a focus on airway macrophage particulate load. Chapter 6 reports on 
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the findings of a case-control study in Malawi, examining potentially avoidable risk factors for 
pneumonia in urban dwelling adults, with a particular focus on the role of air pollution exposure. The 
thesis concludes with a summary of these findings, and a discussion of the implications for future 
public health interventions and research. 
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2. Literature Reviews: Air Pollution and Pneumonia 
  
2.1. Chapter overview 
In this chapter, I summarise the current literature for the two major topics of this thesis: air pollution 
and pneumonia.  
Air pollution is the fourth most important risk factor for DALYs worldwide (7), the exposure of 
interest in this thesis and the focus of the first section of this chapter. Firstly, I provide background 
information regarding different types of air pollution – including their sources, constituents and 
factors affecting exposure – and then discuss the health risks associated with air pollution exposure. 
This is followed by an overview of the factors to be considered when measuring air pollution 
exposure and air pollution reduction strategies. Ambient, occupational and household air pollution, 
as well as tobacco smoke exposure, have each been demonstrated to be associated with poor health 
outcomes, and so are discussed in turn in this section. However, given the heavy reliance of solid 
fuels in Malawian homes as discussed above, and the relative lack of industrialisation or heavy traffic 
in Malawi, the major focus of this and subsequent chapters will be household air pollution. 
In the second section of this chapter, I summarise literature regarding pneumonia, the disease 
outcome of interest in this thesis, which results in the death of 2.7 million adults and children per 
year (16). I provide a background details regarding the pathogenesis, classification and prognosis of 
pneumonia. I then summarise the current evidence regarding risk factors for community acquired 
pneumonia, and provide an overview of the limited literature describing pneumonia in adults in sub-
Saharan Africa.  
2.2. Literature Review: Air Pollution 
2.2.1. Ambient air pollution 
Ambient air pollution, which refers to outdoor air pollution, has long been associated with significant 
health problems. The infamous Great Smog of London 1952, which was later estimated to have been 
responsible for the death of 12,000 people (42), provided the impetus for modern environmental 
and public health research and legislation with the aim of improving air quality. Despite these 
measures, the WHO recently estimated that 3 million premature deaths occur annually worldwide as 
a result of continuing air pollution (43). The impact of ambient air pollution is therefore a major 
cause of concern worldwide and has been a topic of extensive research over recent decades.  
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2.2.1.1. Sources of ambient air pollution 
Ambient air pollution, which is primarily caused by transport engines, industrial emissions, burning 
of biomass and natural sources, is typically highest in urban areas.  
Particulate matter (PM) can be classified according to their mode of formation: primary PM are 
emitted directly from their source into the air; secondary PM are formed from gaseous precursors 
such as sulphur dioxide, nitrogen oxides and ammonia. Both primary and secondary PM can occur 
from man-made sources (anthropogenic) – such as combustion engines, solid fuel combustion for 
household or industrial purposes, agriculture, mining and manufacturing of bricks, cement or 
ceramics – or from natural sources (non-anthropogenic), including dust storms, forest fires and 
volcanic eruptions. Dust and soil re-suspension contribute to PM in particularly arid areas. Diesel 
engines produce up to 40 times more PM10 (particulate matter <10µm diameter) than petrol engines 
with catalytic converters of a similar power (44). Although engines have become more efficient, the 
number of miles travelled by trucks - major contributors to ambient PM - rose from 28,854 million to 
170,246 million between 1960 and 2015 in the USA, thus highlighting ongoing difficulties with traffic 
pollution (45).  
Ozone is formed by a photochemical reaction between sunlight and pollutants such as nitrogen 
oxides or volatile organic compounds, and so occurs at high levels during sunny periods. Nitrogen 
dioxide and sulphur dioxide are primarily generated by fossil-fuel combustion, for power generation, 
domestic heating and vehicle engines. 
2.2.1.2. Exposure to ambient air pollution 
More than 80% of people living in urban areas with air pollution monitoring are exposed to air 
pollution levels that exceed WHO guidelines; in low- and middle-income countries the situation is 
worse, with 98% of cities with more than 100,000 inhabitants not meeting WHO air quality 
guidelines (46). Much of this burden is in Asia, but parts of southern sub-Saharan Africa are also 
severely affected (46). In Asian cities selected by the WHO, annual average suspended PM 
concentrations ranged between 35-220g/m3, compared to 15-60g/m3 in European and North 
American cities (47).  
2.2.1.3. Constituents of ambient air pollution 
Ambient air pollution consists of a complex mix of gaseous, liquid suspensions and PM. Four classical 
indicators of pollution - PM, nitrogen dioxide, sulphur dioxide and ozone - are most commonly 
studied, and each demonstrate differing trends which are used to characterise air quality (47).   
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PM, which consists of a mixture of solid and liquid particles, has been shown to affect more people 
worldwide than any other kind of pollution (43).  PM2.5 (particulate matter <2.5µm diameter) 
constitutes 50-70% of PM10 across most of Europe (48).  The constituents of PM vary greatly by 
geographical setting, as different sources of PM generate different chemical compositions (49): for 
example, high black carbon content in PM generated from coal fired power stations, high “crustal 
matter” in re-suspended desert sand, and diesel exhaust particles (DEP) form a major proportion of 
PM from vehicular emissions (50). 
2.2.2. Occupational air pollution  
Individuals exposed in the workplace to airborne contaminants, which may be aerosols (including 
airborne dusts, mists, fumes and smoke) or gaseous (gases or vapours), are at risk of occupational 
disease. Globally, a wide variety of occupations lead to such exposures, resulting in acute and 
chronic diseases or death, as well as a significant economic burden to employers and society. Many 
countries have implemented strict regulation of workplace exposure to a number of hazardous 
agents, and prevention of exposure can often be low-cost. Despite this, workplace exposures remain 
high and unregulated in many parts of the world, leaving vulnerable workers at risk of occupational 
diseases.  
Airborne dust is generated by a variety of occupations, such as: mineral dusts (including silica) from 
mining quarrying and construction; metallic dusts from manufacturing or metal-industry; chemical 
dusts in agriculture, manufacturing and pharmaceutical industries; vegetable dusts from agriculture 
and food processing, and moulds and spores from farming and food industries. Airborne dusts are 
solid particles with an aerodynamic diameter of less than 100µm, which can be inhaled. Non-soluble 
dust particles deposited in the airways may cause a local reaction: the depth of inhalation, and 
therefore site of reaction, will depend on the size of the particle and breathing pattern. Soluble 
particles, for example lead, may dissolve where it is deposited and be absorbed into the blood 
stream causing systemic disease. Airborne dusts are known to cause occupational asthma, COPD and 
pneumoconiosis, a range of restrictive lung diseases characterised by inflammation and fibrosis.  
2.2.3. Household air pollution  
Household air pollution refers to the presence of airborne pollutants inside the home resulting from 
the burning of fuel for domestic purposes. Almost half the world’s population are exposed to 
household air pollution, usually a result of poverty leading to reliance on cheap but polluting fuels 
(2). Between 3 and 4 million deaths per year are thought to be caused by exposure to household air 
pollution due to the effect on a wide range of diseases (9, 51): the evidence for this, and details 
regarding specific disease associations, are discussed in section 2.2.5.3. In this section, I describe an 
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overview of household air pollution including the major sources, factors which effect exposures and 
the chemical composition of household air pollution. 
In addition to the health effects of household air pollution (discussed in section 2.2.5.3.), there are 
other important consequences of using solid fuel for cooking. Deforestation as a result of using 
firewood or charcoal for domestic energy is a major problem in many countries, leading to changes 
in animal and plant habitats (which may impact on food sources), soil erosion (increasing the risk of 
landslides) and climate change (52). Fuel gathering is time consuming, resulting in less time for 
education or economic activities (51). As it is often women or children who are responsible for fuel 
gathering, it is women and children who are deprived of schooling and business opportunities. They 
are also vulnerable to physical attacks when walking long distances from their home to find fuel (52).   
2.2.3.1. Sources of household air pollution 
Any form of domestic energy consumption, whether it be for cooking, heating or lighting, can lead to 
household air pollution if polluting fuels are used, but it is cooking that requires the most fuel 
consumption worldwide. Household air pollution is usually a result of burning solid fuels, such as 
biomass fuels (including wood, charcoal, plant matter and animal dung) or coal, but may also be 
caused by burning liquid fuels including kerosene or paraffin.  
Choice of fuel for any given household depends on a variety of factors: cost, tax and subsidies, local 
availability, energy requirements, household characteristics, cooking behaviours, cultural traditions, 
and knowledge (53). Fuel use therefore varies widely across different populations in different 
geographical settings and seasons. For example, coal use is extremely common in China, wood 
burning is common in much of rural sub-Saharan Africa and Latin America, whereas charcoal is most 
commonly used in many sub-Saharan African cities. In parts of Asia (including India) and parts of 
northern Africa, pastoralist communities use dried animal faeces – often cow or buffalo dung – to 
make ‘dung cakes’, known as chulha or uple, as a cheap and readily available form of bio-fuel. 
Cost of fuel plays a key role in determining fuel use, with the trade-off for an affordable price being 
the quality and “dirtiness” of a fuel: generally the cheaper a fuel is, the more polluting it is. As a 
consequence, it is the world’s poorest populations who are exposed to the highest levels of air 
pollution as they rely on dirty fuels with poor combustibility. As prosperity increases, fuel use 
becomes cleaner, as shown in the Energy Ladder (Figure 2-1) (54); electricity at the top of the ladder 
causes no household pollution at the point of use, but is only available to the richest of the world’s 
population.  
15 
 
 
Figure 2-1: The energy ladder: household energy and development are inextricably linked.  
Adapted from Rehfuess, WHO, 2006 (55). 
Household air pollution may also result from sources other than combustion fuels, such as the 
burning of mosquito coils or incense sticks. Around 2 billion people burn mosquito coils worldwide, 
particularly in developing countries, to prevent bites from mosquitoes (56). It is estimated that 
burning a mosquito coil can release PM2.5 equivalent to burning 75-137 cigarettes (57), which can 
result in a range of respiratory effects (58). Incense is typically burnt for religious or ceremonial 
reasons in many developing countries, resulting in the release of a variety of pollutants known to 
cause harm, although the evidence for respiratory health effects is inconsistent (58). 
2.2.3.2. Exposure to household air pollution 
In addition to choice of fuel, an individual’s exposure to household air pollution is dependent on a 
number of other factors: cooking behaviours, stove type, food choices, ventilation and season (59). 
Due to traditional domestic roles in many parts of the world, it is women and children who are most 
exposed to household air pollution (60). In many cultures, it is women who are responsible for both 
cooking and childcare, so whilst the mother is tending the fire the young child is playing close by or is 
being carried on the mother’s back.  
The type of stove or fire used to burn the fuel also affects an individual’s exposure. An open or 
“three-stone” fire (an open fire is built in between 3 large stones, which are used for resting the 
cooking pot on) is the traditional cooking method in many parts of the world (60). However, this is 
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an inefficient way of burning fuel, as much of the heat is lost via the open sides of the fire and the 
airflow cannot be controlled to maximise combustion efficiency. Inefficient combustion leads to 
higher levels of waste product emissions, and longer cooking times are required due to the amount 
of energy being lost, prolonging the periods of exposure to pollution (61). Combustion efficiency can 
be improved by using designed technology, such as a cookstove. Many cookstove designs are 
available, from simple locally produced clay stoves to fan-assisted stoves, each of which have their 
own advantages and disadvantages and are described in more detail in section 2.2.7.2. A 
household’s choice of cookstove will depend on the type of food that is typically cooked and cultural 
cooking practices – such as a preference for roasting, boiling, steaming or stewing -  as well as the 
cost and availability of the stove itself (62, 63).  
Ventilation and seasonal variations in weather also play a role in exposure (62). In some parts of the 
world, exposure may be lower during the dry season as individuals are more likely to cook outdoors 
than in the rainy season, or exposure may be higher during cold seasons when fuel is burnt indoors 
for heating. If cooking indoors, an individual’s exposure to household air pollution is affected by the 
design of the house, and whether or not the stove has a chimney or flue. Maintenance of chimneys 
is also required and if neglected can lead to high levels of household air pollution. House design 
varies according to socioeconomic status, geography and climate, but often cooking in the simplest 
mud and thatch homes is performed in small rooms with few windows or doors for ventilation, and 
no chimney (64). In very poor communities, the cooking may take place in the same room where the 
family live and sleep, meaning that pollution exposure is high throughout the day and night. In some 
populations, households prefer to cook indoors as the smoke prevents insects from living inside the 
thatched roof. Ventilation may also be deliberately reduced to conserve energy, particularly in cold 
climates.  
Other behavioural factors also play a role in exposure, such as cooking practices (for example, using 
a lid on a cooking pot will reduce cooking time and therefore exposure), time spent near the fire, 
and drying of fuel before use. Exposure to kerosene pollution has been shown to be higher for men 
in some communities, where men socialise together in the evenings, around a burning kerosene 
light, away from the women (65). Men are also typically exposed to household air pollution when 
they are working away from their home, and therefore take over responsibility for cooking. 
2.2.3.3. Constituents of household air pollution 
Pollution resulting from the burning of fuels comprises of a complex mixture of solid, liquid vapour 
and gaseous constituents, including PM, inorganic gases, hydrocarbons, free radicals, chlorinated 
organics and oxygenated organics (66). The relative proportions of the constituents of pollution vary 
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according to the fuel type, fuel quality (e.g. moist wood vs dry wood) and the combustion 
conditions. Over 200 distinct organic compounds have been detected in wood smoke (67). Many 
components of household air pollution – some of which are listed in Table 2-1 – are known to be 
toxic or irritant to humans, although there is insufficient evidence to know which specific  
Table 2-1: Constituents of household air pollution and their mechanisms of actions and health 
effects (not exhaustive). 
Adapted from Bruce et al, 2006, Naeher et al, 2007 and Fullerton, 2011 (60, 66, 68). 
 
Pollutant Mechanism Potential health effects 
Particulate matter (PM10 and 
PM2.5) 
 Acute: bronchial irritation and 
increased reactivity, 
inflammation 
 Reduced mucociliary clearance 
 Reduced macrophage 
response and reduced local 
immunity 
 Oxidative stress 
 May be allergenic 
 Wheezing, exacerbation of 
asthma 
 Chronic bronchitis and COPD 
 Exacerbation of COPD 
 
Carbon Monoxide  Binding with haemoglobin to 
produce carboxyhaemoglobin, 
resulting in tissue hypoxia and 
cellular death 
 Asphyxiant 
 Neurotoxicity  
 Low birth weight 
 Increased perinatal deaths 
Hydrocarbons e.g. polycyclic 
aromatic hydrocarbons (e.g. 
benzo[a]pyrene) 
 Carcinogenic 
 Mutagenic 
 Irritant 
 Lung upper respiratory cancers 
 Cardiovascular disease 
 
Nitrogen dioxide  Irritant 
 Acute exposure increases 
bronchial reactivity 
 Longer term exposure 
increases susceptibility to 
bacterial and viral lung 
infections 
 Wheezing and exacerbations 
of asthma 
 Respiratory infections 
 Reduced lung function in 
children 
 Acute or chronic bronchitis 
Sulphur dioxide  Acute exposure increases 
bronchial reactivity 
 Longer term difficult to 
dissociate from effects of 
particles 
 Wheezing and exacerbations 
of asthma 
 Exacerbation of COPD and  
cardiovascular disease 
Condensates including polycyclic 
aromatics and metal ions 
 Absorption of toxins into 
ocular lens leading to oxidative 
changes 
 Cataract 
Oxygenated organics e.g. 
aldehydes, phenols 
 Irritant 
 Carcinogenic 
 Mutagenic 
 Teratogenic 
 Bronchoconstriction 
PM10: particulate matter <10µm diameter; PM2.5: particulate matter <2.5µm diameter; COPD: chronic obstructive 
pulmonary disease. 
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components are responsible for the disease burden caused by household air pollution, and that may 
vary according to the disease (60).  
Carbon monoxide (CO) and nitrogen dioxide are two of the principal gaseous components of 
household air pollution, and are known to have harmful effects.  PM are thought to be an important 
indicator for the health effects of pollution (60), and are classified by their size. PM10 are PM with a 
diameter of less than 10µm, PM2.5 have a diameter of less than 2.5µm, and PM<0.1 are “ultrafine 
particles” with a diameter below 0.1 µm. The smaller the size of the particle, the greater its potential 
to cause adverse health effects: it remains airborne for longer; the small size allows deeper 
inhalation into the lungs, evading the mucociliary defence system; and the large surface area-to-
mass ratio means that more toxic compounds can be absorbed onto the surface of the carbonaceous 
core (43). However, this size classification does not take into consideration the chemical composition 
of PM, which varies according to the specific fuel type and combustion conditions (66). It is 
important to note that much of the evidence for the health effects of PM is derived from evidence 
for fossil fuel combustion: the composition of biomass fuel PM differs to that of fossil fuel PM and 
therefore the impact on health may also be different. Not only does the relative proportion of PM of 
different sizes vary depending on the combustion source, but there are also enormous number of 
possible chemical species associated with the particles which can be used to distinguish between 
sources (69). For example, particles derived from fossil fuels with a high mass of aluminium, chloride, 
and chromium are likely to be derived from fossil fuel combustion, whereas high potassium, 
ammonium and sulphate content is associated with biomass burning (70).  
2.2.4. Tobacco smoke 
Given the relatively low prevalence of cigarette smoking and relatively high prevalence of household 
air pollution exposure in Malawi (41), tobacco smoke is not a major focus of this thesis. However, 
tobacco smoke is an important confounder in studies of the health effects of pollution exposure. 
Furthermore, the wealth of evidence for the health risks of tobacco smoke has played an important 
role in informing the literature on household air pollution. For these reasons, some key details 
regarding tobacco smoke are included here but further detail is beyond the scope of this chapter. 
Global Burden of Disease study 2015 estimates that 6.4 million people die per year as a result of 
tobacco smoke, which is the 2nd and 9th most important risk factor for DALYs worldwide, in men and 
women respectively (7). Approximately 10% of deaths are in non-smoking individuals who are 
exposed to second-hand tobacco smoke (71). Active and passive exposure to tobacco smoke is well 
documented to be associated with a wide range of adverse health effects, including respiratory tract 
infections (such as pneumonia and tuberculosis), chronic respiratory diseases (such as COPD, 
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bronchiectasis and exacerbations of asthma), numerous cancers and cardiovascular diseases (7). 
Tobacco smoke exposure is the single most important risk factor for pneumonia in 
immunocompetent adults (72), and possible mechanisms include structural changes to the 
respiratory tract and impaired cell-mediated and humoral immune responses (73). Of the world’s 1 
billion smokers, 80% live in low- and middle-income countries (71). However, in a recent study in 
urban Malawi, only 10% of adults reported ever smoking (9.2% of men and 0.7% of women were 
current smokers), and only 2% of adults reported a pack-year history of 10 years or more (41). 
According to the Malawi Demographic and Health Survey 2015-16, 0.1% of women (age 15-49 years) 
and 11.9% of men (age 15-49 years) in urban areas in Malawi smoke cigarettes (74). Smoking 
increases with age; the highest prevalence of cigarette smoking in women is in 45-49 year olds, and 
in men it most common in 40-44 year olds. For both genders, smoking is most common amongst 
those in the lowest socioeconomic quintile and with no education. Amongst the 7.9% of men in 
urban areas who smoke cigarettes daily, 41% smoke less than 5 cigarettes per day and none smoke 
more than 24 cigarettes per day. The overall prevalence of smoking in Malawi (aged 15-49 years, 
rural and urban) has decreased from 23% in 2000 to 13% in 2015-16, which is in contrast to the 
concerning epidemic of increasing smoking prevalence which is currently seen Africa (74, 75). It is 
important to keep monitoring these trends in Malawi to ensure that exposure to this known risk 
factor for mortality does not increase as has been seen elsewhere in Africa. 
Tobacco smoke is essentially a form of biomass smoke, and combustion of this plant matter 
generates PM and other pollutants including irritant gases, similar to those found in household air 
pollution. It is likely that there will be some differences in health effects between tobacco smoke 
exposure and other biomass smoke exposures due to variation in the exact chemical composition of 
the combustion products and the differences in the mode of exposure. Nonetheless, in the absence 
of specific data regarding other forms of biomass, knowledge of tobacco smoke exposures provide 
useful insight into the potential health effects of household air pollution (10). It is thought that the 
health risks of household air pollution lie somewhere between the risks of active and passive 
tobacco smoking. 
2.2.5. Health effects of air pollution exposure 
In this section, I describe the current evidence for the health effects of the main sources of air 
pollution, with a focus on respiratory and cardiovascular disease – the major outcomes of interest 
for air pollution exposure. I predominantly describe the epidemiological evidence and, for 
pneumonia (the focus of this thesis), I also provide an overview of studies of mechanisms of disease.  
The health effects of each type of air pollution exposure are described separately here as, although 
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similar and overlapping, the health effects are distinct from each other due to the differences in 
pollution constituents and exposures, as discussed above.  
2.2.5.1. Health effects of ambient air pollution 
There has been a wealth of evidence documented for the health effects of ambient pollution in 
recent decades, particularly since the London Smog 1952, which has led to widespread efforts to 
reduce ambient air pollution exposures. Despite this,  3 million premature deaths were estimated to 
be caused by ambient air pollution in 2012, according to the WHO, with 88% of deaths occurring in 
low- and middle-income countries (43). The WHO estimates that ischaemic heart disease and strokes 
are responsible for 80% of ambient air pollution deaths, followed by COPD and ALRI infections (14%), 
and lung cancer (6%) (43). 
Early daily time-series studies showed a strong correlation between daily PM levels and mortality in 
London and several United States of America (USA) cities (76-78). Following this work, an important 
study in six USA cities confirmed this association even when controlling for independent risk factors 
such as sex, age, cigarette smoking, comorbidities, occupation, body mass index (BMI) and 
educational background (79). Schwartz et al. found a stronger association between daily mortality 
and PM2.5, such as combustion-related particles, than with PM10 (80).  A more recent meta-analysis 
confirmed the association between PM2.5 and all-cause mortality: a 10µg/m3 increase is associated 
with a 1.04% (95% Confidence Interval (CI) 0.52% - 1.56%) increased risk of death (81). As a result of 
PM2.5 pollution, life expectancy in the European Union is estimated to be reduced by 8.6 months 
(43). 
Respiratory disease 
Chronic respiratory diseases, particularly obstructive airways disease such as asthma and COPD, and 
acute respiratory infections have been associated with ambient air pollution in ecological, 
observational and experimental studies, as described here.  
Studies of children living nearby to areas with heavy traffic have shown a positive association 
between exposure to lorry traffic and symptoms of asthma and rhinitis, such as wheeze and 
persistent phlegm, as well as an increased occurrence of bronchitis, bronchiolitis and pneumonia 
and decreased lung function (82-84). Admissions to hospital for bronchitis and asthma are strongly 
associated with monthly ambient levels of PM10, especially in children (85). Associations between 
daily levels of PM10 and decreased peak expiratory flow rate, symptoms of respiratory disease, and 
use of asthma medication have been shown (86, 87). Dockery et al. summarised multiple studies and 
concluded that with each 10g/m3 increase in PM10, respiratory deaths, emergency department 
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visits due to respiratory disease, lower respiratory symptoms and asthma attacks increased by 3.4%, 
1.0%, 3.0% and 3.0% respectively (88). 
Studies of both healthy and asthmatic human subjects using exposure chambers have shown that 
airway hyper-responsiveness and airway resistance are increased following exposure to DEP (89-91). 
Changes in pulmonary function tests following exposure to traffic pollution were markedly worse in 
subjects with moderate asthma compared to mild, suggesting that DEP has a more damaging effect 
in humans with already compromised lung function (92).   
Long term exposure to total levels of suspended particles have also been shown to increase 
symptoms of COPD and reduce lung function (forced vital capacity (FVC) and forced expiratory 
volume at one second (FEV1)) in adults (93, 94). A UK cohort study of 16,000 patients found limited 
evidence for an association between ambient air pollution exposure and COPD incidence or COPD-
related hospital admissions (95). A meta-analysis found no significant increased risk of COPD 
prevalence with PM exposure (pooled estimate from 3 studies; OR 1.11, 95% CI 0.93-1.31) but did 
find a significant association between COPD mortality and PM exposure (pooled estimate from 14 
studies; OR 1.03, 95% CI 1.02-1.05) (96). However, some studies have found an association between 
COPD prevalence and PM exposure (97, 98). Given the chronicity of disease development in COPD, it 
is difficult to establish a causal relationship between ambient air pollution and COPD: further large 
studies with long-term follow up and carefully defined exposures are required to clarify the 
relationship (99). 
A meta-analysis of 10 European birth cohorts estimated pollution exposure in over 16,000 children 
(aged 0-2 years) and found an increased risk of pneumonia with PM10 exposure (adjusted OR 1.76, CI 
1.00-3.90, p=0.051) and nitrogen dioxide exposure (Odds Ratio (OR) 1.3, CI 1.02-1.65, p=0.024), but 
found no statistically significant association with PM2.5 (100). It is unclear whether pre-natal or post-
natal exposure is most crucial in childhood pneumonia risk, but a study in Poland demonstrated that 
pre-natal exposure to ambient PM2.5 leads to reduced birth weight, and subsequent increased risk of 
bronchitis and pneumonia (101). 
Cardiovascular and other diseases 
There is strong epidemiological evidence for an association between ambient air pollution and 
cardiovascular disease. A meta-analysis found several air pollutants increased the risk of myocardial 
infarction (102). There are short-term associations between PM2.5 levels and increased 
cardiovascular deaths and hospital admissions for heart rhythm disturbances, cerebrovascular 
events, ischaemic heart disease, peripheral vascular disease and heart failure have been found in a 
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nationwide study in the U.S., with the latter having the strongest association (103, 104). The 
increased cardiovascular risk may in part be explained by evidence for increased blood coaguability 
in healthy subjects following short term increases in ambient PM10 levels (105).   
Epidemiological studies have also linked outdoor air pollution to Type 2 Diabetes Mellitus: air 
pollution exposure may increase the risk of developing Type 2 Diabetes Mellitus, and individuals 
with Type 2 Diabetes Mellitus may be more susceptible to the effects of air pollution (106). Several 
mechanisms for this have been proposed, including endothelial dysfunction, elevated systemic 
inflammation and cardiac autonomic nervous system dysfunction. 
2.2.5.2. Health effects of occupational air pollution 
Although occupational air pollution is not the focus of this thesis, it is briefly described here as it an 
important cause of respiratory disease that is distinct from other exposures in several ways; at risk 
population, pathologies and the economic and legal implications.  
In industrialised countries, occupational asthma is thought to be the most common work-related 
respiratory disease (107) and occupational exposures are thought to account for approximately 15% 
of all adult asthma (108). Over 250 airway-sensitizing substances have been documented to cause 
allergic occupational asthma (109), yet due to the multi-factorial nature of asthma it can often be 
difficult to identify a specific causative agent.  
Occupational exposures account for an estimated 14-15% of the population attributable fraction of 
COPD with a wide range of occupations implicated (108, 110), although studies are often 
confounded by cigarette smoke exposure.  
Three dusts are mainly responsible for the global burden of pneumoconiosis: silica, asbestosis and 
coal dusts cause silicosis, asbestosis and coal workers’ pneumoconiosis respectively. The burden of 
these diseases has declined in developed countries, due to regulation of industrial exposure, but 
pneumoconiosis remains an important occupational lung disease in many parts of the developing 
world. Unlike asthma and COPD, the pneumoconioses are essentially only caused by occupational 
exposures, and therefore the attributable fraction is assumed to be 100% (111). The Global Burden 
of Disease 2010 study estimated there were 125,000 deaths per year caused by pneumoconiosis 
worldwide (112).  
There is also a large number of recognised occupational carcinogens (113). For example, asbestosis 
exposure is known to cause mesothelioma and lung cancer (114); pulp and paper mill workers are at 
an increased risk of lung cancer, lymphoma and leukaemia (115); metal compound inhalation is 
associated with lung cancer (116); workers exposed to wood-dust (for example, carpenters and 
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loggers) are at risk of upper and lower respiratory tract, gastrointestinal and haematological 
malignancies (117); and fire-fighters are exposed to a large number of airborne carcinogens, 
increasing their risk of haematological malignancies, and brain, bladder and lung cancers (118). 
Exposure to airborne pollutants in the work-place is also associated with cardiovascular disease. A 
study of almost 250,000 Swedish construction workers found that exposure to any occupational 
particulate air pollution was associated with an increased risk of ischaemic heart disease (relative 
risk 1.13, 95% CI 1.07-1.19), with the highest risk being associated with exposure to diesel exhaust 
(relative risk 1.18, 95%CI 1.13-1.24) (119). However, no significantly increased risk of 
cerebrovascular disease was identified.  
2.2.5.3. Health effects of household air pollution 
Household air pollution is the eighth most important risk factor for global DALYs according to the 
Global Burden of Disease Study in 2015 (9). This is predominantly due to cardiovascular diseases, 
chronic respiratory diseases, respiratory infections and neoplasms. Global Burden of Disease study 
2013 estimates nearly 3 million premature deaths a year are a result of household air pollution, but 
the WHO estimates this figure is closer to 4 million (51). Due to the lack of available data for the 
specific effects of household air pollution, morbidity and mortality estimates for Global Burden of 
Disease study 2013 are derived from an integrated exposure-response curve using data for ambient 
air pollution and tobacco smoke exposures (9). In this section, I outline the existing evidence for the 
association between household air pollution and several respiratory and cardiovascular outcomes. 
Respiratory disease 
Obstructive lung disease 
Chronic Obstructive Pulmonary Disease 
COPD is estimated to be the twelfth leading cause of years of life lost globally, causing 3 million 
deaths per year (120): 90% of these deaths occur in low income countries. The Burden of 
Obstructive Lung Disease (BOLD) Study found an overall moderate to severe COPD prevalence of 
19% in Cape Town, South Africa (121). Data for the rest of sub-Saharan Africa are scarce (122), but 
more recent studies suggest that COPD prevalence of lower income countries in sub-Saharan Africa 
may be much lower: 3.6% of urban Malawians were found to have moderate to severe COPD (41). 
Given the known association between cigarette smoke – a form of biomass - and COPD, it is 
unsurprising that there is evidence to support household air pollution as a cause of COPD. Two 
meta-analyses, both published in 2010, explored the association between household air pollution 
and COPD (123, 124). Kurmi et al. found 12 studies for inclusion, and concluded a positive 
24 
 
association between solid fuel use and COPD (OR 2.8, 95% CI 1.85-4.0). Hu et al. identified 15 
studies, and reported a similar OR for developing COPD of 2.44 (95% CI 1.9-3.33), compared to those 
with no biomass smoke exposure. However, both of these meta-analyses are limited by the inclusion 
of studies with poorly defined exposures (i.e. no pollutant monitoring) and outcomes (i.e. lack of 
spirometric diagnosis of COPD). It is also of note that neither of these meta-analyses included any 
data from sub-Saharan Africa. A recent study from urban Malawi found no association between 
reported biomass use and obstructive spirometry, although direct pollutant monitoring was not 
performed (41). 
Evidence for the impact of cessation of household air pollution exposure on lung function decline 
has not been consistent. A biogas intervention and a ventilation intervention in China reduced 
annual FEV1 decline by 12% and 13% respectively over a 9 year follow up period, but these 
interventions were not randomly allocated (125).  In the context of randomised control trials (RCT) 
of cookstove interventions, two studies identified a reduction in respiratory symptoms in women, 
but had conflicting findings regarding lung function decline. An RCT in Mexico found a reduction in 
lung function decline (31ml vs 62 ml over 1 year, p=0.01) (126), whereas the RCT in Guatemala found 
no effect on lung function (127). Both these studies had short follow up periods and relatively young 
populations, which may have limited the ability to evaluate the effects on a chronic disease. 
Asthma 
330 million people worldwide have asthma (15), resulting in 400,000 deaths per year (16). A 
systematic review found that prevalence rates vary widely across sub-Saharan Africa, from 4 to 20%, 
with the highest prevalence being found in ‘westernised’ and urban areas (128, 129). However, most 
of the available data relates to children, with only 3 surveys in adults identified.  
Household air pollution is not only a trigger for asthma exacerbations, but exposure may also 
increase asthma prevalence (130). In children aged 6-7 years and 13-14 years, the International 
Study of Asthma and Allergies in Children (ISAAC) found that sole use of an open fire for cooking was 
associated with an increase in reported wheeze in the past year (OR 2.17, 95% CI 1.64-2.87 and OR 
1.35, 95% CI 1.11-1.64 respectively).   
Bronchiectasis  
There is an absence of data on the prevalence of bronchiectasis in sub-Saharan Africa (in part due to 
the requirements for a radiological diagnosis) and no epidemiological evidence available for an 
association between household air pollution and bronchiectasis. However, chronic cough is common 
in countries where household air pollution is highly prevalent, and its pathology and underlying 
aetiology have not been described in detail (2). An association between biomass exposure and 
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sputum expectoration has been reported in Malawi (OR 7.05, 95% CI 2.28-21.80) (41). In an autopsy 
study of Mexican women with COPD, two thirds of women with exposure to biomass smoke but no 
history of cigarette smoke had evidence of bronchiectasis (131). 
Restrictive lung disease 
In the aforementioned spirometric study in urban Malawian adults, restrictive abnormalities were 
more common than obstructive abnormalities across all gender and age strata (41). Using the Third 
National Health and Nutrition Examination Survey (NHANES III) reference ranges, the prevalence of 
spirometric restriction was 38.6% (SE 2.1), although this was much lower using locally derived 
reference ranges (9%, SE 1.2). The majority of individuals (85%) reported biomass exposure for more 
than 6 months, however no association between biomass exposure and restrictive disease was 
found.  
Respiratory cancers 
Emissions from burning coal and solid fuels are classified as known (Group 1) and probable (Group 
2A) carcinogens, respectively, according to the International Agency for Research in Cancer (132).  
A meta-analysis, including 11 mainly small hospital-based studies, detected an OR of 1.70 (95% CI 
1.45-2.00) for the risk of nasopharyngeal cancer associated with exposure to household air pollution, 
increasing to OR 3.18 (95% CI 2.36-4.3, n=6) following adjustment for tobacco smoking (2). However, 
all of these studies relied on self-reported exposures, and none were conducted in sub-Saharan 
Africa.  
Meta-analysis has detected a pooled OR of 2.31 (95% CI 1.94-2.76) for the risk of lung cancer in 
relation to exposure to household air pollution (2). A higher carcinogenic risk has been identified 
with burning coal (OR 1.82, 95% CI 1.6-2.06) compared to biomass fuels (OR 1.50, 95% CI 1.17-1.94) 
(133). Risk is greater in females than in males (p=0.034), and the pooled risks differ according to 
cancer histological subtype (squamous cell carcinoma: OR 3.58, 95% CI 1.58-8.12; adenocarcinoma: 
OR 2.33, 95% CI 1.72-3.17). The majority of studies were conducted in China, where coal is the 
predominant fuel.  
Tuberculosis 
A systematic review published in 2013 identified 13 studies (including 10 case-control studies) 
examining the relationship between household air pollution and tuberculosis (134). These 13 studies 
had varied results, with only three studies reporting a statistically significant association between 
household air pollution and tuberculosis. Meta-analysis of the 10 case-control studies identified a 
pooled overall OR of 1.30 (95%CI 1.04-1.62. p=0.019), with an increased effect size when the analysis 
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was limited to female participants only (7 studies, OR 1.7, 95% CI 1.00-2.89). However, 
methodological limitations in the quality of studies were identified, with risk of exposure 
misclassification (no studies objectively measured pollution exposure), lack of adjustment for 
potential confounders (e.g. tobacco smoking) and potential selection bias (use of hospital controls). 
The underlying mechanisms which may lead to an increased risk of tuberculosis are not fully 
understood. Impaired phagocytosis of Mycobacterium tuberculosis has been demonstrated in 
human alveolar macrophages exposed in vitro to respirable-sized particulates, but there was no 
overall effect on killing of M. tuberculosis (135). In bronchoalveolar lavage (BAL) samples obtained 
from Malawian adults with tuberculosis, alveolar macrophages that were infected with M. 
tuberculosis and uninfected alveolar macrophages were found to be contain high levels of 
particulate matter (presumed from exposure to air pollution) (136). However, the phagocytic 
capacity of the alveolar macrophages appeared to be unaffected by M. tuberculosis infection, HIV 
infection or degree of particulate matter loading (136). 
Pneumonia 
There is experimental evidence from animals and humans which may explain an increased risk of 
respiratory infection from exposure to household air pollution. Experimental installation of 
intranasal ultrafine particles in mice has been shown to not increase susceptibility to pneumococcal 
infection (137). Other animal models have demonstrated an up-regulation of pro-inflammatory 
mediators, including interleukin 6, in response to particulate exposure (138, 139). An in vitro model 
of exposure of human alveolar macrophages respirable particulates, which was demonstrated to be 
morphologically comparable to in vivo exposure to household air pollution, demonstrated increased 
cytokine release and altered macrophage function (135). Phagocytosis of pneumococci was 
impaired, and alveolar macrophage oxidative burst was reduced, providing insight into potential 
mechanisms for increased susceptibility to bacterial pathogens following exposure to household air 
pollution. Reduction in oxidative burst, along with reduced cytokine induction, has been 
demonstrated in alveolar macrophages obtained by BAL from Malawian adults chronically exposed 
to household air pollution from cooking, although phagocytosis and proteolytic functions were 
unaffected (140). Furthermore, exposure to household air pollution has been shown to alter the lung 
microbiome of healthy Malawian adults, with an increased abundance of potentially pathogenic 
bacteria (141). These findings may explain the association between household air pollution and 
pneumonia that has been described in some epidemiological studies. 
Meta-analyses of studies examining the relationship between household air pollution and ALRI in 
children have found a significant association: Dherani et al. reported a pooled OR of 1.78 (95%CI 
1.45-2.18) and Po et al. reported a pooled OR of 3.53 (95%CI 1.93-6.43) (12, 142). Half a million 
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deaths per year are estimated to be caused by childhood ALRI resulting from household air pollution 
exposure (51).  An RCT of a woodstove with a chimney (compared to a traditional open fire) in 
Guatemala (the RESPIRE trial) found that a 50% reduction in CO exposure significantly reduced 
physician-diagnosed pneumonia in children under the age of 5 (rate ratio 0.82, 95%CI 0.70-0.98), but 
risk reduction was not significant in the intention-to-treat analysis (rate ratio 0.84, 95% CI 0.63-1.13) 
due to substantial exposure overlap between the two groups. A recent RCT of an improved 
cookstove in rural Malawi, with almost 16000 years of follow-up, did not find a reduction in 
pneumonia in children under the age of 5 (incidence rate ratio 1.01, 95% CI 0.91-1.13) (143).  
Given the epidemiological evidence in children, supported by laboratory data providing likely 
mechanistic pathways, it is plausible that an association between household air pollution and 
pneumonia in adults exists. The epidemiological evidence for this is explored in detail in chapter 3.    
Cardiovascular disease 
The mechanistic effects of household air pollution on the cardiovascular system have not been 
extensively studied, and it is thought that due to the differences in pollution composition, the effects 
may differ from those of ambient air pollution data (144). Laboratory and observational studies have 
shown that biomass smoke exposure can cause arterial stiffness, decreased heart rate variability and 
raised inflammatory cytokines (145, 146).  Chronic exposure to biomass smoke has been shown to 
be associated with increased carotid intima media thickness and atherosclerotic plaques (147), both 
associated with cardiovascular events (148).  
Exposure to household air pollution has been associated with elevations in blood pressure (149) as 
well as increased prevalence of hypertension (150, 151). A cleaner burning cookstove intervention in 
Nicaragua significantly reduced systolic blood pressure in older women (mean change -5.9mmHg, 
95% CI -11.3 - -0.4, p=0.05), but not in other sub-groups (152). 
Nested within the RESPIRE trial, between-group and before-and-after comparisons were used to 
demonstrate a statistically significant reduction in the occurrence of ST-segment depression on 
electrocardiogram (OR 0.26, 95% CI 0.08-0.90 in between-group comparisons), although no 
significant change in heart rate variability was found (153). These changes in electrocardial activity 
suggest that household air pollution may affect ventricular repolarisation.   
A systematic review of household air pollution and coronary heart disease concluded that the 
evidence base is limited, but that current epidemiological evidences suggests an increased risk of 
coronary heart disease from household air pollution (154). A large cohort study from Iran found an 
increase in ischaemic heart disease mortality (10-year hazard ratio 1.14, 95% CI 1.06-1.21) (155). 
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The same Iranian cohort demonstrated a non-significant increased risk of stroke mortality associated 
with exposure to household air pollution: 10-year hazard ratio 1.08, 95% CI 0.99-1.17 (155). A large 
cross-sectional study from China detected an increased risk of stroke (OR 1.87, 95% CI 1.03-3.38) in 
adults reporting household air pollution exposure (151). Further prospective studies using air 
pollutant monitor to confirm exposure classification are required to confirm these findings.  
2.2.6. Measuring air pollution exposure 
Assessing an individual’s exposure to air pollution is very complex and, to date, there is no gold 
standard method. Studies examining the health impacts of air pollution exposure have used a wide 
variety of methods. Crude assessments, such as questionnaires of participant reported exposure, are 
limited by inaccurate estimates and recall bias, and fail to account for the many different variables 
that will affect levels of pollution, such as differences in cooking practices, fuel type, fuel moisture 
content, combustion conditions in the stove and ventilation. Measuring indoor levels, ambient levels 
or personal exposure to specific pollutants provides quantifiable data but these methods are not 
without their limitations, as discussed below.  
It is not yet clear, from the available data, which components of household air pollution are the most 
harmful to health and should be monitored. Studies that have failed to demonstrated an association 
between one specific component of household air pollution, such as PM10, and disease may be 
misleading as an alternative component of household air pollution may be associated with that 
disease.  
With current available methodology, the most representative exposure assessment is likely to be 
achieved by individual monitoring for a variety of pollutant constituents, to evaluate the combined 
effects of the different pollutants on health. The resource constraints for many studies limit this.   
Inaccurate assessments of exposure leads to biased estimates of the relationship between air 
pollution exposure and health. It is essential to obtain accurate, quantitative emission-specific 
assessments in order to demonstrate the true burden of disease associated with air pollution. More 
detailed information regarding the effects of specific air pollution components will facilitate 
assessment of air pollution interventions, allowing resources and policies to be directed accordingly. 
2.2.6.1. Particulate matter monitoring 
PM monitoring has long been a component of interest in outdoor air pollution studies, and has also 
been used in household air pollution studies (79, 156-158). High PM exposure has been shown to be 
associated with cardiovascular disease, poor neonatal outcomes, lung cancer, respiratory infections 
in children and increased mortality (102, 158-161).  
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Gravimetric methods 
Gravimetric devices use an air pump to draw in a sample of air through a filter, and the PM is 
collected onto the filter. Depending on the pore-size of the filter, different types of PM can be 
collected, for example, PM2.5 or PM10. The filter, which has been pre-weighed prior to sampling, is 
then weighed again using an electronic microbalance under laboratory conditions to quantify the 
mass of PM. In addition, the collected PM can be biochemically analysed to determine the 
constituent components. 
Traditional gravimetric sampling methods are best suited to static monitoring, rather than 
ambulatory monitoring, due to the size and weight of the devices, as well as the noise generated by 
the air pump. Other challenges include the expertise required for using the devices in the field (as 
mishandling of the sensitive filters can destroy the collected sample), and the expense of 
transporting and analysing the filters under laboratory conditions. Electrostatic effects, sorption of 
moisture and volatiles, and temperature must all be carefully controlled to allow accurate 
gravimetric analysis (162). Devices which are solely gravimetric can only provide data on the total 
amount of PM exposure over the sampling period, and do not provide real-time measurements in 
the fluctuations of exposure over time. However, newer designs, such as the RTI MicroPEM 
(www.rti.org) and the TSI DustTRAK DRX Aerosol Monitor 8533 (www.tsi.com), which combine 
photometric monitoring with gravimetric filters for calibration in lightweight devices are overcoming 
many of these limitations (Figure 2-2).  
Photometric methods 
Photometric devices measure PM concentrations using diffraction of light, providing real-time data 
for exposure patterns. Multiple devices are now available including the University of California, 
Berkeley Particle and Temperature Sensor (UCB-PATS) (www.berkeleyair.com), a modified smoke 
alarm which uses a photoelectric detector to measure PM2.5 concentrations as low as 25µg/m3 
(Figure 2-2). Although lightweight and small, the UCB-PATS is not designed to be moved around 
during monitoring, so is best suited for static household monitoring. Devices suitable for ambulatory 
monitoring include the TSI SidePak AM510 (www.tsi.com), which actively samples the air using a 
pump and measure the refraction of a laser beam caused by PM<0.1, PM2.5 or PM10; the ThermoFisher 
Scientific personal DataRAM pDR-1000AN Monitor (www.thermofisher.com) which uses single beam 
nephelometry to detect PM10; or the Aprovecho Indoor Air Pollution Monitor (www.aprovecho.org) 
which uses fan-assisted air sampling and combines red laser scattering photometer PM2.5 detection 
in the range of 0-60,000 µg/m3 with electrochemical cell CO detection in the range of 0-1000 parts 
per million (ppm) (Figure 2-2).   
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Figure 2-2: Devices used for particulate matter air pollution monitoring. 
a) RTI MicroPEM (www.rti.org); b) TSI DustTrak DRX Aerosol Monitor 8533 (www.tsi.com); c) University of California, Berkeley Particle and 
Temperature Sensor (UCB-PATS) (www.berkeleyair.com); d) TSI SidePak AM510 (www.tsi.com); e) ThermoFisher Scientific personal 
DataRAM pDR-1000AN Monitor (www.thermofisher.com); f) Aprovecho Indoor Air Pollution Monitor (www. aprovecho.org).  
 
2.2.6.2. Carbon Monoxide monitoring 
CO monitoring is particularly useful where there is an absence of high PM2.5 levels, for example, with 
charcoal burning. CO monitoring has been used in previous household air pollution studies, and has 
been shown to be associated with pneumonia and poor neurodevelopmental outcomes in children 
(163, 164). Time-weighted average exposures to CO can be measured using passive diffusion tubes, 
such as Gastec CO tubes (Gastec Corp, Kanagawa, Japan) (Figure 2-3), in which a brown stain 
appears in the tube as a result of a chemical reaction in which CO reduces sodium palladosulfite to 
liberate metallic palladium; the length of the stain relates to the cumulative dose of CO (165). 
Ambulatory, real-time exposure measurements can be collected using an Aprovecho Indoor Air 
Pollution Monitor (discussed above) or a very lightweight, portable Lascar EL-USB-CO300 Carbon 
Monoxide USB Data Logger (www.lascarelectronics.com), which can detect CO in the range of 0-
300ppm (Figure 2-3). 
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Figure 2-3: Devices used for carbon monoxide air pollution monitoring. 
a) Gastec CO tubes (Gastec Corp, Japan); b) Lascar EL-USB-CO300 Carbon Monoxide USB Data Logger (www.lascarelectronics.com). 
 
2.2.6.3. Placement of air pollution monitors 
Location of measurement 
Measuring household air pollution exposure is usually conducted with static household monitors, 
often placed in the kitchen where the highest levels of pollution are likely to be detected, or with 
ambulatory personal monitors which are carried by or attached to the participant.  
Static monitoring fails to consider how an individual’s behaviour may affect their exposure, but can 
be useful if the emissions from a particular source are of interest (e.g. if an improved cookstove is 
being tested). Studies which combine household air sampling with time-activity diaries or global 
positioning system tracking of individuals go some way to address this, but as pollutant levels vary 
greatly even between different parts of the same room, their accuracy is be limited. For this reason, 
placement of the monitors should be standardised across study participants. In several studies, the 
monitor is placed 1m away from the cooking fire and 1m off the ground to sample the air space of 
people who are using or sitting by the fire, without damaging the monitor by placing it too close to 
the heat source.  
Personal exposure monitoring - using devices attached to a participant’s clothes or carried by the 
participant - may provide more accuracy in terms of an individual’s overall exposure as it can 
account for both indoor and outdoor exposures, as well as behavioural factors (2). However, 
personal monitoring does not truly reflect their exposure which is dependent on their respiratory 
rate and tidal volume. Many studies have been limited to only measuring one or two pollutants, such 
as CO or PM10, in this way and it can be burdensome for the participant. The position of the device 
on the person must also be considered – ideally the air sampling component of the monitor should 
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be placed close to their breathing space (i.e. near to their face) and should be standardised across 
participants.  
Timing of measurement 
The timing and length of pollution monitoring needs to be carefully considered as the methodology 
used will influence the findings. If short-term exposures are of interest, then one-off short-term 
monitoring may be acceptable, although variations in behaviour and exposure over different days 
will not be accounted for. If chronic air pollution exposure is of interest, repeated measurements 
over time will improve reliability of results, and may help to account for seasonal changes in 
exposure. Practical and resource limitations, as well as the burden to participants, must also be 
considered. Studies are required to find a compromise between continuous long-term monitoring 
and the financial cost of this. Cynthia, A.A. et al. demonstrated no substantial difference in results 
obtained in a 48 hour period to a 96 hour period, and argued that the difference observed could be 
accounted for by a small increase in sample size (156). 
It is not established whether average exposures, peak exposures or time exposed to pollutants 
above a certain threshold level correlate best with health outcomes (2). This may vary depending on 
the pollutant and the health outcome of interest. Detailed real-time exposure measurements of a 
variety of pollutants may help to clarify this.  
2.2.6.4. Biomarkers of air pollution exposure 
An alternative approach to directly monitoring environmental exposures is to test for the presence 
of a substance in human samples, such as blood, urine or sputum samples, which indicates that 
individual has had a particular environmental exposure. Several biomarkers have been identified as 
potential surrogate markers for exposure to household air pollution, but all have limitations (166-
170).  
A biomarker to be used for exposure monitoring and intervention purposes, should be closely 
associated with exposure, be adequately sensitive and specific, have strong correlations with 
currently used methods for measuring exposure, reflect relatively short-term fluctuations in 
exposures, be consistent across heterogeneous populations, be cost-efficient, have sampling 
methods that are acceptable to the user population, and be feasible for use in the field (ideally 
point-of-care testing or be stable to temperature, storage and transport conditions)(170).  
Airway macrophage particulate load (AMPL) has been demonstrated to be a potential biomarker of 
household air pollution exposure, as increased AMPL has been detected in individuals who report 
exposure to household air pollution compared to those who do not (171). Furthermore, AMPL has 
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been shown to be significantly different in individuals who use different types of fuel for cooking and 
lighting (65). However, to date, this has not been correlated with careful exposure monitoring. The 
feasibility of measuring AMPL is discussed in Chapter 4. 
Exhaled carbon monoxide (eCO) has also been proposed as a potential biomarker of household air 
pollution exposure, which will be discussed in more detail in Chapters 5 and 6.  
Epithelial/endothelial activation, damage, or death and increased oxidative stress are well 
recognised as playing a role in the early pathophysiology of COPD resulting from cigarette smoke 
exposure (172), and similar processes may play a role in air pollution induced lung damage; 
increased oxidative stress and antioxidant up-regulation has been identified in household air 
pollution exposed individuals in Malawi (173). Identification of a mediator of these 
pathophysiological processes which correlates with air pollution exposure will not only provide a 
useful tool for exposure assessment but will also provide insight into mechanisms of pulmonary 
damage that occur. Exposure or response molecules that potentially meet the criteria for biomarkers 
discussed above include those in   
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Table 2-2. However, a limitation of using downstream markers of tissue damage is that they are not 
specific to lung damage, and not limited to the effects of inhaled exposures. 
Degradation products from biomass combustion, such as levoglucosan, methoxyphenols, and 
metabolites of hydroxylated polycyclic aromatic hydrocarbons, can be detected in urine and are 
increased following wood smoke exposure (166, 169, 174-176). However, results have not been 
consistent and the utility of these biomarkers is limited by the fact that these compounds are not 
specific to biomass combustion, and methoxyphenols and levoglucosan can be ingested in food 
products (168, 170). 
Identification of an appropriate biomarker could obviate the need for costly and intensive exposure 
monitoring. Furthermore, a biomarker will account for differences in exposure caused by 
behavioural factors and tidal volumes that external monitoring cannot assess. Further exploration of 
potential biomarkers is warranted, with careful characterisation of their association with exposure. 
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Table 2-2: Pathophysiological molecules – potential biomarkers of household air pollution 
exposure. 
 
Pathophysiological 
effect of pollution 
exposure 
Potential  
biomarker 
Potential 
methods of 
detection 
Previous applications  
Endothelial 
activation, damage 
and death 
Ceramide,  a pro-apoptotic 
sphingolipid implicated in 
alveolar cell apoptosis and 
increased oxidative stress 
(177) 
Liquid 
chromatography / 
tandem mass 
spectrometry, 
Western blotting, 
ELISA 
Detected in rat urine in 
hepatotoxicity (178) 
Detected in human urine in 
Farber disease (179) 
 
RTP801,  a stress induced 
molecule  implicated in 
alveolar cell apoptosis and 
increased oxidative stress 
Detected in urine 
EMAP II,  a monocyte- and 
epithelial- secreted 
cytokine stimulated by 
smoke exposure and 
hypoxic stress that induces 
cell apoptosis and 
inflammation (180) 
Detected in serum  
Epithelial damage RAGE 
(181) 
 
ELISA Detected in induced sputum 
in asthma (182, 183)  
 
Surfactant protein D Detected in induced sputum 
in asthma (184) 
Detected in serum in wood 
smoke exposure (185) 
 
Collagen 
degradation 
PGP,  a collagen 
degradation product 
which amplifies smoke 
induced inflammation 
Liquid 
chromatography / 
mass spectrometry 
Detected in induced sputum 
in COPD (186, 187) 
 
Oxidative stress and 
damage 
MDA,  a lipid peroxidation 
marker 
 
ELISA, liquid 
chromatography, 
radioimmunoassay 
Detected in serum, urine, 
sputum and exhaled breath  
in humans exposed to air 
pollution, patients with COPD, 
nephropathy and those 
exposed to arsenic (188-191) 
8-isporostane Detected in urine of humans 
exposed to wood smoke (192) 
Detected in sputum and 
exhaled breath in COPD and 
asthma (193, 194) 
 
8-oxodG,  indicates 
oxidative induced DNA 
damage 
 
Detected in urine in 
nephropathy  (190) 
Detected in induced sputum 
of healthy children (195) 
ELISA: enzyme-linked immunosorbent assay; EMAP II: endothelial monocyte-activating polypeptide-II; RAGE: receptor 
for advanced glycation end products; PGP: proline-glycine-proline peptide; COPD: chronic obstructive pulmonary 
disease; MDA: malondialdehyde; 8-oxodG: 8-oxo-7,8-dihydro-2’-deoxyguanosine. 
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2.2.7. Reducing exposure to air pollution 
To address the health impacts of air pollution exposure there is growing international recognition of 
the need to reduce exposure to air pollution: multiple strategies aim to achieve this.  
2.2.7.1. Reducing ambient air pollution exposure 
WHO Air Quality Guidelines were first produced in 1987 with the aim of reducing the health impacts 
of air pollution (196). Specific targets for selected air pollutants are given, to assist countries in 
implementing their own standards, pollution monitoring programmes and pollution reduction 
policies. Such policies vary from country to country, according to economic, political and social 
factors as well as feasibility of implementation, but may include legislation for industrial and 
transport related pollution. 
2.2.7.2. Reducing household air pollution exposure 
Improved cookstoves 
In response to growing concerns about household air pollution, The Global Alliance for Clean 
Cookstoves (www.cleancookstoves.org) - a public-private initiative hosted by the UN Foundation -
aims to address the public health impact of household air pollution. One aspect of their strategy is to 
have clean, efficient cooking solutions in 100 million homes by 2020. This will have wide-reaching 
economic, social and environmental impacts,  but to ensure that investment in intervention 
programmes is appropriately directed from a public health perspective, the true burden of disease 
needs to be clarified (197, 198).  
Improved cookstove is an umbrella term used to describe a wide variety of stove designs which 
improve the efficiency of fuel combustion compared to a traditional open 3-stone fire (see Figure 
2-4). Not all improved cookstoves reduce emissions enough to have a measurable health benefit, but 
may provide other benefits for the user. Improved combustion efficiency means that less fuel is 
required to generate the same amount of energy: in fuel-scarce environments, this can save the user 
a large amount of time (as less fuel needs to be gathered) or money. As woman and children bear 
responsibility for fuel collection in many societies, reducing the time spent doing this can create time 
for education or income generating activities. In some settings, women and children are vulnerable 
to physical attacks when collecting firewood in rural areas: reducing fuel consumption can reduce 
the risk of this happening. 
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Figure 2-4: Examples of types of improved cookstoves 
a) Chitezo Mbaula stove; b) Plancha stove (image reproduced from http://aprovecho.org/newsletters/); c) Rocket stove (StoveTec Rocket 
Cascadia Cookstove 1-door, image reproduced from  https://theepicenter.com/stovetes-cascadia-biomass-cookstove.html); d) Gasifier 
stove (African Clean Energy, ACE-1 Ultra-Clean Biomass Cookstove, image reproduced from 
www.catalog.cleancookstoves.org/stoves/268); e) Fan assisted gasifier stove (Philips Cookstove, image reproduced from 
https://www.changemakers.com/discussions/entries/dazin-renewable-cooking-fuel-all).    
One of the lowest cost stoves available are simple portable clay stoves for burning biomass fuels, 
known in Malawi as Chitetezo Mbaula, which translates to “protecting cookstove”. The benefits of 
these are that they reduce fuel consumption, and can be made locally using local materials and 
limited expertise: a local market can therefore be established, generating employment. However, 
there is no evidence to support claims that there is large enough emission reduction to have a health 
benefit. Larger, immobile stoves, which have a stone or concrete combustion chamber which can be 
made locally, come in a variety of designs and can be fitted with a “plancha” (metal stove top) and 
chimney, to reduce household air pollution. A disadvantage it that the lack of portability means that 
the stoves cannot be moved for cooking outside during dry weather, so may lead to higher levels of 
pollution within the home if a chimney is not fitted or maintained. Portable rocket stoves have a 
small combustion chamber containing an insulated vertical chimney. This ensures almost complete 
combustion before the flame reaches the cooking surface, and have been demonstrated to reduce 
fuel consumption and emissions compared to a 3-stone fire. However, the metal double-skinned 
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chamber and insulation can often not be sourced locally, increasing the cost of these stoves. 
Biomass burning stoves which have the greatest impact on emissions, also come at the highest 
financial cost.  
Gasifying technology provides a cleaner solution, whilst still using widely available biomass fuels. 
‘Gasification’ describes the process of converting solid fuel into a gaseous fuel. If this is done in a 
controlled manner, in a biomass gasifier, rather than simultaneously with all other stages of 
combustion, as occurs in an open fire, then energy is generated with far fewer emissions (199). 
Natural-draft gasifier stoves are a relatively simple way of achieving this, and can often be made 
using locally sourced materials such as scrap metal sheets. Many gasifier stoves also have the 
capabilities to produce charcoal, and the heat created in the process is used for cooking. Fan assisted 
gasifier stoves, such as the Philips cookstove (www.philips.com) which comes with a solar powered 
fan to assist the air draw through the combustion chamber, create a cleaner burn. This can reduce 
emissions by up to 90% (200), but the high cost means this stove is currently unaffordable for many 
who are reliant on solid fuel use. 
Fuel diversification  
Alternatively, where available, diversification of fuel type away from solid fuels can reduce 
household air pollution. By 2040, access to electricity is projected to have improved thanks to 
growth in renewable energy resources, but more than half a billion people – mainly in rural areas – 
will remain without electricity (201).  
Domestic biogas production is increasingly popular in the Indian Subcontinent: dairy manure is 
anaerobically digested in airtight circular pits outside the home to produce biogas, which is then 
piped directly to the kitchen for cooking. Where livestock are readily available, this can be an 
affordable and sustainable method for generating domestic energy.  
Although more expensive, liquid petroleum gas, which predominantly consists of propane and 
butane, is a less polluting fuel at the point of use that is a realistic option in many middle-income 
countries in Asia or Latin America. Solar power and hydro-power are further examples of sustainable 
clean energy, but lack of infrastructure and high costs make widespread use challenging.  
Even where cleaner fuels are available, ‘fuel stacking’ prevents households achieving very low levels 
of household air pollution. ‘Fuel stacking’ is the concept of a household using multiple fuel types for 
their energy needs. Use of multiple fuel types and technologies is the norm in many settings, as one 
cooking method is rarely suitable for all types of food consumed (2). Fuel use depends on the 
current availability and cost, cultural norms, as well as what the fuel is required for, as fires often 
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fulfil several functions rather than just cooking (202). As household income increases, the number of 
types of fuel that are used increases, rather than a complete switch to an alternative fuel (203). This 
can have important policy implications when trying to address household air pollution, as income is 
not the sole factor to be considered. 
Ventilation 
As mentioned above, an important strategy to reduce household air pollution is to improve 
ventilation in the cooking area. This can be achieved by installation of chimney stoves or smoke 
hoods, by ensuring kitchens have opening windows or simply by cooking outside when the weather 
allows. Chimney stoves can theoretically cause significant reductions in pollution, as the smoke is 
contained within an enclosed system. However, poorly designed or poorly maintained chimneys can 
lead to inefficient combustion resulting in higher emissions. Smoke hoods, which simply sit over the 
stove or fireplace, provide a simpler alternative and can reduce household air pollution by up to 80% 
in field testing (204). A disadvantage of relying on ventilation to reduce indoor exposures is that the 
pollutants are simply diverted to the outdoor environment (163, 197): domestic use of solid fuels is 
thought to be an important contributor to ambient pollution levels, particularly in urban areas. 
Conversely, ambient air pollution may move from the outdoor environment into the household; this 
infiltration is determined by house air exchange rates (2). This movement of pollution between the 
two environments gives rise to several challenges: monitoring of exposures must take a variety of 
sources into consideration; apportioning causality of health effects to either household or ambient 
pollution is complex; and interventions to reduce exposure must take this movement of pollution 
(and its impact on neighbouring households, for example) into consideration.    
Behaviour 
Interventions to impact the behavioural aspects of exposure, as discussed in section 2.2.3.2., may 
also help but there is currently little evidence to support a health benefit from such interventions.  
2.2.8. Household air pollution in Malawi 
A comparison of rural and urban areas in Malawi in 2008 found rural homes tend to use firewood 
and therefore have high PM levels, whereas urban homes tend to use charcoal and so have high CO 
levels (3). Whilst 100% of households reported using wood as their main fuel for cooking in rural 
areas, only 21% of households in urban areas did. Charcoal was reported as the main fuel type by 
66% of urban households, whilst 6% reported using both wood and charcoal, and 9% used 
electricity. Kerosene use for lighting was also more common in rural areas compared to urban areas 
(87% vs 61%), where 29% of households had electricity for lighting, compared to only 3% in rural 
areas. Further differences were noted in cooking locations: only 6% of rural households reported 
40 
 
cooking inside the main house during dry season, whereas 52% of urban households cooked inside 
the main house.  
Household air sampling in both the rural and urban areas revealed pollution levels in excess of WHO 
air quality guidelines in all homes sampled in the above mentioned study from Malawi (3). The WHO 
Air Quality Guidelines recommend that 24-hour mean exposures of PM2.5 should not exceed 25 
µg/m3 (196). Using UCB-PATS devices (see section 2.2.6.1.), in the above study, the mean PM2.5 time 
weighted average for all homes was 204µg/m3, with no significant difference detected between rural 
and urban homes. However, 52% vs 17% of homes had PM2.5 levels in excess of 250µg/m3 for more 
than 1 hour per day in rural and urban areas respectively (p = 0.112). There was no significant 
difference in transition metal content of gravimetric PM samples when compared by fuel type. 
Urban homes had significantly higher levels of CO than rural homes (mean CO time weighted 
average 6.14 ppm vs 1.87 ppm, p<0.001), and this was associated with charcoal use (p<0.001) (3).  
2.3. Literature review: Risk factors for pneumonia 
2.3.1. Pneumonia 
2.3.1.1. Definition and classification  
Pneumonia is inflammation of the alveoli, with associated accumulation of inflammatory exudate 
resulting in pulmonary consolidation, often caused by infectious agents. Pneumonia usually presents 
with productive cough, shortness of breath, pleuritic chest pain and fever, and may lead to hypoxia 
and systemic compromise if severe.  
ALRI is a term that encompasses a broad range of diagnoses - including pneumonia, acute bronchitis 
and bronchiolitis - that, unlike upper respiratory infections, affect the lower respiratory tract, below 
the level of the epiglottis. Infections of the respiratory tract that have a natural history that persists 
longer than 2 weeks, such as tuberculosis, are not usually referred to as ALRI.  
Pneumonia can be classified by its aetiology, or by the anatomical location of affected lung. 
Community-acquired pneumonia – the subject of this thesis – refers to pneumonia caused by 
infection acquired outside of healthcare facilities, and therefore the onset is prior to admission to or 
within 48 hours of admission to a healthcare facility. Healthcare-associated or hospital-acquired 
pneumonia refers to pneumonia caused by organisms acquired in healthcare facilities (onset 48 
hours or more after admission), including hospitals and nursing homes, and is more likely to be 
caused by multi-drug resistant organisms. Ventilator-associated pneumonia is that which is 
41 
 
contracted whilst a patient is receiving mechanical ventilatory support, arising more than 48 hours 
after endotracheal intubation. 
Lobar pneumonia refers to infection of a single lobe of the lung, or multi-lobar pneumonia describes 
the consolidation in multiple lobes which is often more severe. Bronchopneumonia affects the 
bronchi and bronchioles, whereas interstitial pneumonia is the inflammation of the pulmonary 
interstitium which can be caused by viruses or atypical bacteria.  
Expert bodies and research studies have used a variety of definitions for pneumonia (see   
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Table 2-3). It is of note that the only study listed here to restrict their definition by symptom 
duration (to 14 days or less) is the study conducted in Kenya by Scott et al. where tuberculosis and 
HIV prevalence are high (6). This may be because the authors of this study felt it was important to 
exclude individuals with tuberculosis, whereas this may have been less of a priority in other settings 
where the burden of tuberculosis is lower. 
2.3.1.2. Pathogenesis 
Bacterial or viral pneumonia are most common, but other microorganisms – including fungi – and 
non-infectious insults may also be responsible. Microbiological aetiology varies across different 
regions globally (6, 205-207), but Streptococcus pneumoniae – a Gram positive, facultative anaerobic 
bacterium – is recognised as being the most common cause of bacterial pneumonia worldwide (6, 
208, 209). The diagnosis can be complicated by tuberculosis, which may present as an acute 
pneumonic illness (6, 207), or by opportunistic infections in susceptible patients (210, 211), 
particularly in settings where tuberculosis and HIV infection prevalence are high.      
2.3.1.3. Diagnosis 
Diagnosis of pneumonia is usually based on clinical assessment of history and examination of signs, 
supported by radiological evidence of pulmonary consolidation, usually by chest radiograph (see   
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Table 2-3). Distinguishing pneumonia from other forms of ALRI, such as milder, self-limiting viral 
infections which cause acute bronchitis, using clinical signs alone can be challenging. No individual 
sign or symptom is useful for making this distinction. Pneumonia is defined as involving 
consolidation of the lung parenchyma, however, a prospective study of individuals treated with 
antibiotics for ALRI with new focal chest signs found that only 39% of individuals had chest x-ray 
changes (212). Early chest radiograph may fail to identify parenchymal opacifications which develop 
over subsequent days (213).  
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Table 2-3: Definitions of pneumonia 
Expert body / 
Research study 
Diagnosis Definition 
British Thoracic Society, 
2009 (214) 
 
Community Acquired 
Pneumonia 
Symptoms and signs consistent with an acute lower 
respiratory tract infection associated with new 
radiographic shadowing for which there is no other 
explanation. 
 
European Respiratory 
Society, 2011 (215) 
 
Suspected Community 
Acquired Pneumonia 
An acute illness with cough and at least one of new 
focal chest signs, fever >4 days or 
dyspnoea/tachypnoea, and without other obvious 
cause. 
Definite Community 
Acquired Pneumonia 
As above, but supported by chest radiograph findings 
of lung shadowing that is likely to be new. In the 
elderly, the presence of chest radiograph shadowing 
accompanied by acute clinical illness without other 
obvious cause. 
 
Scott et al, 2000 (6) 
 
Community Acquired 
Pneumonia 
An illness of 14 days duration or less that consisted 
of at least two respiratory symptoms (cough, 
sputum, breathlessness, chest pain, haemoptysis, or 
fever) with evidence of pulmonary consolidation on 
chest radiograph. 
Farr et al, 2000 (209) 
 
Community Acquired 
Pneumonia 
Acute respiratory illness with radiological pulmonary 
shadowing which was at least segmental or present 
in more than one lobe. 
Almirall et al, 2008 (216) 
 
Community Acquired 
Pneumonia 
Acute lower respiratory tract infection for which 
antibiotics had been prescribed, in association with 
the appearance of previously unrecorded focal signs 
on physical examination of the chest and new 
radiological findings suggestive of pneumonia 
infiltrate. 
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2.3.1.4. Management and prognosis 
Management varies according to severity and aetiology, with the mainstay of treatment for bacterial 
pneumonia being antibiotics (oral or intravenous, depending on severity), escalating to 
supplementary oxygen, circulatory support, and ventilatory support in a high dependency or 
intensive care unit as required.   
Severity assessment can be made using a variety of clinical scores – such as CURB65, CURB, SMRT-
CO and Pneumonia Severity Index – which have been validated for use in different populations in 
well resourced-settings (217). Such tools may not be valid in low-income settings such as sub-
Saharan Africa, where the patient demographics and underlying aetiologies are likely to be different. 
CURB65, SMRT-CO and the IDSA/ATS minor criteria – which were all derived from community 
acquired pneumonia populations in well-resourced settings – performed poorly as predictors for 
mortality in the MARISO (Malawian Adult Lower Respiratory Tract Infection Severity, Aetiology and 
Outcome Study) cohort (218). Reasons for this may include the different age of the pneumonia 
cohort, the impact of advanced immunosuppression and malnutrition, as well as altered healthcare 
seeking behaviours and under-resourced healthcare facilities leading to delays in treatment. The 
MOST score – derived from the MARISO cohort – uses simple parameters (male sex, oxygen 
saturation, inability to stand and tachycardia) and provides good discriminative capability for the 
prediction of 30-day mortality (area under the receiver-operating curve 0.79, 95% CI 0.73-0.85) but 
requires external validation in another sub-Saharan Africa setting. 
A meta-analysis of 127 unique study cohorts found an overall mortality rate for community-acquired 
pneumonia of 13.7%, ranging from 5.1% in ambulatory and hospitalised patients to 36.5% in 
intensive care patients (219). The mortality rate varied widely according to aetiology. More recently, 
a study in Spain found a mortality rate of 17.0% (95% CI 16.9-17.1%) for all-cause community-
acquired pneumonia in hospital (220), suggestion little improvement in mortality despite advances 
in treatment in recent decades. In Europe, mortality has been found to be associated with advanced 
age, co-morbid conditions, female gender, microbial aetiology, multi-lobar involvement and 
community acquired pneumonia severity (205). Mortality risk in elderly patients persists for several 
years following an episode of pneumonia, even when pre-existing comorbidities are accounted for 
(221). 
2.3.2. Risk factors for pneumonia 
The risk factors for developing pneumonia in developed countries are well described, with old age, 
male sex, comorbidities (including chronic respiratory diseases, immunosuppression, congestive 
heart failure, cerebrovascular disease and diabetes) and lifestyle factors such as tobacco smoking 
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and high alcohol intake being frequently being cited (208, 209, 222-224). Being underweight or 
having poor dental hygiene have also been identified as risk factors for pneumonia, as has contact 
with young children (216, 225, 226). A large case-control study of community-acquired pneumonia in 
Spain found a wide range of risk factors to be statistically significant in multivariate analysis, 
including epilepsy (OR 5.95, CI 1.62-21.74),  sudden temperature changes at work (OR 2.64, CI 1.67 – 
4.15), oxygen therapy within the last year (OR 2.42, CI 1.16-5.05), upper respiratory infections in the 
last month (OR 2.28, CI 1.81-2.89), chronic bronchitis (OR 1.81, CI 1.19-2.75), asthma (OR 1.67, CI 
1.28-2.19), contact with young children (OR 1.48, CI 1.2-1.82), and smoking (>150 pack years: OR 
1.46, 95% CI 1.14-1.86) amongst others (216).   
2.3.2.1. HIV  
HIV is associated with an up to 25-fold increase in bacterial pneumonia rates (23-25) and a reduction 
in CD4 cells increases the risk of pneumonia (26, 227). In a cohort study of female sex-workers 
(81.6% of women were HIV seropositive) in Kenya in the pre-antiretroviral era, the relative risk of 
developing acute pneumonia with HIV infection was 17.1 (95% CI 2.4-121.8) (24). In the HIV-positive 
women, 35.5% of these pneumonias were confirmed to be pneumococcal. Women with a first 
presentation of pneumonia had a mean CD4 count of 329cells/µl compared to 204 cells/µl in 
recurrent episodes of pneumonia. Antiretroviral therapy does not provide full pneumococcal 
protection (228): the risk of pneumonia in HIV infected individuals remains elevated even when on 
antiretroviral therapy (229), and individuals with HIV commonly present with pneumonia even when 
their CD4 count is in the normal range (26). Unsurprisingly, therefore, despite reductions in 
pneumonia since the roll-out of antiretroviral therapy in some parts of sub-Saharan Africa (230), 
pneumonia remains one of the commonest reasons for admission to hospital in HIV endemic areas 
(5).  
Community-acquired pneumonia is commonly complicated by other HIV-associated infections, in 
particular tuberculosis (231), raising challenges for empirical treatment regimens in high HIV-
prevalence settings (29). There is a lack of available data regarding whether this major risk factor for 
pneumonia interacts with the effects of household air pollution.  
2.3.2.2. Tobacco smoke exposure 
Risk of pneumonia is increased in individuals who have ever smoked (OR 2.0, 95% CI 1.24-3.24); for 
current smokers and ex-smokers the ORs were 1.88 (95% CI 1.11-3.19) and 2.14 (95% CI 1.26-3.65), 
respectively (14). The same study, conducted in the 1990’s in Spain, found that the proportion of 
community acquired pneumonia attributable to smoking in all cases was 32.4% (95% CI 14.8-50.1%), 
reduced to 23% (95% CI 3.3-42.7%) in cases who did not have a co-existing history of COPD. A dose-
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response relationship between smoking pack-years and community acquired pneumonia was also 
identified. Although community acquired pneumonia risk was increased in ex-smokers, this risk 
reduced after 5 years of cessation (1-4 years cessation OR 3.52, 95% CI 1.72-7.17; 5-9 years cessation 
OR 1.21, 95% 0.48-3.04) suggesting a possible reversal of airway damage, although only small 
numbers of participants were included in these sub-groups.  
Tobacco smoke is known to cause histological changes in the airway epithelium creating conditions 
more favourable for microbial survival (232-235), and induces an inflammatory reaction triggering 
innate and adaptive immune responses (236, 237). Key immune signalling pathways, including the 
response of Toll-like receptor 2 and nuclear factor kappaB are inhibited (238, 239), as are 
opsonisation and phagocytic functions (240): this modulation of the lung’s immune response to 
pathological organisms increases susceptibility to infection.  
2.3.3. Pneumonia in African adults 
There are estimated to be 4 million episodes of pneumonia in adults in Africa causing 200,000 
deaths per year (19). Pneumonia has been one of the commonest causes of adult admission to 
hospital in both the pre- and post-antiretroviral era (5, 20). Unlike in developed settings, young 
adults are affected (over half of patients were 35 years or younger in two large African cohorts), with 
an increased prevalence in males (6, 218); the effect of pneumonia on the working-age population 
results in a large economic burden (19).  
2.3.3.1. Aetiology and prognosis of pneumonia in African adults 
Few studies detailing the aetiology and outcomes of pneumonia in Africa have been published. The 
most comprehensive study published to date, by Scott et al, evaluated 281 adults with radiologically 
confirmed pneumonia in urban and rural Kenya between 1994-1996 (6). The majority of patients 
were male (63%) and 52% were HIV seropositive; patients presenting to an urban hospital were 
more likely to be male and HIV-positive than those presenting to a rural hospital. Lung aspiration 
was performed on 259 patients, blood cultures were performed on all and 275 had urinary 
pneumococcal antigen testing: 146 patients (52%) had a positive lung aspirate or blood culture or 
pneumococcal antigen – of those, 6 patients had dual culture positivity.  37 patients (13%) were 
found to be Mycobacterial culture or polymerase chain reaction (PCR) positive (14 of whom also had 
blood or lung aspirate culture positivity) and 23 patients (8%) had positive viral or atypical serology 
(10 of whom also had blood or lung aspirate culture positivity). Two patients had a positive lung 
aspirate or blood culture, positive Mycobacterial culture or PCR and positive viral or atypical 
serology. An aetiological agent was identified in 65% of patients: Streptococcus pneumoniae 
infection was the most commonly identified pathogen, found in 46 % of patients. Other pathogens 
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identified included Staphylococcus aureus (1.4%), Haemophilus influenzae (3.6%), Salmonella species 
(2.1%), other Gram-negative bacteria (1.4%), Mycobacterium tuberculosis (8.9%), Non-tuberculous 
mycobacteria (3.6%), Nocardia species (0.4%), Mycoplasma pneumoniae (2.5%), Influenza A or B 
virus (5%), and Adenovirus (0.7%). Mycobacterium tuberculosis was detected almost twice as 
frequently from HIV-positive patients than HIV-negative patients. Of 255 patients in whom the 
outcome at 3 weeks was known, 176 (69%) recovered, 34 (13%) were on anti-tuberculous therapy, 
20 (8%) complained of ongoing respiratory symptoms and 25 (10%) had died. Factors associated 
with death within 3 weeks of acute pneumonia in a multivariate analysis included age (OR 1.51, 95% 
CI 1.04-2.19), unemployment (OR 4.42, 95% CI 1.21-16.1), prior visit to a traditional healer (OR 5.26, 
95% CI 1.67-16.5), prior visit to a pharmacy (OR 0.30, 95% CI 0.10-0.91), Herpes labialis (OR 15.4, 
95% CI 2.22-107) and heart rate (per 10 beats/min rise) (OR 1.64, 95% 1.24-2.16).  
In a study of pneumococcal pneumonia in Malawi in the pre-antiretroviral era, the presence of 
multi-lobar chest signs was associated with a worse prognosis at follow-up compared to those with 
unilateral signs (OR 6.6, 95% CI 2.3-19.0) (241). There was 20% inpatient mortality, and hypotension 
at presentation was associated with in patient death (OR 10.4, 95% CI 1.8-60.6). 
In the MARISO study, a recent prospective cohort study of 459 hospitalised pneumonia patients in 
Blantyre, Malawi, there was a male preponderance (62%), median age was 34.6 years and HIV-
prevalence was 78% (218). In patients with a symptom duration of 14 days or less, Mycobacterium 
tuberculosis and Streptococcus pneumoniae were the most commonly identified pathogens (23% 
and 21%, respectively). This high prevalence of tuberculosis amongst individuals presenting with 
acute pneumonia is a striking finding, which adds to the growing body of evidence which challenges 
the conventional understanding that tuberculosis presents with insidious symptoms (6, 242). 
Mortality at 30 days was 14.6%, with increased mortality associated with male sex (adjusted Odds 
Ratio (aOR) 2.57), increased length of pre-presentation symptom duration (aOR 1.11 per day 
increase), inability to stand (aOR 4.38), heart rate (aOR1.02 per beat/minute rise), oxygen 
saturations (aOR 0.95 per % rise), white cell count (aOR 0.91 per 109/L rise) and haemoglobin (aOR 
0.90 per g/dL rise).  
A systematic review of pneumonia studies from sub-Saharan Africa identified 44 studies for 
inclusion, with 39 studies providing mortality data and 30 studies providing aetiological data (218). 
Pooled data found an average age of 38 years and HIV prevalence of 52%. Streptococcus 
pneumoniae and Mycobacterium tuberculosis were identified in 27% and 19% of cases respectively. 
The overall mortality rate in hospitalized patients was 9.5%. 
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2.3.3.2. Risk factors for pneumonia in African adults 
Risk factors for developing pneumonia are less well understood in developing countries like Malawi 
where HIV has dominated the recent picture. As HIV management improves and living with HIV 
becomes life with a chronic disease, risk factors for pneumonia other than HIV will become 
increasingly important. Poverty and crowded living conditions have previously been identified as risk 
factors for adult pneumonia in sub-Saharan Africa (227, 243). Many other preventable exposures 
may play a role but are unproven in this setting, including air pollution exposure, chronic respiratory 
disease (CRD), tobacco smoke, malnutrition, excess alcohol and animal ownership (12, 14, 209, 216, 
244-250).  
Household air pollution is an established risk factor for childhood ALRI, increasing a child’s risk of 
ALRI by 78% (pooled OR = 1.78 (95% CI 1.45 to 2.18) (12). Half a million deaths per year from 
childhood pneumonia are thought to be caused by exposure to household air pollution (12). As 
discussed in Chapter 3, the risk in adults is yet to be established, and the impact of HIV infection on 
that risk is unknown. As the burden of pneumonia and air pollution is high in sub-Saharan Africa, if 
an association present the attributable risk is potentially very high.  
2.3.4. Conclusion 
Pneumonia causes a high burden of morbidity and mortality in sub-Saharan Africa, but the majority 
of the literature describing aetiology, risk factors and prognosis for pneumonia is from well-
resourced settings. The picture of pneumonia in sub-Saharan Africa is different, due to differences in 
demographics, social factors, comorbidities and health care provision. Several potential risk factors, 
including household air pollution, are modifiable and therefore provide potential opportunities for 
targeted reduction of pneumonia risk. However, before resources are directed towards specific 
interventions, the risk factor profile in sub-Saharan Africa should be accurately described. 
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3. Systematic Review – Is household air pollution a risk factor for 
Acute Lower Respiratory Tract Infections in adults? 
 
3.1.  Introduction 
As discussed in Chapter 2, disease outcomes in adults attributed to household air pollution from 
solid fuels include ALRI in children, COPD and cardiovascular disease (7). Based on the evidence for 
an association between household air pollution and child ALRI (12), an association between 
household air pollution and adult ALRI is plausible, but this lacks strong evidence. This is an 
important gap in the evidence base: although the Global Burden of Disease study incorporated adult 
ALRI as an outcome for household air pollution exposure, the risk estimate was derived from an 
integrated exposure-response curve for PM2.5 from ambient and household air pollution, and 
tobacco smoke (7, 9, 11). This extrapolation simplifies and risks misclassifying the exposure-response 
relationship, because it ignores the fact that health risks may vary depending on the combustion 
source, due to the heterogeneity of constituents found in PM2.5 (66). If an association is confirmed 
then the attributable risk is potentially high, because household air pollution exposure and ALRI 
burden are both concentrated in developing countries. This chapter follows on from the narrative 
literature reviews presented in Chapter 2 and reports on a systematic review of the literature on 
household air pollution and ALRI in adults. 
3.1.1. Objectives 
To describe and summarise the evidence base for the relationship between household air pollution 
exposure from domestic solid fuel use and adult ALRI worldwide, to identify knowledge gaps and 
future research opportunities.  
3.1.2. Contributors to this chapter 
I developed the protocol for this systematic review with input from Dr Deborah Havens (Liverpool 
School of Tropical Medicine, (LSTM), UK), Dr Daniel Pope (University of Liverpool, UK) and Professor 
Nigel Bruce (University of Liverpool, UK). I performed all database and grey literature searching and 
collated the full list of titles. Title searching was performed by myself, Deborah Havens and Hope 
Simpson (London School of Hygiene and Tropical Medicine, UK). I reviewed all abstracts and full text 
articles and the second review was performed by either Hope Simpson, Deborah Havens or Dr 
Geoffrey Manda (University of Malawi, Malawi). I extracted data, with assistance from Hope 
Simpson, and I collated the data and performed all quality assessments and risk of bias assessments. 
I wrote the manuscript for publication, with assistance from Hope Simpson, and editing input from 
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Deborah Havens, Daniel Pope, Nigel Bruce and Dr Kevin Mortimer (LSTM, UK). Translation of French 
and Spanish language manuscripts was performed by Dr Christine Kelly (University of Liverpool, UK) 
and Mariana Gallo, respectively. 
3.2. Methods 
This systematic review is registered with the Centre for Reviews and Dissemination (Registration 
number: CRD42015028042). The full protocol is available at http://www.crd.york.ac.uk/prospero. 
3.2.1.  Eligibility criteria 
The participants, exposures and outcomes of interest are defined below. All studies were included in 
the review if they provided an effect estimate for the exposure of interest on the outcome for 
relevant participants, in the form of a relative risk or OR with 95% CI (or data allowing calculation), 
and met the following criteria: 
 Human studies. 
 Study designs: Individually- and cluster-randomised control trials; controlled before-and-
after trials; cohort studies; case-control studies and cross-sectional surveys were included. 
Case reports, case series and review articles were excluded. 
 English language papers or non-English language papers where a translation is available 
(translation was not available for Chinese literature). 
3.2.1.1. Participants 
All adults (age ≥18 years old) were eligible, without geographical restriction. Studies exclusively 
focussed on children (<18 years) were excluded. Studies including both adults and children were 
included if the data was presented separately. To avoid the exclusion of potentially useful data on 
adults, studies that included low numbers of under 18-year olds within a primarily adult population 
were included.  
3.2.1.2. Exposure 
Exposure was defined as air pollution from indoor burning of any solid fuels - including wood, 
charcoal, animal dung, crop residues and coal - for household purposes. We included studies that 
quantified exposure through direct measurement of specific pollutants, questionnaires regarding 
exposure history, comparison of groups exposed to types of exposure (e.g. different stove types), or 
before and after an intervention to reduce exposure. Studies examining outdoor air pollution, 
occupational exposures, non-fuel combustion sources or non-solid fuels were excluded. Non-fuel 
combustion sources in households, such as insect coils, air fresheners or tobacco smoke, were also 
excluded as the exposures, health effects and control measures for these pollution sources are likely 
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to differ significantly from that of solid fuel (58). Exposure assessments or interventions may be 
implemented at an individual or household level. 
3.2.1.3. Outcomes 
The primary outcome of interest was ALRI including pneumonia, acute bronchitis or bronchiolitis, 
assessed by any of the following: 
 Physician diagnosed ALRI 
 Patient/caregiver recall of ALRI diagnosed by a physician 
 Patient/caregiver recall of key symptoms (recall of up to 14 days) and direct observation of 
signs compatible with ALRI by a health worker / staff trained by WHO guidelines, as follows: 
o Symptoms: cough plus one of dyspnoea, pleuritic pain 
o New focal chest signs on examination (e.g. Bronchial breathing) 
o Systemic Signs: one of sweating, fever, shivers, myalgia or pyrexia >38°C 
o No other explanation for the illness 
 Patient/caregiver recall of key symptoms and signs (recall of up to 14 days) 
 Physician issued death certificate indicating ALRI 
 Verbal autopsy diagnosis of ALRI 
Chest X-ray findings and positive blood/sputum culture results improve diagnostic certainty and so 
were considered to provide a higher quality of evidence, but were not essential for the purpose of 
this review.  
Studies that defined the outcome as “acute” or specified duration of less than 14 days were 
included, even if infection was not confirmed, since acute respiratory illnesses in the absence of 
underlying disease is usually infectious in origin. Studies reporting illnesses lasting longer than 14 
days were excluded, to avoid inclusion of chronic diseases or chronic infections such as tuberculosis. 
Studies examining exacerbations of chronic conditions such as asthma or COPD were included if an 
acute infectious exacerbation was defined. Studies that did not distinguish between upper 
respiratory tract infections and ALRI were excluded. 
3.2.2. Search strategy 
The databases listed in Box 3-1 were searched on 17/12/2015 using the search terms and Boolean 
phrases listed in Box 3-2. An example search strategy is shown in Box 3-3. Searches were limited to 
papers published from 01/01/1960 onwards, and to human studies where possible. Identified papers 
were imported into EndNote X7.  
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Alternative sources were also searched for eligible studies:  
 www.who.int/trialsearch  
 www.clinicaltrials.gov  
 EAGLE (European Association for Grey Literature Exploitation), www.opengrey.eu  
 Reference lists of all selected papers were reviewed for any potentially eligible titles.  
 Reference lists of relevant review articles were reviewed for any potentially eligible titles.  
Following removal of duplicates, titles of identified papers were reviewed for eligibility. The first 20% 
of titles were reviewed in duplicate by two independent authors to check for agreement, and the 
remaining titles were reviewed by a single author, with an overlap of 10% of titles between authors 
to ensure continued agreement.  
Abstracts of the selected titles and then full text of the selected articles were reviewed for eligibility, 
according to the selection criteria. Abstracts and full text articles were all reviewed in duplicate by 
two independent authors. Where discordant decisions were not resolved by discussion, the decision 
was made by a third author.  
If the full text article was not available in English, translation was sought to determine eligibility. 
Box 3-1. Databases searched 
• MEDLINE (OVID) 
• Scopus (including EMBASE) 
• Web of Science 
• CINAHL (Ovid) 
• Global Health (Ovid) 
• Cochrane Central Register of Controlled 
Trials (CENTRAL) 
• Database of Abstracts of Reviews of Effects 
(DARE) 
• Latin American and Caribbean literature 
(LILACS) 
• SciELO 
• African Index Medicus 
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For studies where relevant details were not available, authors were invited to supply information if 
their contact details were available.  
 
 
 
 
 
 
 
3.2.3. Data extraction  
Data were extracted from the selected papers using a previously piloted data extraction form, from 
which a summary table and narrative synthesis were produced. Where effect estimates were not 
provided, these were calculated from the published data.  
Box 3-3. Example search strategy for Medline (OVID) 
1. “respiratory infection*”.mp,tw. 
2. “respiratory tract infection*”.mp,tw. 
3. pneumonia.tw,mp. 
4. “respiratory illness”.tw,mp. 
5. 1 or 2 or 3 or 4 
6. “household air”.tw,mp. 
7. “indoor air”.tw,mp. 
8. biomass.tw,mp. 
9. smoke,tw,mp. 
10. stove.tw,mp. 
11. fuel.tw,mp. 
12. 6 or 7 or 8 or 9 or 10 or 11 
13. 5 and 12 
Box 3-2. Search terms and Boolean phrases used 
Outcomes (OR): “respiratory infection*”, “respiratory tract infection*”, pneumonia, 
“respiratory illness*” 
AND 
Exposures/Interventions (OR): “household air”, “indoor air”, biomass,*smoke, fuel*, 
*stove*. 
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3.2.4. Quality assessment 
Studies that quantified exposure by direct household or personal measurement of specific pollutants 
were regarded to provide a higher quality of exposure assessment than those that relied on self-
reported exposure. 
Studies using prospective assessment of ALRI by a physician or trained health care worker using 
predefined criteria or diagnostic investigations were considered to be of higher quality than those 
reliant of self-reported episodes of ALRI.  
3.2.5. Risk of bias assessment 
Risk of bias was assessed using the Liverpool Quality Assessment Tool (see Section 9. Appendix 1), 
which reviewed the study methodology in four domains - subject selection, exposure assessment, 
outcome assessment and adjustment for confounders - and assigned quality ratings (low, moderate 
or high risk of bias). I adopted this instead of the Cochrane Collaboration's tool for assessing risk of 
bias due to the variety of study designs identified. Publication bias was not assessed due to the small 
number of papers identified. 
3.2.6. Data analysis  
Methodological heterogeneity in exposure and outcome assessment precluded a meta-analysis, but 
a narrative summary of the selected papers and a summary of findings table were produced.  
3.3. Results 
3.3.1. Summary of literature search 
Database searches identified 8605 records and 330 records were identified from alternative sources. 
After removal of duplicates 4616 records remained. The number of titles, abstracts and papers 
reviewed was 4616, 512 and 72 respectively, as summarised in the PRISMA flow chart (Figure 3-1), 
with the reasons for exclusion at the abstract and full text stages. Agreement between the 3 
independent authors was 95-96% for the first 20% of titles reviewed, and 95-98% for the 10% 
overlap of remaining titles. It was not possible to locate 5 selected abstracts (251-255) and 2 
selected full text papers - both published in Chinese (256, 257) - for review. Two authors were 
contacted for further details about their recent or ongoing studies identified at 
www.clinicaltrials.gov. One study is a prospective cohort study of febrile adults in Tanzania for which 
recruitment has been completed but the data are not yet available. The second study is a 
randomized trial of smoke reduction interventions in Native American populations, but we were 
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unable to obtain further details. One further study identified, the case-control study presented in 
Chapter 6 (the AIR study), was not included at results were not yet available. 
 
Figure 3-1: Systematic review PRISMA flow chart. 
ALRI: acute lower respiratory tract infection 
Ten papers met the criteria for inclusion; data from 2 of these were duplicated in other selected 
papers (258, 259), and therefore not extracted.  
The main findings of all included studies are summarised in Table 3-1, which demonstrates the 
heterogeneity of study participants, exposure definitions and outcome definitions.   
3.3.2. Study designs 
The 8 selected papers included 4 cross-sectional (260-263), 2 cohort (264, 265) and 2 case control 
studies (266, 267). The largest study was a retrospective cohort study from China, which reported on 
the causes of death in 42,422 farmers (264).  
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3.3.3. Study settings 
The articles covered study locations from 8 countries (Kenya, Tanzania, Sierra Leone, China, Nepal, 
Canada, Mexico and Serbia) across 4 continents. Most studies were based in rural settings and 
recruited participants from communities. There were 3 exceptions, which were hospital or health-
centre based studies, conducted in urban areas of Canada, Mexico and Serbia (262, 266, 267).  
3.3.4. Study participants 
Most studies predominantly or exclusively recruited females (accounting for 48-100% of participants 
within studies). In the study from Tanzania, the cooks were mainly female but the gender and age of 
the unexposed group were not reported (261).  
Except for the study from Canada, which restricted recruitment to individuals over 65 (266), and the 
study from China (264), in which deaths occurred between 25 and 80 years of age, all studies 
recruited younger adults.  Five studies restricted participants to adults over 18, whilst the 3 
remaining studies - from Sierra Leone, Tanzania and Kenya - included younger participants but were 
conducted in predominantly adult populations (261, 263, 265).  
3.3.5. Exposure assessments 
One study evaluated coal use (Shen et al) and the 7 others evaluated biomass fuel use, 
predominantly wood. Four studies measured levels of household pollutants directly, but only 1 
presented an estimate for the effect of pollutants on ALRI risk. In Kenya, Ezzati et al. measured 
particulate matter <10µm diameter (PM10) for 14-15 hours per day for 200 days in 55 households, 
and demonstrated a dose-response relationship between exposure to PM10 and ALRI risk (265). All 
studies monitoring air pollution levels measured PM10 rather than PM2.5. This may misrepresent the 
true harmful exposure, as smaller PM2.5  particles are inhaled deeper in to the lungs than PM10 and 
are therefore thought to be more pathogenic (43).  
The 7 studies that did not provide an effect estimate for measured pollutants all used questionnaire 
data to classify exposure to household air pollution, based on a variety of self-reported measures 
including fuel or stove type, quantification of fuel use, ventilation, cooking frequency and location. 
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Table 3-1: Summary of findings table for four studies investigating the effects of household air pollution on adult acute lower respiratory tract infections. 
Study 
 
Sample 
selection  
Sample 
size 
Subject 
description 
Exposure  Outcome  Adjustment for 
confounders 
Effect size 
COHORT STUDIES 
 
Ezzati, 2001 
(265) 
 
Kenya, rural 
 
Conducted 
1996-1999 
55 randomly 
chosen 
households 
 
Response rates of 
household 
members not 
stated 
229 
individuals 
47.6% 5-14 years 
52.4% 15-49 years 
 
(Age groups 
treated as one 
category, but ALRI 
more common in 
the latter) 
 
55% female 
 
Continuous 
measurement of 
PM10 in households 
for 14-15 hours a 
day for 200 days 
ALRI (including 
bronchitis, 
pneumonia and 
broncho-
pneumonia) 
diagnosed by a 
nurse who visited 
all households 
every 1-2 weeks 
for 2 years, and 
examined anybody 
reported to have 
respiratory 
symptoms 
Adjusted for age, 
sex, smoking, 
village, and 
household 
occupancy. 
 
No adjustment for 
socioeconomic 
status, but 
homogenous group 
of participants 
Adjusted logistic regression, OR 
(95% CI, p value): 
Reference category: <200µg/m3 
PM10 
200-500 µg/m3: 1.65 (0.5-5.45, 
0.41) 
500-1000 µg/m3 1.87 (0.6- 5.71, 
0.27) 
1000-2000µg/m3 2.74 {0.93-
8.12, 0.07) 
2000-4000µg/m3 3.28 (1.09-
9.85, 0.03) 
4000-7000 µg/m3: 3.21 (1.01-
10.24, 0.05) 
>7000 µg/m3: 7.10 (2.26-22.32, 
0.001) 
 
Shen, 2009 
(264) 
 
China, rural 
 
Conducted 
1992-1996 
Identified from 
local 
administrative 
records 
44,850 
individuals 
identified 
 
42,422 
followed up 
to endpoint 
All famers in 4 
communes born 
between 1917 and 
1951 and living in 
Xuanwei on 
1/1/1976 
 
49% female 
Principal use of 
smoky or 
smokeless coal, 
and presence of 
chimney, assessed 
by standardised 
questionnaire 
Death from 
pneumonia 
obtained from 
public records of 
death certificates, 
which were 
completed by 
physicians 
Adjusted for 
annual coal use, 
stove 
improvement, 
smoking, years of 
cooking, education, 
house size and 
occupancy, coal 
mining, COPD and 
time spent indoors 
 
Cox proportional hazards 
model, HR (95%CI, p value):  
Stove improvement vs no stove 
improvement 
Men: 0.49 (0.31-0.78, 0.002) 
Women: 0.53 (0.32-0.88, 0.014) 
Smokeless coal vs smoky coal 
Men: 1.52 (0.98-2.36, 0.060) 
Women: 1.44 (0.90-2.31, 0.129) 
 
 
Continued overleaf 
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Table 3-1 continued 
Study 
 
Sample 
selection  
Sample 
size 
Subject 
description 
Exposure  Outcome  Adjustment for 
confounders 
Effect size 
CASE CONTROL STUDIES 
 
Loeb, 2009 
(266) 
 
Canada, 
urban 
 
Conducted 
2002-2005 
Cases were 
patients who 
presented to 
emergency 
departments. Not 
stated if all 
consecutive 
patients 
recruited. 
Controls recruited 
contemporaneou
sly using random-
digit dialling. 
Response rates 
not reported 
717 cases 
867 controls 
Cases: pneumonia 
patients, 40% 
female, age >65 
(mean 79) 
Controls: 
unmatched healthy 
community 
controls, 68% 
female, age >65 
(mean 74) 
The same 
geographical 
restrictions were 
used for both 
groups 
 
Recall of fireplace 
use in previous 12 
months, assessed 
by structured 
questionnaire. No 
quantification of 
exposure 
Pneumonia, based 
on appropriate 
clinical criteria plus 
radiographic 
findings, all 
performed by 
physicians 
 
Backward-stepwise 
logistic regression 
performed 
adjusting for 
multiple variables 
but fireplace use 
not retained in the 
final model so only 
unadjusted results 
reported 
 
 
Unadjusted logistic regression, 
OR (95%CI, p value): 
Fireplace use vs. no fireplace 
use 
0.69 (0.54-0.87, 0.002) 
Figueroa, 
2012 (267) 
 
Mexico, 
urban 
 
Conducted 
2000-2007 
Retrospective 
review of hospital 
records and social 
work department 
records. Implied 
that all 
consecutive 
records included 
but not implicitly 
stated 
948 cases 
1305 
controls 
Cases: bacterial 
pneumonia, 42% 
female, age >18 
(mean 55) 
 
Controls: 
otolaryngeal 
patients, 38% 
female, age >18 
(mean 32) 
Past or current 
exposure to 
woodsmoke in the 
home, based on 
retrospective 
review of 
secondary source 
documents. No 
quantification of 
exposure 
 
Bacterial 
pneumonia, based 
on retrospective 
review of hospital 
records by 
specialists using a 
standardised 
format and clinical 
definition of 
pneumonia 
Adjusted for age, 
gender, 
occupational 
exposures, Type 2 
Diabetes, smoking, 
and household 
ventilation. 
 
No adjustment for 
socioeconomic 
status or outdoor 
exposures 
Logistic regression, OR (95% CI, 
p value): 
(unadjusted results calculated 
from raw data) 
Current wood smoke exposure 
vs No current wood smoke 
Unadjusted: 2.62 (1.78-3.86, 
<0.0001) 
Past wood smoke exposure vs 
No past wood smoke 
Unadjusted: 2.14 (1.89-2.55, 
<0.0001) 
Adjusted: 1.1 (0.9-1.4, 0.5) 
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Table 3-1 continued 
Study 
 
Sample 
selection  
Sample 
size 
Subject 
description 
Exposure  Outcome  Adjustment for 
confounders 
Effect size 
CROSS-SECTIONAL STUDIES 
 
Shrestha, 
2005 (260) 
 
Nepal, rural 
(81%) & 
urban (19%) 
 
Conducted 
2003-2004 
Households 
randomly 
selected 
 
Household 
member response 
rates not stated 
98 
households 
 
168 
respondents 
94% female, mean 
age 36 years (S.D. 
16.7), minimum 
age not stated 
Use of 
“unprocessed fuel” 
(solid bio-fuels) vs 
“processed fuels” 
(gas / kerosene), 
assessed by 
questionnaire 
ALRI, based on 
physician 
examination and 
review of 
symptoms but no 
definition stated. 
Not stated 
whether 
retrospective 
diagnoses included 
 
No adjustment for 
confounders 
Unadjusted OR (95% CI): 
 
Unprocessed fuel vs processed 
fuel use 
2.69 (0.76-9.52) 
Kilabuko, 
(2007) (261) 
 
Tanzania, 
rural 
 
Conducted 
2004 
Random sampling 
of household 
 
No refusal rates 
for household 
members stated 
100 
households 
 
390 
participants 
 
No demographics 
of participants 
stated, but 
includes age 5 and 
over  
“Chief cooks” were 
mainly wives of 
household heads, 
so assumed 
predominantly 
adult but not 
necessarily 
“Chief cooks” 
compared to other 
household 
members. No 
explanation of how 
chief cooks were 
chosen or defined. 
Likely significant 
overlaps between 
2 groups. No 
quantification of 
exposure 
 
ARI, defined as 
household 
member reported 
cough with rapid 
breathing, 
assessed by 
questionnaire. 
No recall period 
defined 
 
No adjustment for 
confounders 
Unadjusted OR (95% CI, p 
value) calculated from raw data 
 
Chief cook vs other household 
members 
3.76 (2.19-6.48, <0.0001) 
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Table 3-1 continued 
Study 
 
Sample 
selection  
Sample 
size 
Subject 
description 
Exposure  Outcome  Adjustment for 
confounders 
Effect size 
CROSS-SECTIONAL STUDIES continued 
 
Stanković, 
2011 (262) 
 
Serbia, 
urban. 
 
Conducted 
2008. 
 
Individuals 
recruited from a 
health centre 
when attending 
for health checks. 
No description of 
how the sample 
was selected. 
Response rates 
not reported 
1082 
participants 
All female, age 20-
40  
Smokers and 
occupational 
exposures 
excluded 
Self-reported ‘use 
of biomass fuels’, 
assessed by 
questionnaire. No 
quantification of 
exposure 
Self-reported 
“doctor diagnosed 
pneumonia’ or 
‘doctor diagnosed 
bronchitis’ in their 
life time, assessed 
by questionnaire 
 
Adjusted for age, 
education, family 
history of 
respiratory illness 
and outdoor air 
pollution. Not 
explicit whether 
adjusted for 
environmental 
tobacco smoke, 
home dampness or 
pets. Not adjusted 
for comorbidities 
or socioeconomic 
factors 
Adjusted logistic regression, OR 
(95% CI) 
 
Biomass use vs no biomass use  
Bronchitis: 0.91 (0.71 - 1.15).  
Pneumonia: 0.99 (0.80 - 1.22). 
Taylor, 2012 
(263) 
 
Sierra 
Leone, rural 
and peri-
urban 
 
Conducted 
2011 
Participants 
randomly 
selected from all 
eligible 
individuals in the 
study area in 16 
community 
strata, using 
stratified 
sampling.  
Response rates 
not stated 
520 
participants 
All female, age 15-
45 
Kitchen location, 
type of fuel 
normally used and 
number of hours 
spent in the 
kitchen, assessed 
by questionnaire 
ARI, defined as 
self-reported 
cough followed by 
rapid breathing, 
assessed by 
questionnaire with 
a 2 week recall 
period 
Adjusted for age, 
marital status, 
kitchen type, 
smoking, housing 
type and number 
of rooms.  
 
Not adjusted for 
other pollution 
exposures 
comorbidities or 
socio-economic 
factors 
Logistic regression, OR (95% CI, 
p value): 
Wood vs charcoal  
Adjusted: 1.14 (0.71 - 1.82,  
0.580) 
Kitchen inside the main house 
vs separate kitchen 
Adjusted: 0.68 (0.38 - 1.24, 
0.210) 
Effect of spending 4-6 hours in 
kitchen or >7 hours vs <3 hours 
Unadjusted: 1.31 (0.88-1.94, 
0.179) and 2.40 (0.86- 6.72, 
0.094), respectively. 
PM10 = Particulate Matter < 10µm diameter; ALRI = Acute Lower Respiratory Infection; ARI = Acute Respiratory Infection; COPD = Chronic Obstructive Pulmonary Disease; OR = Odds Ratio; HR = 
Hazard Ratio; CI = Confidence Interval 
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3.3.6. Outcome assessments 
Two studies defined the outcome using prospective health care worker diagnosis of ALRI; in Canada, 
hospitalised cases had symptoms or signs, and radiological changes consistent with pneumonia (266); in 
Kenya, the outcome was defined as nurse-diagnosed ALRI (including bronchitis, pneumonia or broncho-
pneumonia) following review and physical examination at 1-2 weekly visits over a 2 year period (265). A 
third study, from Nepal, included a physician’s review to diagnose ALRI, but no further definition was 
provided and it is unclear whether retrospective diagnoses were included (260). The study from China 
used retrospective review of death certificate records, which had been completed by physicians on the 
basis of clinical and radiological investigations (264). Similarly, the study in Mexico used a retrospective 
review of hospital records by specialists to identify cases (267). The remaining studies used self-reported 
symptoms or past diagnoses, with varying recall periods, to define the outcome (261-263). 
3.3.7. Adjustment for confounders 
Five of the 8 studies made some adjustment for potential confounders in their analysis of the effect of 
household air pollution on ALRI (262-265, 267), but several studies failed to make adjustments for 
important potential confounders, such as economic status and smoking. 
3.3.8. Effect estimates 
The effect estimates quantified by the studies are shown in Table 3-1. There were inconsistent findings 
across the studies. Whilst the 2 cohort studies have marked differences in study design, they 
demonstrated statistically significant harmful effects of household air pollution exposure on ALRI after 
adjustment for confounders. A dose-dependent relationship between PM10 and ALRI was detected in 
Kenya,  (OR=7.10,  (95% CI 2.26 to 22.32) for exposure to >7000µg/m3 PM10 (highest exposure category) 
vs. <200 µg/m3 PM10), and a reduction in risk of pneumonia deaths was observed in participants using an 
improved coal stove instead of a traditional coal stove (OR=0.49 (95% CI 0.31 to 0.80) and 0.53 (95% CI 
0.32 to 0.88)) in Chinese men and women respectively (264). The studies from Mexico and Tanzania 
both reported harmful effects of household air pollution exposure in univariate analysis (261, 267), but 
these were no longer significant after adjustment for confounders in the Mexican study.  The studies 
from Nepal, Serbia and Sierra Leone did not identify a significant association between household air 
pollution and risk of ALRI (260, 262, 263). The study from Canada found that fireplace use (no further 
details provided) was associated with a reduction in the risk of pneumonia, although this was 
unadjusted (266).  
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3.3.9. Quality and Risk of Bias assessment 
The methodological quality of each study is summarised in Table 3-2, according to 4 domains of study 
design. An overall risk of bias is given, based on assessment of the sources of potential study bias found. 
The 2 cohort studies were considered to be of a generally higher standard, with a lower risk of bias, than 
the other studies, which were all thought to have a high risk of bias in at least 2 of 4 domains. 
Table 3-2: Assessment of risk of bias, by four domains of methodology, using the Liverpool Quality 
Assessment Tool. 
Study Subject 
Selection 
Exposure 
Assessment 
Outcome 
Assessment 
Adjustment 
for 
Confounding 
Overall Risk 
of Bias 
COHORT STUDIES 
Ezzati, 2001 
Kenya, rural 
MODERATE LOW MODERATE MODERATE MODERATE 
Shen, 2009 
China, rural 
LOW MODERATE MODERATE LOW LOW / 
MODERATE 
CASE CONTROL STUDIES 
Loeb, 2009 
Canada, urban 
MODERATE HIGH LOW HIGH MODERATE / 
HIGH 
Figueroa, 2012 
Mexico, urban 
HIGH HIGH MODERATE MODERATE MODERATE / 
HIGH 
CROSS-SECTIONAL STUDIES 
Shrestha, 2005 
Nepal, rural (81%) & 
urban (19%) 
MODERATE HIGH MODERATE HIGH MODERATE / 
HIGH 
Kilabuko, (2007) 
Tanzania, rural 
MODERATE HIGH HIGH HIGH HIGH 
Stanković, 2011 
Serbia, urban. 
HIGH HIGH HIGH MODERATE HIGH 
Taylor, 2012 
Sierra Leone, rural 
and peri-urban 
MODERATE HIGH HIGH MODERATE MODERATE / 
HIGH 
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The two studies with the lowest overall risk of bias (low/moderate or moderate rating) both found a 
positive association between air pollution exposure and ALRI risk in adjusted analyses (264, 265). Studies 
with an overall moderate/high risk of bias found either a negative association between air pollution 
exposure and ALRI risk (1 study, (266)) or had equivocal findings (3 studies, (260, 263, 267)). Of the two 
studies with the highest risk of bias, one found a positive association between air pollution exposure and 
ALRI (261) and the other had equivocal findings (262). Due to the variety of methodologies used for 
selecting participants and assessing exposures and outcomes, different aspects of different studies are 
likely to have biased the findings in both directions (towards and way from the null hypothesis). It is 
therefore difficult to establish an overall direction of bias for these studies. 
3.4. Discussion 
This chapter describes a synthesis of the current evidence base for the relationship between household 
air pollution and adult ALRI, identifying 8 eligible studies that have quantified this relationship. Despite a 
paucity of available studies, the available data provides some evidence for an increased risk of adult 
ALRI from exposure to household air pollution.  The review has highlighted disparities between the 
findings of the studies, although these are unsurprising given the methodological heterogeneity seen. 
Methodological limitations were also noted, including poor exposure and outcome classifications, and 
potential biases including selection and recall biases. The current evidence is not sufficient to make a 
direct assessment of the potential impact of household air pollution on adult ALRI. 
Methodological differences in exposure classification are a likely source of variation between study 
findings in this review. Indirect classification of exposure to household air pollution was common, and 
may have resulted in exposure misclassification. Accurate measurement of exposure to pollutants such 
as PM2.5 is challenging in the field.  Monitoring is becoming more practical, with a variety of devices now 
available, which will benefit future population studies of health impacts such as ALRI. Exposure, 
however, needs to be measured at repeated intervals to accurately classify levels for diseases with a 
long latency period from defined exposures (COPD/ALRI), and this remains a challenge.  
With regards to major sources of bias and error, the quality of studies identified was varied. Two studies 
used retrospective records of patients, and none of the prospective studies reported response or refusal 
rates of participants, so may have been subject to selection bias. Several studies did use some form of 
random sampling (although details were scarce), but the cross-sectional study from Serbia only 
recruited women who attended a health centre so the findings are not generalisable to the wider 
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population. The case-control study from Mexico used patients with otolaryngeal disease as controls, but 
as household air pollution can also be a risk factor for this outcome (2), this may have biased the 
findings towards the null. Only one study directly measured exposure to household pollutants. All other 
studies relied on questionnaire responses regarding exposures, which are prone to recall bias, with 
varying recall periods and often poor definitions of exposure. Similarly, several studies relied on 
potentially biased and inaccurate recall of previous illness; outcome misclassification may have diluted 
the true effect. Three studies used prospective assessment of patients by a health-care worker for the 
outcome classification, although the quality of definitions used varied. Three studies made no 
adjustment for confounders, and other studies failed to adjust for some important confounders such as 
smoking, and so their findings may be misleading. Four studies were cross-sectional and are therefore 
unable to establish temporality between exposure and outcome.  
Although the literature was previously reviewed as part of the Comparative Risk Assessment conducted 
for the Global Burden of Disease study 2010 (10), this review provides an update, adding 5 studies to the 
evaluation.  This review also provides a narrative summary of the current evidence which was not 
previously available, and a critical appraisal of methodological limitations. The review included a 
comprehensive search of published bibliographic databases - including databases from Africa and Latin 
America - and available grey literature, including contact with known researchers in the field 
undertaking relevant research. The review could have been enhanced with appraisal of Chinese 
language databases, as a lot of relevant research has been undertaken in relation to the Chinese 
National Stove Programme, however this was not practical. Due to the paucity of evidence, publication 
bias was not assessed.  
Diseases associated with household air pollution disproportionately affect those living in poverty, who 
rely on solid fuels to meet their energy needs (currently 3 billion people (268)). To consolidate Global 
Burden of Disease study estimates - which currently use modelled data from other sources of air 
pollution - we have attempted to quantify the association between household air pollution and adult 
ALRI. Whilst it is likely that the burden of disease from household air pollution in adults includes ALRI, 
we have not been able to confirm this association based on the current evidence. Prospective research, 
using robust direct exposure measurement and accurate classification of outcome with adjustment for 
confounders, is required to improve the evidence base. However, this is difficult to achieve in the 
challenging and resource-limited environments in low and middle income countries where exposure to 
household air pollution is mostly seen. Chapters 4 and 5 further explore the methodological challenges 
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associated with conducting such studies in resource-poor settings, with a focus on developing tools to 
improve exposure assessments.     
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4. Exploring airway macrophage particulate load from induced 
sputum as a potential biomarker of air pollution exposure 
 
4.1. Introduction 
In Chapter 3 we presented the findings of a systematic review of the literature on the association 
between household air pollution and ALRI in adults. Whilst we found some evidence for an association 
we noted important methodological limitations to the studies we included. One of these was the robust 
ascertainment of exposure to household air pollution. In this chapter we describe work exploring AMPL 
from induced sputum samples as a potential biomarker of air pollution exposure. For convenience, this 
work was completed in Liverpool, UK, taking advantage of pre-existing ethical approval for conducting 
research with respiratory patients. This study was conducted to inform the methodology for a future 
study of household air pollution and ALRI in adults in Malawi (presented in Chapter 6) and to inform the 
methodology for future trials of interventions of household air pollution reduction strategies on health 
outcomes. 
Airway macrophages (AM) are inflammatory cells that provide a first line of immunological defence in 
the lungs, by ingesting and clearing foreign bodies – including particulate matter (PM) - and pathogens. 
The phagocytic action of AM may provide the basis for a biomarker of PM exposure. The particulate load 
within AM is: increased in individuals who report exposure to household air pollution compared to those 
who do not (171); statistically different between individuals who use different types of domestic fuel 
(65); and associated with exposure to outdoor PM in commuters who cycle in London (269). Correlation 
between AMPL and worsening lung function supports a possible pathophysiological role (270). A recent 
systematic review of studies calculating AMPL concluded that this biomarker is suitable for assessing 
personal exposure to PM, but that technical improvements are needed before this method is suitable 
for widespread use (271).  
Measuring AMPL involves examining AM - usually obtained by inducing sputum using nebulised 
hypertonic saline or BAL - using light microscopy. Once cell monolayers (CytospinsTM) have been 
obtained, several different digital image analysis software programmes can be used to calculate AMPL. 
ImageJ software (http://rsbweb.nih.gov/ij/, superseding a similar software, Scion Image) and Image SXM 
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software (272) (http://www.ImageSXM.org.uk) have both been used for this purpose and are both 
available in the public domain (68, 173, 269).  
ImageJ has been shown to successfully identify areas of cytoplasm and PM, but requires the operator to 
manually adjust the threshold settings, and so is time consuming and subjective (269). The Image SXM 
method was developed to be less labour intensive and less subjective (68), and can automatically 
calculate the area of PM within a macrophage using threshold settings that are set at the beginning, 
allowing a batch of images to be analysed without further operator input. It is unknown whether these 
two methods provide comparable results, and there is no previously reported objective comparison of 
the feasibility of these two methods. Furthermore, whilst ImageJ has previously been used for induced 
sputum samples, Image SXM has only been used with BAL samples. BAL is not a feasible sampling 
method for use as a field biomarker, due to its invasive nature, but induced sputum potentially could be.  
4.1.1. Objectives 
 To establish whether Image SXM methodology can be extrapolated for use with induced sputum 
samples.  
 To compare the particulate load results obtained using Image SXM and ImageJ. 
 To provide an objective assessment of whether Image SXM and ImageJ methods are feasible – 
with regard to resources, expertise and time required - for use as a biomarker. 
Comparison of particulate load with air pollution exposure measurements is beyond the scope of this 
project, and further work to establish a correlation will be required before particulate load can be used 
as a biomarker. 
4.1.2. Contributors to the chapter 
The study was devised by myself, with input from Dr Jamie Rylance (LSTM, UK), and I wrote the study 
protocol. Ethical approval was sought by Dr Kevin Mortimer (LSTM, UK). I was responsible for all aspects 
of the study implementation, including participant recruitment (with assistance from Dr Latifa Patel and 
Kevin Mortimer), sputum induction, sputum processing (with assistance from Dr Andy Cross, University 
of Liverpool, UK), sputum analysis, data management and analysis. I wrote the manuscript for 
publication, with editing from Jamie Rylance, Latifa Patel, Stephen Gordon (MLW, Malawi) and Kevin 
Mortimer. Dr Will Monteiro and Beverley Hargadon (both Glenfield Hospital, Leicester, UK) taught me 
how to conduct sputum induction and process sputum. Dr Rossa Brugha (Barts and the London School of 
Medicine and Dentistry, UK) taught me ImageJ methodology. 
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4.2. Methods 
4.2.1. Participant involvement 
Respiratory patients were recruited via outpatient respiratory clinics at Aintree University Hospital, 
Liverpool, UK. All consenting adults over 18 years old with asthma or bronchiectasis, who did not meet 
safety exclusion criteria (according to local safety guidelines for conducting spirometry based on known 
contraindications (273), see Box 4-1), were recruited.  
 
4.2.2. Sputum induction 
Participants underwent sputum induction on one occasion each in August-October 2013 following 
standard procedures (274). Pre-procedure Salbutamol (200 micrograms) was given to prevent 
bronchoconstriction. Baseline spirometry was performed to European Respiratory Society and ATS 
standards (275) using a MicroMedical MicroLab Mk8 Spirometer (Cardinal Health UK). Three x 5mls of 
hypertonic saline (3%, 4%, 5% saline given in stepwise fashion, lasting up to 5 minutes per nebulisation) 
Box 4-1: Safety Checklist – Exclusion Criteria for Sputum Induction 
 FEV1 < 60% / < 1.0L (post Salbutamol 200 micrograms) 
 SpO2 < 90% on room air 
 Unable to take salbutamol 
 Extreme shortness of breath 
 Acute Respiratory Distress Syndrome 
 Known haemoptysis 
 Known arrhythmias/angina 
 Known thoracic, abdominal or cerebral aneurysms 
 Recent pneumothorax 
 Pulmonary emboli 
 Fractured ribs / recent chest trauma 
 Recent eye surgery 
 Known pleural effusions 
 Pulmonary oedema 
 Thrombocytopenia (Platelets < 25) 
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were nebulised via Omron NE-U17 Ultrasonic Nebuliser (Omron Healthcare Europe) to induce sputum 
production. Lung function was monitored throughout the procedure to observe for 
bronchoconstriction. If the FEV1 dropped by 10-20% during the procedure, induction was continued but 
without an increase in hypertonic saline strength. If the FEV1 dropped by more than 20% the procedure 
was abandoned for the participant’s safety. 
4.2.3. Sputum processing 
Sputum samples were processed in laboratories at Aintree University Hospital, Liverpool, UK. Sputum 
samples were kept on ice and sputum plugs were manually extracted and treated with 0.1% Sputolysin 
(Merck Chemical Ltd, UK) for fifteen minutes to remove mucus. Phosphate Buffered Solution (Sigma-
Aldrich, UK) was added and cells were filtered and centrifuged at 2200 revolutions per minute (rpm) for 
ten minutes at 4°C (Heraeus Megafuge 1.0R, ThermoFisher Scientific, USA). The pellet was re-suspended 
at 0.5x106 cells per ml and two x 100µl of suspension was cytocentrifuged (Shandon Cytopsin 4, 
ThermoFisher Scientific) onto microscope slides at 450rpm for 6 minutes to produce three cytospins per 
participant. Slides were fixed in methanol and stored until staining. One slide per participant was stained 
using Hemacolor Staining kit (Merck-Millipore, Germany) for ImageJ analysis. One slide was stained 
using Hemacolor Solution 2 (eosin) only (dipped for 9 seconds), so that only the cytoplasm was stained 
(a method previously developed for optimising Image SXM analysis (68)).One slide per participant was 
stained with Diff-Quik (Dade Behring, Deerfield, IL, USA) for differential cell counts : 400 cells were 
counted per participant, using a Leica DM IL light microscope at x40 magnification, and result are 
reported as a percentage of the total cells seen. Cytospins with a leukocyte/squamous epithelial cell 
ratio of ≤5 were deemed inadequate and therefore excluded from the analysis (276). 
4.2.4. Digital image acquisition 
Cytospin slides for ImageJ analysis were photographed at x60 magnification using Nikon Eclipse 80i 
digital microscope (Nikon Instruments Europe BV) with Nikon NIS-Elements BR software; 50 
macrophages were captured per participant where possible (in cases where less than 50 macrophages 
were present on the cytospin a reduced number was used). Slides for Image SXM analysis were imaged 
at x40 magnification using a Leica DM IL light microscope (Leica Microsystems UK Ltd) with a Nikon E990 
digital camera (Nikon Inc., USA); where possible 50 microscope fields (with at least one macrophage per 
field) were captured per participant - all the macrophages captured in a field were analysed. In cases 
where less than 50 images from the whole cytospin contained a macrophage this reduced number of 
macrophages-containing images, and all macrophages within those images, were included in the 
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analysis. Images for both methods were taken systematically using a predefined method to prevent 
duplication or biased image selection, as shown in Figure 4-1.  
 
Figure 4-1: Systematic digital image acquisition.  
The pathway used to acquire digital images of 
cytospin ‘spots’ is shown. 
 
4.2.5. Image SXM analysis 
Image SXM automatically calculates the area of cytoplasm within an image and the area of PM within 
that cytoplasm. As I intended to calculate the amount of carbon within macrophages only, other cells 
and debris were removed by hand from the images prior to the analysis using Adobe Photoshop 
Elements version 6.0, to prevent incorrect calculations of cellular and PM areas (Figure 4-2). Image SXM 
(version 1.92, April 2011) variable settings were optimised for cytoplasm (upper and lower size limits 
and density threshold) and PM (density threshold) detection by adjusting settings for a range of images 
from different participants. Values which consistently maximised identification of PM without increasing 
false positive identification were used. These settings were then applied to the analysis of all images 
from all participants. Fifty images per participant were analysed to generate output images (Figure 4-2) 
and the arithmetic mean percentage of total cellular area occupied by PM was calculated by Image SXM. 
The blink comparison function, which provides an overlay of images, was used to compare original and 
output images; subjective discordance between total cellular or PM area led to removal of that image 
from the analysis. Participants with fewer than ten images remaining were excluded from the analysis.  
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Figure 4-2: Image SXM methodology.  
Digital images of the cytospins (a) were edited to remove all non-
macrophage cells and debris (b). Image SXM then calculated the area of 
cytoplasm (blue) and particulate matter (red), mapped out in the 
output image (c). 
 
4.2.6. ImageJ analysis 
A stage micrometer (Agar Scientific, UK) was used to calibrate image size. Colour images were converted 
to 32-bit black and white images using ImageJ (version 1.46r). The “threshold” settings were manually 
adjusted to obtain the best fit of red over black areas (264) (Figure 4-3). The freehand select function 
was used to select PM (Figure 4-3) that was within the cell, and to exclude red areas other than PM, 
such as nucleus. ImageJ calculated the area of PM within the selection. Thresholds were adjusted to 
obtain the best fit for different particle aggregates in each macrophage. The median area from 50 
macrophages was calculated. This methodology is a refinement of previously used techniques (269), 
a 
b 
c 
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adapted from earlier Scion Image methodology (171).  Since publication of this methodology, the 
technique has been refined by the same research group and no longer requires editing of images to 
remove the nucleus, as the same results can be achieved by using the freehand select function to select 
the particles (personal correspondence, Dr R. Brugha, Barts and the London School of Medicine and 
Dentistry). 
 
Figure 4-3: ImageJ methodology.  
The threshold level was adjusted until the 
areas black of particulate matter seen in 
the original image (a) turned red (b). The 
particulate matter was then selected using 
the freehand selection function (c). 
 
a
 
 
b 
b 
c 
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4.2.7. Feasibility comparison of methods 
The time taken for image capture and analysis of the final 11 samples was recorded, along with an 
inventory of the required equipment and expertise for each method. The analyses for the first two 
participants were not timed, to prevent inaccurate results whilst becoming familiar with the 
software programmes. 
4.2.8. Statistical analysis 
Data was analysed using SPSS v21. As Image SXM calculates the mean proportion of cytoplasm occupied 
by PM in 50 macrophages, whereas ImageJ calculates the area of PM (in μm2) per macrophage, the 
results cannot be directly compared. Results for each method were therefore ranked according to 
particulate load, and the rank order was compared using a Spearman Rank Order Correlation test. 
Participant characteristics were compared using Chi-square and Mann-Whitney U tests. Time taken to 
conduct the analyses was compared by Wilcoxon Signed Rank test. A p value of <0.05 was considered 
statistically significant.  
4.2.9. Ethical approval 
The East Midlands – Derby 1 Research Ethics Committee (REC)2 approved this work (REC reference: 
11/EM/0269). Written informed consent was obtained from all participants. 
4.3. Results 
4.3.1. Sputum induction 
21 participants were recruited and attended for sputum induction and 1 participant was excluded due to 
baseline hypoxia (28 other recruited participants failed to attend). Of 20 participants undergoing sputum 
induction, samples were successfully obtained from 19 (Figure 4-4). No adverse events occurred. 
Cytospins from six (32%) participants were inadequate due to their leukocyte/squamous epithelial cell 
ratio. The characteristics of the 13 participants who provided an adequate sample are shown in Table 
4-1. There was no significant difference in characteristics between those who provided an adequate 
sample and those who did not (data not shown). The differential cell counts are shown in Table 4-2. 
                                                          
2 Approval was awarded by a REC outside of Liverpool due to a system in which the next available REC in the NHS 
Health Research Authority reviews applications for ethical approval. 
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Figure 4-4: Participants and samples.  
The flow chart shows the number of consented and recruited patients, and how many samples were obtained and included in the 
final analysis. 
 
4.3.2. Feasibility of methodology 
Median time for analysis of each participant was significantly lower for ImageJ (26 mins, interquartile 
range (IQR): 21-30) than for Image SXM (54 mins, IQR: 43-68), p=0.008. Including the time taken for 
image acquisition, the median time was not significantly different between ImageJ (51 mins, IQR: 46-65 
mins) and Image SXM (66 mins, IQR: 59 – 84), p = 0.424. For the Image SXM method, 58% of the 
‘analysis time’ was spent editing the images prior to analysis: editing the images to remove non-
macrophage cells and debris using Adobe Photoshop Elements was necessary (a step not required when 
using BAL samples).  
 
 
 
76 
 
Table 4-1: Characteristics of 13 participants. 
Participant characteristic  
Gender Male, n (%) 9 (69) 
Female, n (%) 4 (31) 
Age Median (IQR) 57 (39-67) 
Respiratory 
diagnosis 
Asthma, n (%) 8 (62) 
Bronchiectasis, n (%) 2 (15) 
Both, n (%) 3 (23) 
Smoking status Never smoked 8 (62) 
Ex-smoker 5 (38)  
Spirometry FEV1, median (IQR), litres 1.80 (1.47-2.26) 
FEV1 % Predicted*, median (IQR) 73.5 (60.1 - 77.6) 
FVC, median (IQR), litres 2.8 (2.47 – 3.82) 
FVC % predicted*, median (IQR) 91.2 (87.6 – 109.0) 
*Normal values: FEV1 % Predicted and FVC % Predicted: ≥80%  
IQR: Interquartile Range; FEV1: Forced Expiratory Volume in 1 second; FVC: Forced Vital Capacity. 
 
Table 4-2: Differential cell counts. 
Cell type Cell count (%) 
(Median (IQR) of 13 participants) 
Neutrophil 72.5 (51.1-90.1) 
Macrophage 10.0 (4.1-25.8) 
Eosinophil 1.6 (1.0-8.5) 
Lymphocyte 2.3 (1.2-3.5) 
Metachromatic 0.0 (0.0-0.0) 
Bronchial epithelial 2.8 (1.1-12.6) 
Squamous epithelial 2.3 (0.8-6.5) 
Normal values (median %): neutrophils 24.1%, macrophage 62.9%, eosinophils 0.5%, lymphocytes 1.3% (274).  
IQR: Interquartile Range 
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A mean of 49 macrophages per participant were included in the ImageJ analysis (total 632 
macrophages). A mean of 43 images of per participant were captured for Image SXM analysis (total 558 
images). During the Image SXM process, 72% of images were removed following the initial analysis as 
they were deemed to be inaccurate (either over- or under-estimating AMPL) using the blink comparison 
function (Figure 4-5), resulting in a further four participants being excluded from the study. The analysis 
was repeated with only the remaining 143 images (median 14 images (IQR 11.5-20) per participant). If 
only these nine participants are included, median time taken increased to 67 mins (IQR 47-72) for Image 
SXM analysis and 83 mins (IQR 64-87) including image acquisition time.  After this second analysis, the 
images were visually checked again: it appeared that some images – which had been accurately 
analysed during the first analysis – were inaccurately analysed in the second analysis, despite threshold 
settings remaining the same (Figure 4-6). Further exclusion of images and repeat analysis was not done 
at this stage, as the process was deemed inaccurate, inconsistent and unfeasible. 
 
Figure 4-5: An example of inaccurate Image SXM analysis.  
Comparing the original image (a) to the output image (b), the cytoplasmic 
area (blue) of the airway macrophage on the left has been overestimated, 
and the particulate matter (red) of the airway macrophage on the right has 
been overestimated. 
 
 
a 
b 
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Figure 4-6: An example of inconsistent SXM analysis. 
The same image of the same AM was analysed twice using the same threshold settings. The output image 
from the first analysis (a) is grossly different to the output image from the second analysis (b). 
A comparison of the resources required for each method is shown in Table 4-3. ImageJ software can be 
downloaded for free for use with both Windows and Mac operating systems. Image SXM software can 
also be downloaded for free, but can only be used with a Mac operating system, and Adobe Photoshop 
Elements software must be purchased. Whilst the Image SXM process only requires a microscope (with 
digital image acquisition capabilities) with a x40 objective, the ImageJ process should be used with a 
x100 objective. In this study a x60 objective was used, as greater magnification was not available. 
4.3.3. Airway macrophage particulate load 
Considerable morphological heterogeneity was seen between AM, both within samples and between 
participants, with wide variations in AMPL (Figure 4-7). The cytoplasms of the AM in this study were 
noted to be granular and heterogeneous (Figure 4-7), unlike the homogenous appearance of cytoplasm 
seen in macrophages obtained by BAL (65). 
ImageJ analysis of 13 cytospins revealed a median AMPL of 0.38µm2 (IQR 0.17-0.72 µm2) (Table 4-4). 
Image SXM analysis of 9 cytospins calculated a median total cellular area occupied by PM of 4.0% (IQR 
2.3-6.0%) (Table 4-4). There was no statistically significant correlation between results obtained using 
the two methods (correlation coefficient = -0.42, p = 0.256). 
 
 
 
a b 
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Table 4-3: Comparison of resource requirements for methods. 
Resource Image SXM ImageJ 
Equipment required for sputum 
induction and sample processing 
Identical specialist equipment and facilities required regardless of 
analysis method 
Image acquisition equipment Microscope with x40 objective 
and digital image capturing 
capabilities 
Microscope with x100 objective 
and digital image capturing 
capabilities 
Analysis software availability In the public domain – available 
free of charge 
In the public domain – available 
free of charge 
Additional image editing software Purchase required Not required 
Operating system for analysis 
software  
Compatible with Mac operating 
systems 
Compatible with Mac and 
Windows operating systems 
File type availability TIFF JPEG, TIFF, GIF, BMP, DICOM, FITS 
and ‘raw’ 
Time required for sputum induction 
and processing 
Approximately 90-120 minutes per participant 
Time required for image acquisition 15 min 27 min 
Time required for image analysis 
(including image editing if required) 
54 min 26 min 
 
 
 
Figure 4-7: Airway macrophage heterogeneity.  
The morphology of airway macrophages (shown with red arrows) was varied within the same sample 
(a) and between different participant samples (a & b). The particulate load also varied between 
macrophages in the same sample (a). 
a b 
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Table 4-4: Airway macrophage particulate load results using Image SXM and ImageJ methodology. 
Participant Image SXM Result  
Mean cytoplasmic area occupied by 
particulate matter, % (standard error) 
ImageJ Results 
Median particulate load per 
macrophage, µm2 
1 2.5 (0.5) 0.64 (0.00 - 2.10) 
2 4 (2) 0.70 (0.00 - 2.93) 
3 6 (5) 0.20 (0.00 - 1.64) 
4 6 (4) 0.34 (0.00 - 2.53) 
5 1 (2) 0.73 (0.00 - 3.83) 
6 3 (3) 0.38 (0.00 - 2.31) 
7 6 (5) 0.00 (0.00 - 0.13) 
8 Rejected 0.13 (0.00 - 2.47) 
9 Rejected 0.33 (0.00 - 0.77) 
10 11 (7) 2.41 (0.00 - 4.88) 
11 2 (0.5) 2.42 (0.35 - 5.71) 
12 Rejected 0.00 (0.00 - 0.79) 
13 Rejected 0.63 (0.00 - 1.51) 
 
4.4. Discussion 
A biomarker which can be used in the field to assess an individual’s air pollution exposure will be a 
valuable tool for research into the health effects and benefits of interventions. This study set out to 
explore the feasibility of using induced sputum samples for assessment of AMPL as a potential 
biomarker.  
Although the procedure was well-tolerated by all participants who underwent sputum induction, there 
was a low appointment attendance rate despite multiple appointments being offered at their 
convenience. This may be due to participant’s availability, but may also reflect an unwillingness to 
undergo the procedure suggesting that sputum induction may not be acceptable to the wider 
community. A third of participants were unable to produce adequate samples. These factors resulted in 
a small sample size, a major limitation of this study, but also reflects a potential limitation in the 
feasibility of using induced sputum as a biomarker. 
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The time taken for the Image SXM method was substantially lengthened by the need to manually edit 
images prior to analysis to improve accuracy. This editing is not required when using this software with 
BAL samples, which tend to have few other cells or debris. This negates one major perceived advantage 
of using Image SXM, which was previously seen to be quicker, easier and more automated than ImageJ. 
Despite editing images to improve quality, this study has demonstrated that Image SXM makes 
inaccurate assessment of the majority of images, with 72% of images needing to be removed following 
inspection. This substantially reduces the number of macrophages included in the analysis, thereby 
reducing the accuracy of the estimate for particulate load obtained. 
ImageJ was the quicker method for image acquisition and analysis (median 51 minutes). Image capturing 
software used in this study for the ImageJ method delayed the process by approximately 15 minutes. A 
limitation of this study as there was that different equipment was used for acquiring images for the two 
methods, as there was no equipment available with both a x40 and x60 (or x100) objective. In future 
studies, if a simpler method for acquiring images at x60 or x100 magnification is available then this could 
reduce the amount of time required for the ImageJ method. However, when combined with the time 
taken for sputum induction and processing (usually >90 minutes), this process is unlikely to be feasible 
for widespread use in large studies given the total time required (>2 hours per participant).  
Both methods require considerable expenditure for clinical and laboratory equipment. Previously 
published studies using ImageJ method report using a microscope with a x100 objective, while the 
Image SXM method requires a x40 objective, both with digital image acquisition capabilities. In this 
study a x60 objective was used for the ImageJ method, as greater magnification was not available with 
digital image capturing capabilities. Although this may have theoretically reduced the accuracy of the 
ImageJ methodology in this study, I experienced no difficulties visualising PM within the macrophages 
and still found ImageJ to be the more reliable of the two methods for detecting PM. As I do not 
comment on the accuracy of the ImageJ method in comparison to a gold standard assessment of 
exposure, this limitation of this study does not have a major impact on the findings. However, it does 
emphasise the need for specialised equipment, which has implications for feasibility. 
Both software programmes are available free of charge but ImageJ is more widely compatible. Image 
editing software must be also purchased if using Image SXM with induced sputum. The facilities and 
equipment required for inducing and processing sputum are likely to preclude the use of this technique 
in rural or resource poor settings.  
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A further limitation of this study is that image capture of macrophages – which can be difficult to 
differentiate from other cell types (particularly on cytospins stained only with eosin for Image SXM 
analysis) - was only performed by one reader, with support from a senior cell biologist, without a priori 
criteria for inclusion.  This may have resulted in incorrect identification of some cells. Independent 
image capture and slide analysis by two individuals with a high level of expertise may improve accuracy 
of macrophage identification, although this represents an additional challenge for implementing these 
methods in resource limited settings.  
ImageJ method requires higher levels of operator training for image analysis than Image SXM, due to the 
subjective nature of the analysis process. Further work to assess intra- and inter-observer reliability 
using the ImageJ method is required before this is widely used – this was not evaluated as part of this 
study in which only one unblinded reader performed the analysis. 
Although previously successfully used with BAL samples, Image SXM appears to not perform as well with 
induced sputum macrophages. This is possibly due to the heterogeneous and granular nature of these 
macrophages making it difficult for the software to distinguish between cytoplasm and PM, as has been 
observed in previous studies (271). I postulate that the difference in appearance compared to BAL 
macrophages is either due to these being a different population of macrophages, taken from a more 
proximal part of the airways, or due to cell stress or apoptosis resulting from the sputum induction 
process, although I did not measure cell viability in this study. Steps were taken to ensure threshold 
settings were optimised for this batch of images, but due to the heterogeneity seen these settings were 
not always optimal for each individual image. Image SXM does include an option to adjust the threshold 
settings manually for different images. This might improve accuracy but would make the process more 
time-consuming, and would not account for heterogeneity of macrophages within the same image 
(Figure 4-7). Optimising the threshold settings for each image might reduce the number of images 
discarded from Image SXM following visual checking for accuracy (Figure 4-5). This might increase the 
sample size and therefore the precision of estimates, although would make the process more subjective. 
Of major concern is that, when the Image SXM analysis was repeated (following removal of images), the 
retained images often had different results to the results for the same images in the initial analysis, 
despite no change to the software settings. This has highlighted worrying inconsistencies with software, 
leading to inaccurate estimates of particulate load. 
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The lack of correlation observed in AMPL results between the two methods is unsurprising given some 
of the difficulties outlined above. To determine the accuracy of either method, comparison with an 
external comparator is required, such as an individual’s PM exposure data. This, and assessment of 
intra- and inter-observer reliability, were beyond the scope of this study. An association between AMPL 
calculated and the number of peak exposures to PM has been demonstrated in London cyclists (277), 
but further exploration of this relationship in other settings is required. The results obtained by the 
ImageJ method in this study are comparable to that of healthy British children (0.41 µm2 PM per 
macrophage) (270). Other studies using ImageJ methodology have suggested that AMPL does correlate 
with exposure (171, 270).  
Given the fundamental role of AM in the defence against inhaled pollutants, further exploration of the 
relationship between AMPL and pathophysiology is an intuitive way to improve understanding of the 
health impacts of air pollution. Optimising digital analysis software or using alternative methods for 
quantifying AMPL, such as spectrophotometry, may assist with this, but is unlikely to provide a useful 
field biomarker of exposure. 
Direct measurement of air pollution exposure is costly, logistically complicated and intrusive to the 
individual. Studies investigating the health impacts of air pollution exposure and the benefits of 
interventions are limited by the challenges associated with accurately quantifying exposure (170). A 
biomarker of air pollution exposure will be a useful tool to facilitate research addressing the high burden 
of disease associated with air pollution. This small study has not established whether AMPL is an 
accurate biomarker of pollution exposure, but has identified that digital analysis AMPL from induced 
sputum samples is unlikely to be appropriate for widespread use as a tool for large-scale clinical 
epidemiological and intervention studies. Priority should be given to developing a point-of-care 
biomarker of exposure, without the need for specialist training and equipment, to facilitate the large 
public health intervention trials that are urgently needed. Potential biomarkers requiring further 
exploration include direct measures of combustion products, such as eCO (explored further in Chapters 
5 and 6), exhaled carboxyhaemoglobin, exhaled volatile organic compounds or levoglucosan and 
methoxyphenols in urine (168, 170, 174, 278, 279). Indirect measures of exposure in sputum, blood and 
urine, including markers of oxidative stress and endothelial or epithelial damage (such as 8-isoprostane, 
malondialdehyde, nitric oxide, or surfactant-associated protein D), may also be promising biomarkers.  
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5. Exploring exhaled carbon monoxide as a potential biomarker of 
air pollution exposure: a feasibility study for a randomised controlled 
trial of a cookstove intervention in Malawi 
 
5.1. Introduction  
In Chapter 4 we explored AMPL from induced sputum as a potential biomarker of air pollution exposure 
for use in a future study of household air pollution and ALRI in adults. We concluded that this approach 
would not be suitable for use on scale in future clinical epidemiological and intervention studies and 
that other potential biomarkers including eCO should be looked at instead. In this chapter we describe a 
pilot intervention study in which we evaluate the feasibility of using eCO as a biomarker of household air 
pollution.  
5.1.1. Objectives 
 To determine whether eCO is a feasible biomarker of household air pollution that can be used in 
Malawi. 
 To determine whether research of household air pollution exposure and its health effects is 
feasible in Malawi. 
5.1.2. Contributors to this chapter 
The study was designed by Dr Kevin Mortimer (LSTM, UK) and Professor Stephen Gordon (MLW, 
Malawi), with input from Vincent Doyle (Concern Universal, Malawi), Conor Fox (Clioma Ltd, Malawi), 
Elizabeth Banda (Clioma Ltd, Malawi), Christa Roth (Fuel and Food Consultants, Germany) and Dr Sean 
Semple (University of Aberdeen, UK). I oversaw the set of up study activities in Malawi. James Kachidihu, 
Howard Bandah and Macfary Kapanga (all Concern Universal, Malawi) performed participant 
recruitment and data collection, under supervision of myself and Kevin Mortimer. I performed data 
analysis and synthesis of the feasibility report.  
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5.2. Methods  
5.2.1. Participants and setting 
Women living in Ntcheu (a rural district in central Malawi) who cooked on traditional open wood fires 
(Figure 5-1), but wished to purchase a Chitetezo stove (see section 5.2.2.), were invited to take part in 
this pilot randomised controlled trial (RCT). Community engagement meetings were held by study 
workers prior to commencing the study and informed written consent was subsequently obtained in 
private. The consent process was completed in Chichewa, the local language. Individuals were excluded 
if they were current smokers or lived with a smoker. Inclusion and exclusion criteria are shown in Box 5-
1. 
Box 5-1. Inclusion and exclusion criteria 
 
Inclusion Criteria 
 Female 
 Lives in Ntcheu district 
 Interested in purchasing a Chitetezo 
stove 
 Uses an open fire 
 
Exclusion Criteria  
 Current smoker 
 Lives in same household as a smoker 
 
5.2.2. Intervention  
The Chitetezo stove is a simple clay cookstove (Figure 5-1) for burning solid fuels which was chosen as 
the intervention in this study as it reduces fuel consumption by approximately 40% compared to a 
traditional “three-stone” fire (62), it is produced locally using local materials (by women’s production 
groups in villages) and has a low cost (approximately $2USD). 
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Figure 5-1: Cooking practices in rural Malawi 
 a) A traditional open “three-stone” wood fire; b) a wood burning clay stove (Chitetezo). 
Women in the intervention group purchased a Chitetezo stove on the day of recruitment, or the 
following day. They were asked to stop using their traditional open wood fire and commence cooking on 
their Chitetezo stove with immediate effect, following instructions from the study workers regarding use 
and maintenance. Women in the control group were asked to continue cooking on a traditional open 
wood fire and were able to purchase a Chitetezo stove seven days later. 
5.2.3. Randomisation 
Women were individually randomised to one of two parallel groups, in a 1:1 ratio with block 
randomisation (block size 10), generated using a random number table. Randomisation was concealed 
using pre-prepared, sequentially numbered, opaque sealed envelopes.  
5.2.4. Blinding 
Study workers and participants were not blinded to group allocation following the randomisation 
process. 
5.2.4.1. Primary outcome 
The primary outcome of this study was the feasibility of conducting research to assess the impact of a 
cookstove intervention in this setting, including exploring any logistical challenges faced. Due to the 
exploratory nature of this study no hard outcomes were measured, but feasibility was assessed by 
considering details such as participant recruitment, retention rates, and data completeness.  The 
acceptability of the research methodology to the study population was also considered. 
a b 
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5.2.4.2. Secondary outcomes 
Given the pilot nature of this study, the performance or impact of the Chitetezo stove were not assessed 
but data regarding household air pollution exposure and health were collected as secondary outcomes, 
to provide insight into the feasibility of assessing these outcomes. Exposure outcomes included eCO 
levels (potential biomarker of exposure), household PM2.5 (particulate matter <2.5µm diameter) levels 
and ambulatory CO levels. Health outcomes included symptom burden (including respiratory, ocular, 
backache and headache symptoms in the preceding seven days) and oxygen saturations (SpO2). 
Secondary outcomes were measured at baseline and seven days.  
5.2.5. Data collection 
5.2.5.1. Household air pollution exposure assessments 
Handheld CareFusion MicroCO meters were used to assess eCO levels as a single measurement at both 
baseline and Day 7 assessments. 
Pollution exposure monitoring was performed for a minority of women (limited by the number of 
monitors available) at baseline and Day 7 assessments. A TSI SidePakTM Personal Aerosol Monitor 
AM510, used to measure PM2.5 in real time, was placed in a woman’s home for 24 hours.  Personal CO 
monitors (Lascar USB Dataloggers), which clipped to clothes, were worn continuously for 24 hours. 
5.2.5.2. Health assessments 
Questionnaire data were collected in the villages using a paper based case report form then collated in 
an Excel spreadsheet by a study worker. SpO2 was measured using finger pulse oximeters. 
5.2.6. Sample Size 
A convenience sample of 50 participants (including both groups) was chosen based on the requirement 
to assess feasibility of study methodology, rather than to detect any clinical difference between the two 
groups.  
5.2.7. Compensation 
Women were compensated for their inconvenience with a gift to the value of approximately $2 USD.  
This gift varied between villages, depending on what was agreed prior to the recruitment process, and 
included either Pigeon Pea seeds or a Chitetezo stove.  
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5.2.8. Statistical Methods and Analysis 
SPSS Statistics 19 was used to analyse data. Histograms were reviewed to assess data distribution. Chi-
square tests or Fishers exact tests for comparison of categorical data between the two groups, and 
Mann Whitney U-tests for continuous data. A p-value of <0.05 was considered to be statistically 
significant. Missing data were excluded from the analysis on a case-by-case basis for health and 
exposure outcomes. Feasibility and acceptability aspects were reviewed through dialogue with all 
members of the study group during and after completion of the study.  
5.2.9. Ethical Approval 
This work was carried out through collaboration between LSTM, Concern Universal 
(www.concernuniversal.org), and Clioma Ltd (Malawi registered consultancy company).  Staff from 
Concern Universal provided the study group with access to these communities, and approval of village 
elders was sought. The study received ethical approval from the LSTM REC (11.74) and the College of 
Medicine REC (University of Malawi) (P.07/11/1103).  The study was registered with the Pan African 
Clinical Trials Registry (PACTR201110000324321). 
5.3. Results  
5.3.1. Recruitment 
The study took place in November-December 2011. All women approached were keen to participate. 
Two women were not eligible for participation due to exclusion criteria (Figure 5-2). Following 
assessment by 2 study workers, one elderly woman was deemed unable to give informed consent due 
to a lack of understanding. Fifty-one women were recruited from 5 villages and recruitment stopped 
once the desired sample size had been reached.  No adverse events occurred during the study. Although 
all of the recruited women wished to purchase a Chitetezo stove, many were unable to afford this on 
the day of the visit – therefore many opted to have a Chitetezo stove as their compensation gift, in order 
to allow them to participate. 
5.3.2. Randomisation 
26 women (51%) were randomised to the control group and 25 (49%) to the intervention group (Figure 
5-2). There were no objections raised to the randomisation process or to a delay in receiving a Chitetezo 
stove.  
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Figure 5-2: Consort flow diagram showing recruitment to the study, randomisation and loss to follow up. 
 
5.3.3. Retention 
50 women (98%) completed the main study – one woman from the intervention group did not attend 
the follow-up session.  
5.3.4. Baseline data 
As shown in Table 5-1, limited resources were available to the participants. Sources of household air 
pollution exposure are reported in Table 5-2. Almost all participants (98%) used wood as their primary 
fuel source and most cooked inside a building separate from their main house in both dry and wet 
seasons. The majority of women did not use any form of heating. Simple battery powered light-emitting 
diode lights were used by 90% of women. All of the women denied any other forms of smoke exposure. 
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Table 5-1: Baseline characteristics of study participants. 
Parameter Control  Group (n=26) Intervention Group (n=25) Total 
(n=51) 
n (%) 
 
n (%) 
Missing data 
n (%) 
 
n (%) 
Missing data 
n (%) 
Age  – median [IQR]  36.5 [36.0]  2 (7.7) 33.0 [18.0] 0 (0) 38.1 [15.5] 
Number of rooms in 
household - mean ± STD 
2.5 ± 0.9 0  2.6 ± 1.0 0  2.5 ± 0.9 
Number of adults in 
household - mean ± STD 
1.8 ± 0.4 2 (7.7) 2.2 ± 0.6 1 (4.0) 2.0 ± 0.5 
Number of children in 
house – median [IQR] 
1.5 [2.0] 2 (7.7) 2.0 [2.0] 1 (4.0) 1.9 [1.6] 
Roof type 
          Corrugated 
          Grass 
 
21 (80.8) 
5 (19.2) 
0   
22 (88.0) 
3 (12.0) 
0   
43 (84.3) 
8 (15.7) 
Window type 
          No window 
          Space only 
          Glass 
 
6 (25.0) 
10 (41.7) 
8 (33.3) 
2 (7.7)  
2 (8.7) 
12 (52.2) 
9 (39.9) 
2 (8.0)  
8 (17.0) 
22 (46.8) 
17 (36.2) 
Water supply type 
          Communal pipe 
          Well / bore hole 
          River / other  
Communal pipe & 
well or bore hole 
 
5 (19.2) 
8 (30.8) 
1 (3.8) 
12 (46.2) 
0   
7 (28.0) 
10 (40.0) 
0 (0) 
8 (32.0) 
0   
12 (23.5) 
18 (35.3) 
1 (2.0) 
20 (39.2) 
Owned by a member of 
the household 
          Car 
          Motorcycle 
          Bicycle 
          Radio 
          Refrigerator 
          Television 
          Telephone 
          Computer 
 
 
0 (0) 
0 (0) 
10 (38.5) 
7 (26.9) 
0 (0) 
1 (3.8) 
5 (19.2) 
0 (0) 
0   
 
0 (0) 
0 (0) 
11 (44.0) 
11 (44.0) 
0 (0) 
0 (0) 
7 (28.0) 
0 (0) 
0  
 
0 (0) 
0 (0) 
21 (41.2) 
18 (35.3) 
0 (0) 
1 (2.0) 
12 (23.5)  
0 (0) 
IQR = interquartile range; STD = standard deviation 
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Table 5-2: Participant household air pollution exposure at baseline. 
Parameter Control  Group (n=26) Intervention Group (n=25) 
 
n (%) 
Missing data 
n (%) 
 
n (%) 
Missing data 
n (%) 
Primary cooking method 
          Wood 
          Mbaula* 
 
24 (96.0) 
1 (4.0) 
1 (3.8)  
24 (100.0) 
0  
1 (4.0) 
Secondary cooking method 
          None used 
          Wood fire 
          Mbaula* 
          Crop residue fire 
 
21 (84.0) 
1 (4.0) 
2 (8.0) 
1 (4.0) 
1 (3.8)  
24 (100.0) 
0  
0  
0  
1 (4.0) 
Dry season primary cooking location 
          Inside main living area 
          Elsewhere inside main house 
          Separate building 
          Outside 
 
0  
2 (8.0) 
17 (68.0) 
6 (24.0) 
1 (3.8)  
1 (4.0) 
2 (8.0) 
21 (84.0) 
1 (4.0) 
0 
Wet season primary cooking location 
          Inside main living area 
          Elsewhere inside main house  
          Separate building 
          Outside 
 
0  
2 (8.0) 
17 (68.0) 
6 (24.0) 
1 (3.8)  
1 (4.0) 
2 (8.0) 
21 (84.0) 
1 (4.0) 
0 
Primary heating method 
          No heating used 
          Wood fire 
          Mbaula* 
 
21 (80.8) 
3 (11.5) 
2 (7.7) 
0  
21 (84.0) 
4 (16.0) 
0  
0 
Primary lighting method 
          No lighting used 
          Paraffin / kerosene lamp 
          Battery powered torch 
          Hurricane lamp 
 
2 (7.7) 
2 (7.7) 
21 (80.8) 
1 (3.8) 
0   
0  
0  
22 (100.0) 
0 
3 (12.0) 
Exposure to other smoke sources 
          None 
 
25 (100.0) 
1 (3.8)  
25 (100.0) 
0 
*Traditional stove. 
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5.3.5. Exposure measurements 
No problems with measuring eCO were encountered: participants had no objections or difficulties 
performing the test correctly, and we experienced no faults with the equipment. Median eCO was 2 
(IQR 2) and 3 (IQR 2) for the control and intervention group at baseline respectively. At follow-up, 
median eCO was 3 (IQR 2) and 2 (IQR 1) for these groups respectively. The median change in eCO from 
baseline to follow-up was significantly different between the two groups (median change in eCO 0.0ppm 
(IQR 3) and -0.5ppm (IQR 3) for the control group and intervention respectively, p=0.035). 
Four women (two from each study group) wore personal CO monitors for 24 hours at baseline and 
peaks of up to 150ppm were detected ( 
 
Figure 5-3). One of these women (control group) declined to wear the CO monitor at follow-up due to 
beliefs regarding the monitor removing oxygen from the air. The results for the remaining three women 
at follow-up are shown in  
 
Figure 5-3. One static PM monitor was placed in the home of a participant for 24 hours at baseline and 
follow-up (data not shown). It was  
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Figure 5-3: Personal exposures to CO at baseline and at follow-up in four participants.   
These graphs show the detected level of ambient CO over two separate 24-h periods, measured by personal CO monitors (Lascar 
USB Dataloggers), which clipped to the clothes of four participants at baseline (left) and three participants at 7-day follow-up (right). 
A peak reading of 150ppm was detected. The black dotted line indicates the level the WHO considers unsafe if exposed for >1 hour 
(26ppm). Participants 1 & 2 were in the intervention group, participants 3 & 4 were in the control group. WHO = World Health 
Organization; ppm = parts per million; CO = carbon monoxide. 
 
not possible to leave the monitor in the separate building where this woman cooked due to security 
concerns so it was instead placed inside her main living area (where there was no fire). National fuel 
shortages during the study period resulted in logistical difficulties relating to delivery and collection of 
air pollution monitors to the rural areas. 
5.3.6. Symptom Burden and Oxygen Saturations 
All of the recruited women completed the questionnaire, with no objections raised to any of the 
questions asked. Headache, back pain and cough were the most commonly reported symptoms at 
baseline (Table 5-3). Of those reporting a headache at baseline, the median number of days that 
headache had been experienced in the seven days preceding baseline was 3 (IQR 2-4) with those 
reporting back pain having experienced it for median 5 days (IQR 2-7). Symptom burden at follow-up 
was very similar (Table 5-3).  There was no significant difference in change in symptoms over the seven 
day period between the two groups (data not shown).  
No problems with measuring SpO2 were encountered. Median SpO2 when breathing room air was 98% 
and 99% in the control group and intervention group at baseline respectively, and 99% in both groups at 
follow-up.  
5.4. Discussion  
This study demonstrated that, despite the significant logistical challenges faced, it is feasible to conduct 
clinical epidemiological and intervention studies addressing household air pollution in Malawi and that 
eCO is an appropriate methodology for use in this context. The exploratory nature of this study, using a 
convenience sample, does not provide objective evidence regarding the effects of the intervention, but 
provides important insights into the feasibility of the research methods used which can inform future 
studies. The high level of interest observed in participating villages, including village elders, suggests that 
larger studies will be possible.  Recruitment and retention rates over this short study period were 
excellent. The main findings of this feasibility study were that the methodologies used, including 
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randomisation, a short delay in receiving the cookstove, eCO measurement, household and ambulatory 
air pollution exposure monitoring, personal health questionnaires and SpO2 measurement were 
acceptable to the participants. As the compensation gift given to participants was approximately the 
same value as the cost of the cookstove ($2), we are unable to comment on the willingness of 
individuals to purchase a stove, but this was not an objective of the study. Difficulties relating to 
superstitious beliefs were encountered with a minority of women. Larger studies will require careful 
community sensitisation to address superstitious beliefs and achieve excellent retention rates.  
Table 5-3: Symptoms reported at baseline and follow-up. 
Symptom Control Group  Intervention Group  P value 
 
n (%) 
Missing data 
n (%) 
 
n (%) 
Missing data 
n (%) 
Baseline 
Cough 9 (34.6) 0 7 (28.0) 0 0.611* 
Mucus 2 (7.7) 0 0 (0) 0 0.490† 
Shortness of Breath 2 (7.7) 0 3 (12.0) 0 0.668† 
Wheezing or whistling in chest 1 (4.0) 1 (3.8) 1 (4.0)  0 1.000† 
Sneezing or runny nose 7 (28.0) 1 (3.8) 2 (8.3) 1 (4.0) 0.138† 
Headache 12 (46.2) 0 13 (54.2) 1 (4.0) 0.571* 
Burning or watery eyes 6 (23.1) 0 3 (12.0) 0 0.465† 
Back pain 12 (46.2) 0 5 (20.8) 1 (4.0) 0.059* 
Burns 2 (8.3) 2 (7.7) 1 (4.3) 2 (8.0) 1.000† 
Family member with burns 2 (7.7) 0 1 (4.0) 0 1.000† 
Follow-up 
Cough 5 (19.2) 0 5 (20.8) 1 (4.0) 1.000† 
Mucus 2 (7.7) 0 1 (4.2) 1 (4.0) 1.000† 
Shortness of Breath 1 (3.8) 0 0 (0) 1 (4.0) 1.000† 
Wheezing or whistling in chest 1 (4.0) 1 (3.8) 0 (0) 1 (4.0) 1.000† 
Sneezing or runny nose 3 (11.5) 0 5 (20.8) 1 (4.0) 0.456† 
Headache 8 (30.8) 0 6 (25.0) 1 (4.0) 0.650* 
Burning or watery eyes 6 (23.1) 0 1 (4.2) 1 (4.0) 0.100† 
Back pain 6 (24.0) 1 (3.8) 2 (8.3) 1 (4.0) 0.247† 
Burns 5 (19.2) 0 3 (12.5) 1 (4.0) 0.704† 
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Family member with burns 0 (0) 0 0 (0) 1 (4.0) - 
*The statistical difference between the two groups for ‘Number of individuals reporting symptom’ was tested using the 
Pearson’s χ2 test; †The statistical difference between the two groups for ‘Number of individuals reporting symptom’ was 
tested using the Fisher’s exact test. 
 
Although only a brief snapshot of exposure has been captured by the present study; CO peak levels of 
150ppm detected in these households suggest concerning levels of household air pollution exposure. 
The WHO Air Quality Guidelines recommend that individuals should not be exposed to CO 
concentrations of greater that 26ppm for more than one hour (shown in  
 
Figure 5-3) or to concentrations exceeding 87ppm for more than 15 minutes (280). Due to the small 
sample size, it is not possible to make statistical comparison between the before and after exposure 
monitoring, but the high levels of pollution seen even after introduction of the intervention may be a 
result of inadequate emissions reduction by the cookstove or individuals using more than one stove or 
fuel type in order to meet their needs, a concept known as fuel stacking (2). Air pollution exposure 
monitoring was logistically challenging, requiring additional visits to retrieve the equipment. In a 
resource-poor setting, this significant additional demand on transport and fuel resources should be 
considered when planning larger studies. Of note, there was a national fuel shortage at the time of this 
study, resulting in additional logistical challenges for the study team. Security of study equipment should 
also be considered, particularly with respect to air pollution monitors, as security concerns may dissuade 
participants from consenting to household monitoring.  
Previous studies have used intensive methods of monitoring PM and CO, at individual and household 
levels (3, 163). However, these techniques are expensive, logistically challenging, burdensome for the 
participant and interpretation of results is not standardised. In order to effectively evaluate the impact 
of household air pollution reduction strategies, a standardised and convenient approach to assessing 
household air pollution exposure is required. Development of a biomarker that is representative of 
household air pollution exposure over the preceding weeks or months could remove the need for 
complex air sampling, and aid timely delivery of effective interventions to market. Several potential 
biomarkers have been explored but none are suitable for routine use yet (167, 281, 282). In this study, 
measurement of eCO was trialled and although the majority of readings were within the normal range, a 
significant reduction was seen at follow up in the intervention group. Small changes in eCO may be a 
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sensitive and responsive marker of exposure if a larger sample size were tested. Furthermore, in this 
study the eCO measurements were taken outdoors away from the fires/stoves; measuring eCO in the 
vicinity of smoke exposure may improve the sensitivity of eCO as a biomarker.  
Further studies exploring household air pollution exposures and their impact on health are needed. 
Although the complex nature of exposure means that such studies are challenging, the findings here 
suggest that a larger scale study will be feasible and acceptable in Malawi. Adequate community 
sensitisation and careful consideration of appropriate outcome measures will be required. Intensive 
monitoring of household air pollution exposure levels or development of a biomarker of exposure is 
warranted, but significant investment will be required to achieve this. This study suggests that 
measurement of eCO would be worthwhile in a larger study, as a biomarker of exposure. Findings from 
this pilot study informed the design of two larger studies of air pollution in Malawi: the Cooking and 
Pneumonia Study (www.capstudy.org, (143)) and the AIR Study (described in Chapter 6).    
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6. Household air pollution, chronic respiratory disease and 
pneumonia in Malawian adults: a case-control study 
6.1. Introduction 
This chapter describes a case-control study, the Acute Infection of the Respiratory tract (AIR) study, 
which set out to test the hypothesis that household air pollution is associated with an increased risk of 
pneumonia in adults living in urban Malawi. This follows from the systematic review of the literature 
described in chapter 3 that identified a gap in the literature regarding the association  between 
household air pollution and ALRI in adults (283) and it was informed by the methodological 
development work described in chapters 4 and 5. The AIR study provided opportunities to explore other 
potential risk factors for pneumonia, including CRD, socioeconomic status, crowding, malnutrition and 
alcohol intake alongside the main focus on household air pollution. 
6.1.1. Objectives 
 To determine whether household air pollution is a risk factor for pneumonia in urban Malawian 
adults. 
 To determine whether CRD is a risk factor for pneumonia in urban Malawian adults. 
 To explore other potential risk factors for pneumonia in urban Malawian adults. 
 To determine whether eCO is an accurate biomarker of household air pollution exposure. 
 To describe air pollution exposure in urban Malawi. 
 To describe CRD in urban Malawian adults. 
6.1.2. Integration with concurrent studies 
The AIR study was integrated with other studies of adult respiratory infection which were operating 
concurrently at QECH and MLW at the time of recruitment, in order to maximize research efficiency 
whilst minimizing the burden to participants. The Burden and Severity of HIV-associated Influenza 
(BASH-FLU) Study (Principal Investigator: Dr Antonia Ho) aimed to establish the association between HIV 
infection and influenza disease severity using a case-control design. The Malawian Adult Lower 
Respiratory Tract Infection Severity, Aetiology and Outcome (MARISO) study (Principal Investigator: Dr 
Stephen Aston) was a prospective observational study nested within the Burden and Severity of HIV-
associated Influenza (BASH-FLU) study, aiming to describe the clinical features aetiology and outcome of 
community acquired pneumonia in Malawian adults. A surveillance programme of severe acute 
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respiratory infection (SARI) (Principal Investigators: Dr Dean Everett and Dr Ingrid Peterson) was also in 
place at QECH, describing the local epidemiology of respiratory viruses. All of these studies were already 
operational at the time of commencing recruitment for the AIR study. 
The case definition for the AIR study was aligned with the case definitions for the BASH-FLU, MARISO 
and surveillance studies, meaning that it was possible to co-recruit patients to multiple studies. 
Individuals meeting the case definitions were invited to participate in the studies they were eligible for, 
but were under no obligation to participate in all studies. A separate consent process was conducted for 
those wishing to participate in the AIR study. The recruitment and clinical assessments (using integrated 
data collection systems) were conducted by an integrated respiratory infection clinical research study 
team, and study data (including clinical specimen results) were shared between the studies if consent 
was given by the participant.  
6.1.3. Contributors to this chapter 
The study concept and design was conceived by myself, Dr Kevin Mortimer (LSTM, UK), Professor 
Stephen Gordon (MLW, Malawi) and Dr Ingrid Peterson (MLW, Malawi), with input from Professor 
Robert Heyderman (formerly MLW, Malawi) and statistical advice from Professor Brian Faragher (LSTM, 
UK). Research operations within QECH were supported by Dr Jane Mallewa and Dr Mulinda Nyirenda, 
and in the community by Dr Medson Matchaya (Blantyre District Health Officer). I coordinated study set-
up and execution, with assistance from Dr Ho (BASH-FLU Study) and Dr Aston (MARISO Study). 
Community control recruitment and field logistics were conducted by Chimwemwe Kambudzi, Malumbo 
Ng’oma, Patrick Munthali, Gift Sagawa, Stain Nkata and Paul Yonah. Community follow up appointments 
were conducted by Beatrice Chinoko. Hospital recruitment and assessments were conducted by the 
integrated respiratory infection clinical research study team (including Collins Chiliwawa, Blessings 
Mkwaila, Dan Chunda, Sitithana Muyaso, Rosaleen Ng’oma, Emily Lifa, Hannah Masangwi, Wezi 
Chimang’anga and Tiwonge Chinunda).  I oversaw all community field work and the integrated hospital 
study team were jointly supervised by myself, Dr Ho and Dr Aston (until BASH-FLU and MARISO studies 
completed in January 2015). In the final months of the study, Dr Newton Kalata (MLW, Malawi) assisted 
with supervision of both the community and hospital study teams.  
Augustine Choko (MLW, Malawi) provided support for mapping and geo-spatial aspects of the study. 
Chest x-rays were photographed and interpreted by myself, Dr Ho, Dr Aston or Dr Kalata. Spirometry 
quality assurance and interpretation was conducted independently by myself and Lindsay Zurba 
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(Spirometry Training Services Africa CC, South Africa). Laboratory testing of clinical samples was 
supervised by Brigitte Denis and George Selemani (MLW, Malawi) and tuberculosis diagnostics were 
supervised by Aaron Mdolo (MLW, Malawi). Assistance with operating and interpreting Aprovecho 
Indoor Air Pollution monitors was provided by Samuel Bentson and Alex Siedel (Aprovecho Research 
Centre, Oregon, USA). Support with operating University of California, Berkeley Particle and 
Temperature Sensor (UCB-PATS) monitors was provided by Charity Garland and Maneet Kaur (Berkeley 
Air Monitoring Group, University of California Berkeley, USA). Clemens Masesa (MLW, Malawi) and 
Rachel Lloyd (LSTM, UK) provided data management assistance.  We thank the Burden of Obstructive 
Lung Disease (BOLD) Study coordinating centre (www.boldstudy.org) for providing permission to use 
BOLD questionnaires.  
 Dr Nico Nagelkerke (formerly MLW, Malawi) performed the interim analysis. I performed the final 
analysis with support from Dr Emanuele Giorgi (Lancaster University, UK), except for the geospatial 
analysis and data imputation using spatial interpolation which was conducted by Dr Giorgi. Dr Peterson 
performed the principal components analysis to construct the socioeconomic score. 
6.2.  Methods 
6.2.1. Study design and setting 
A case-control study set in Blantyre, Malawi with all cases being recruited from QECH and all controls 
recruited from within the city limits. HIV-positive and HIV-negative sub-groups were analysed 
separately, owing to anticipated lack of statistical power to explore interactions between HIV (a known 
major risk factor for pneumonia) and other potential risk factors for pneumonia. Furthermore, the risk 
factor profile for pneumonia is potentially different between individuals with HIV infection and those 
without, and therefore a combined analysis could be difficult to interpret. 
6.2.2. Participants 
6.2.2.1. Cases 
Cases were defined by the presence of radiologically confirmed pneumonia requiring hospitalisation. All 
adult admissions to QECH were screened by study clinical officers. All medical patients admitted with 
respiratory symptoms were evaluated against inclusion and exclusion criteria (see Box 6-1). Due to 
anticipated delays in acquiring chest x-rays for patients at QECH, it was possible for a patient to be  
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recruited without a chest x-ray, and they were subsequently excluded if an x-ray was not obtained or if 
there was no evidence of pneumonia. 
 
Box 6-1. Inclusion and exclusion criteria for cases and controls 
Inclusion criteria for cases 
 
 Age 18 years or over 
 Resident in Blantyre city 
 Reported cough OR chest  pain OR 
breathlessness OR hemoptysis 
 Reported fever OR recorded fever 
(≥38°C) 
 Crepitations OR pleural rub OR bronchial 
breathing 
 Radiological changes judged to be new 
and consistent with pneumonia, without 
another obvious cause 
 Requires hospitalisation 
 
Exclusion criteria for cases 
 
 Pre–admission diagnosis of terminal 
illness (e.g., metastatic malignancy, 
terminal AIDS) 
 Current anti–tuberculosis treatment or 
evidence of current tuberculosis 
infection 
 Prior hospitalisation within the last 4 
weeks 
 Prior participation in the study 
 Lives in a residential institution (e.g., 
prison) 
 Death prior to follow–up assessment 
 Alternative diagnosis explaining their 
presentation 
 Symptoms for 14 days or more 
 
Inclusion criteria for controls 
 
 Age 18 years or over 
 Resident in Blantyre city 
 
 
Exclusion criteria for controls 
 
 Diagnosis of terminal illness (e.g., 
metastatic malignancy, terminal AIDS) 
 Current anti–tuberculosis treatment or 
evidence of current tuberculosis 
infection 
 Hospitalisation for a pneumonia–like 
illness in the past 4 months or current 
pneumonia–like illness 
 Current symptoms of pneumonia 
 Prior participation in the study 
 Lives in a residential institution (e.g., 
prison) 
 Death prior to follow–up assessment 
 Utilizes private health care facilities if 
has illness requiring hospitalisation 
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6.2.2.2. Controls 
Controls, recruited from the community, were defined by absence of pneumonia: willing volunteers 
were screened for inclusion and exclusion criteria (Box 6-1).  
Recruitment was stratified by HIV status to enable the data to be analysed as two separate case–control 
studies. Within these two sub-groups, controls were frequency–matched to cases by age (18–34 years 
or ≥35 years) and sex. As poverty was a risk factor of interest (and is inextricably linked to household air 
pollution exposure), no matching on socioeconomic status was undertaken but controls were restricted 
to those who used government (not private) healthcare facilities for non-routine treatment. Controls 
(and cases) were restricted to individuals who lived within the city of Blantyre, and as cases resided in 
neighbourhoods spread all across the city, controls were recruited from randomly selected 
neighbourhoods across the city (as described below) to ensure good geographical and socioeconomic 
variation. To ensure the absence of pneumonia in controls, the study team were trained to enquire 
about acute respiratory symptoms (as per the exclusion criteria), and in the event of uncertainty, this 
was discussed with a study doctor.  
To identify potential controls, residential census enumeration areas were randomly selected from all 
enumeration areas within Blantyre city, with selection weighted by population size. Field workers 
followed randomly generated routes within the enumeration areas and screened all potential 
participants in each household along the route. A maximum of one individual was recruited per 
household, selected randomly. Screening continued until 2 controls had been recruited from that 
enumeration area.  
As more HIV-positive than HIV-negative controls were needed (see section 6.2.5.), but the prevalence of 
HIV in Blantyre is approximately 18%, all potential controls underwent a HIV test as part of their 
screening process (unless their known HIV status could be confirmed). Recruitment targets were set for 
each 3-month period to ensure that the correct ratios of individuals were recruited according to their 
HIV status, age and gender. 
To supplement door–to–door recruitment, HIV–positive individuals attending community antiretroviral 
clinics within Blantyre city were also screened.  
Chest x-rays were not performed in controls as, due to the potential of harm of radiation, it was deemed 
that the absence of symptoms was sufficient to exclude the presence of pneumonia.  
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6.2.3. Study procedures 
6.2.3.1. In-patient case assessment 
Initial assessment of cases included medical history and examination by study clinical officers, and 
diagnostic tests (Box 6-2). Pneumonia was confirmed on review of a chest X-ray by a study doctor. 
6.2.3.2. Follow-up assessments 
Follow-up assessments were conducted in the participants’ homes. For cases, assessments were 
conducted a minimum of 2 months after their admission for pneumonia to allow time for recovery to 
normal function, but within a period of 4 months. For controls, the assessments were usually conducted 
within a week of recruitment. 
 
Air pollution exposure monitoring 
Continuous ambulatory and household monitoring of PM2.5 (µg/m3) and CO (ppm) was performed for 48 
hours. Participants wore backpacks with Aprovecho Indoor Air Pollution meters (PM2.5 and CO) for 
ambulatory monitoring. UCB-PATS (PM2.5) and Lascar EL-USB-CO Data Logger monitors (CO) were placed 
1 meter (m) from the household’s cooking stove or fire at an elevation of 1 m.  
Spirometry 
Height and weight were measured in a standardized manner to allow calculation of predicted 
spirometry values. Spirometry was conducted using an EasyOne Spirometer (ndd Medical Technologies, 
Zurich, Switzerland) to ATS standards (275). The Third National Health and Nutrition Examination Survey 
Box 6-2. Hospital diagnostic tests for pneumonia cases 
 HIV test +/- CD4 count 
 Malaria rapid diagnostic test 
 Blood culture 
 BinaxNOW® Streptococcus pneumoniae urinary antigen  
 Sputum for acid-fast bacilli smear, mycobacterial culture, and 
GeneXpert® MTB/RIF assay 
 Pleural fluid specimen for acid-fast bacilli smear and mycobacterial 
culture (if clinically indicated) 
 Chest X-ray 
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(NHANES III) reference ranges, corrected for Caucasian and African-American populations, were used to 
calculate predicted values. Results calculated using Caucasian reference ranges were used in the primary 
analysis (to allow comparison to the findings of BOLD studies (121)), and secondary analyses were 
performed using African-American reference range values. Two reviewers independently performed 
quality assurance and interpreted the spirometry data.  
Questionnaires 
Questionnaires, including items from the Burden of Obstructive Lung Disease (BOLD) questionnaires 
(284), were used to evaluate a range of potential risk factors and socioeconomic status. The questions 
taken from the BOLD questionnaires used the Chichewa translations that had been approved by the 
BOLD Study Centre and used in the previous BOLD study in Malawi. All other questions were translated 
to Chichewa by translation staff at MLW Clinical Research Programme, and checked for accuracy by 
study team members whose mother tongue is Chichewa. 
Tuberculosis diagnostics 
Cases who had not submitted sputum samples during their in-patient admission and controls who 
reported chronic cough during their follow up assessment were invited to attend the hospital for 
sputum induction (conducted as per the methods in Chapter 4) in order to perform tuberculosis 
diagnostics as above. 
6.2.4. Exposures of interest 
6.2.4.1. Primary exposures of interest 
The primary exposures of interest were mean ambulatory PM2.5 exposure and presence of CRD (defined 
using a composite questionnaire assessment (Box 6-3)).  
The definition for CRD used was deliberately inclusive of a range of potential chronic respiratory 
problems, and did not constrain the variable to recognised western diagnoses. This approach was 
chosen as - due to multiple respiratory insults experienced by individuals throughout their life - the 
spectrum CRD seen in sub-Saharan is different to that seen the UK (41). A pragmatic approach was taken 
by using a predominantly symptom based definition, as individuals who are experiencing symptoms are 
more likely have clinically significant disease than those who don’t.  
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6.2.4.2. Secondary exposures of interest 
The following exposures were also evaluated as potential risk factors for pneumonia: 
 Mean ambulatory CO exposure 
 Mean household CO exposure 
 Mean household PM2.5 exposure 
 History of previous respiratory disease or symptoms 
 Spirometric evidence of airway obstruction or restriction 
 Self-reported air pollution exposures (including household, outdoor, occupational) 
 Self-reported tobacco smoke exposure (current and previous smoking and passive exposures, 
from cigarettes, cigars and other forms of tobacco smoke inhalation) 
 CD4 count (HIV-positive only) 
 Antiretroviral use (HIV-positive only) 
 Body mass index (BMI) 
 Alcohol use 
 Socio-economic status (using poverty indicators including asset ownership, education, housing 
conditions) 
Box 6-3. Composite definition of chronic respiratory disease 
Answering affirmative to any of the following in the BOLD 
questionnaire: 
 Current usual cough 
 Current usual sputum production 
 Current breathlessness 
 Wheeze in past 12 months 
 Ever had diagnosis of emphysema 
 Current diagnosis of chronic bronchitis 
 Current diagnosis of asthma 
 Current long-term respiratory medication 
Note: Cases were asked to recall their status from 6 months previously, 
prior to their episode of pneumonia.  
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 Contact with children, people with illnesses and animals 
 Marital status 
6.2.5. Sample size 
Based on assumptions of α=0.05, β=0.2, and an estimated percentage of controls with CRD of at least 
15%, the target sample size was 160 cases and 160 controls in the HIV-positive sub-group (ratio 1:1) to 
detect an OR of 2.2 or greater. A smaller exploratory study was planned with 60 cases and 90 controls in 
the HIV-negative sub-group (ratio 1:1.5).  
6.2.5.1. Recruitment targets 
Based on preliminary data from the MARISO study, it was anticipated that 30% of patients (who will be 
predominantly recruited prior to a chest x-ray being taken) would subsequently be found to be ineligible 
(as only 88% of patients would get an x-ray, and only 80% of these will have x-ray confirmed 
pneumonia). It was estimated that 30% of HIV-positive cases and 10% of HIV-negative cases would have 
died or started tuberculosis treatment by 2-4 month follow-up, and 20% of the remaining participants 
will be lost to follow up. Therefore case recruitment targets were set at HIV 406 positive cases and 118 
HIV-negative cases. 
10% of controls were expected to be lost to follow up, therefore recruitment targets were 178 HIV-
positive controls and 100 HIV-negative controls. Based on an 18% HIV-positive rate in the community, it 
was anticipated that approximately 1000 individuals would undergo HIV testing to find 178 HIV-positive 
controls. 
6.2.6. Statistical considerations 
Data files were exported to Stata 13.1 (Statacorp, College Station, Texas, USA) for analysis. Missing air 
pollution exposure data were imputed using spatial interpolation. Missing questionnaire data were 
imputed using multivariate multinomial models by exploiting their association with other observed 
variables. A socioeconomic status score was generated using principal components analysis, based on 
data regarding asset-based measures, education level, and household characteristics (the variables used 
are indicated in Table 6-4) (285).  
Comparisons between clinical and exposure data were made using Independent t-tests, Mann-Whitney 
U tests and Pearson’s Chi-squared tests. Bivariate associations between various outcomes and 
exposures were made using logistic regression, one-way ANOVA and Pearson’s Chi2 tests and 
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Spearman’s rank correlation tests. A p value of <0.05 was considered statistically significant. No 
adjustments for multiple testing were made. 
Table 6-1: A priori potential confounders included in the multivariate logistic regression model. 
Forced variables included in 
the logistic regression model 
A priori potential confounder 
with Likelihood Test Ratio P 
value <0.2 therefore entered 
into the logistic regression 
model  
A priori potential confounder 
with Likelihood Test Ratio P 
value >0.2 therefore not 
entered into the logistic 
regression model 
Age 
Gender 
 
Alcohol intake 
Smoking status (all forms) 
BMI 
CD4 count 
Antiretroviral therapy 
Co-trimoxazole prophylaxis 
Chronic respiratory disease 
Mean ambulatory PM2.5 exposure* 
Mean ambulatory CO exposure* 
Mean household CO exposure* 
Cooking with solid fuel frequency 
Civil status 
Current occupation 
Carer for somebody with chronic 
illness 
Wall material 
Animal ownership 
Work related dust/smoke 
exposures 
Socioeconomic status quintile 
Mean household PM2.5 exposure* 
Primary cooking fuel 
Ventilation whilst cooking 
Pollution from heating/lighting 
Education level 
Passive tobacco smoke exposure 
Roofing material 
Floor material 
Number of people per room in 
household 
Contact with children 
Population density 
*PM2.5 and CO exposures included as potential confounders for CRD analysis only. 
BMI: body mass index; PM2.5: particulate matter with <2.5µm diameter; CO: carbon monoxide. 
 
For analysis of the HIV-positive sub-group, univariate logistic including a priori potential confounders 
was performed (a list of a priori potential confounders can be found in Table 6-1).  Mechanistically 
plausible potential confounders with a univariate likelihood ratio test p-value of <0.2 were entered into 
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a multivariate forward stepwise logistic regression model (criteria for entry p<0.05 and removal p>0.1) 
for each of the main exposures of interest. For analysis of the HIV-negative sub-group, owing to the 
smaller sample size, multivariate logistic regression was performed, with only matching factors (age and 
gender) entered into the model as forced variables. To test the hypothesis that pneumonia cases are 
spatially clustered, we used generalized additive models and smoothing latitude and longitude over the 
geographic reach of the study area (286).  
6.2.6.1. Interim analysis 
An interim analysis was performed in August 2015 after approximately 50% of the planned sample size 
had been recruited. Although an interim analysis had not been pre-specified, this was undertaken to 
inform a decision about whether to extend recruitment beyond the planned recruitment period, as 
recruitment had been slower than anticipated. Bootstrapping was used to create a simulated dataset 
(using random sampling with replacement based on the existing data already collected), which was 
combined with the existing dataset, to create a synthetic complete dataset. This was repeated 50 times 
(to create 50 synthetic complete datasets) in order to explore the probability of obtaining a significant 
result, based on the assumption that future data will be similar to that already collected. Point estimates 
and their standard errors were calculated using logistic regression.  
6.2.7. Ethical considerations 
This study was approved by the College of Medicine REC, University of Malawi (P.02/14/1518) and the 
LSTM REC (14.016). All participants gave written informed consent prior to participation in the study.  
6.3. Results 
6.3.1. Participant recruitment 
The interim analysis indicated that there was a high chance of detecting (with at least 80% power) a 
significant association between ambulatory mean CO exposure (but not ambulatory mean PM2.5 
exposure) and pneumonia, as well as CRD and pneumonia, in the HIV-positive sub-group if recruitment 
was stopped at the end of the planned recruitment period with a smaller sample size than initially 
planned (110 cases and 140 controls in the HIV-positive sub-group). Recruitment was therefore stopped 
in February 2016, as originally planned.  
We screened 2148 and 1492 potential cases and controls, respectively, between July 2014 and February 
2016 (Figure 6-1). Of the screened cases, 58.5% were men with a median age of 36 years (IQR 30-47). Of 
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the screened controls, 61.6% were men, with a median age of 30 (IQR 23-40). Of the 1273 potential 
controls identified via door-to-door screening, 540 potential controls (42.4%) underwent HIV testing as 
part of their screening process (41 HIV-positive, 496 HIV-negative, 3 withheld result), 107 (8.4%) already 
knew their HIV status (76 HIV-positive and 31 HIV-negative), 36 (2.8%) declined to be screened and the 
remaining 590 (46.4%) were either unavailable for testing or did not reach that part of the screening 
process due to ineligibility on other criteria. All 219 potential controls screened at health centre HIV 
clinics were already known to be HIV-positive. From HIV-positive and HIV-negative sub-groups, 
respectively, we recruited 349 and 79 cases, and 208 and 92 controls (Figure 6-1). Of the recruited 
participants, 64.7% and 59.3% were male, with a median age of 35 (IQR 30-42, range 18-89) and 35 (IQR 
29–43, range 18–78) in the cases and controls, respectively, and lived across Blantyre city (Figure 6-2). 
The reasons for ineligibility amongst potential cases and controls are listed in Table 6-2. 
One hundred and forty-five (117 HIV-positive, 28 HIV-negative) cases and 253 (169 HIV-positive, 84 HIV-
negative) controls completed follow-up. Reasons for not completing follow-up amongst recruited cases 
were subsequent exclusion for ineligibility (265, 61.9%; including lack of radiological evidence of 
pneumonia [108, 25.2%], commencement of tuberculosis treatment [140, 32.7%], and death [64, 
15.0%]), and loss to follow-up (18, 4.2%; Figure 6-1). Twenty-five of the individuals who were started on 
tuberculosis treatment subsequently died. Among recruited controls, 34 individuals (11.3%) were lost to 
follow-up and 13 (4.3%) were ineligible and subsequently excluded.  
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Figure 6-1: Participant flow chart showing the number of cases and controls screened, recruited, and followed up in the HIV–positive and 
HIV–negative sub-groups. 
HIV: Human Immunodeficiency Virus; TB: tuberculosis. 
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Figure 6-2: Participant household locations. 
A map of Blantyre city, Southern Region, Malawi showing the location of case (•) and control (•) 
households. Mapping software: Google Earth Pro (7.1.5.1157). 
6.3.2. Hospital admission details for cases 
Details regarding the presentation and in-patient hospital stay for all 428 recruited cases (including 
those who were subsequently excluded) can be found in Table 6-3. Treatment was sought prior to 
attending QECH by 276 (64.5%) of all recruited cases. Of those, 221 (80.1%) had attended a primary 
health care centre and 33 (12.0%), 9 (3.3%) and 5 (1.8%) had attended a private clinic, other hospital 
and pharmacy, respectively. None reported visiting a traditional healer. Anti-malarial treatment had 
been taken by 50 (11.7%) cases in the two weeks prior to admission and 16 (3.7%) had taken traditional 
medicine. Only one person had travelled more than three hours to reach QECH, but 55.84% of recruited 
cases had travelled for more than one hour. 
The symptoms reported by all recruited cases (including those who were subsequently excluded) are 
shown in Figure 6-3. HIV-positive cases were more likely to report weight loss, but otherwise the 
symptom profiles were similar between the two groups. Respiratory crepitations were heard on 
auscultation in 342 (79.9%) and 168 (39.3%), 75 (17.5%), 40 (9.4%) and 17 (4.0%) had bronchial 
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breathing, signs of a pleural effusion, pleural rub and wheeze, respectively. Abnormalities were detected 
on examination of the upper respiratory tract in 34 (7.9%) of recruited cases.   
Table 6-2: Reasons for ineligibility for potential cases and controls. 
  
Reason for ineligibility Cases, n (%) 
(Total screened = 2148; 
total ineligible = 1663)  
Controls, n (%) 
(Total screened = 1492; 
total ineligible = 804)  
Symptom duration greater than 14 days 913 (42.5) N/A 
Didn’t meet age/gender/HIV criteria for 
stratified recruitment 
N/A 676 (45.3) 
Lack of clinical signs consistent with pneumonia 416 (19.4) N/A 
Living outside of urban Blantyre 385 (17.9) - 
Absence of fever 304 (14.2) N/A 
Hospitalisation within past 4 weeks 134 (6.2) - 
Obvious alternative diagnosis 131 (6.1) N/A 
No x-ray taken or no changes present 108 (5.0) N/A 
Current tuberculosis treatment 95 (4.4) 55 (3.7) 
Recent pneumonia-like illness N/A 45 (3.0) 
Doesn’t use government healthcare facilities N/A 21 (1.4) 
Terminal illness 38 (1.8) 11 (0.7) 
Lack of relevant symptoms 37 (1.7) N/A 
Age <18 years 31 (1.4) - 
Didn’t require hospitalisation 14 (0.7) N/A 
Lives in an institution 14 (0.7) - 
Previously enrolled in AIR Study 12 (0.6) - 
Unknown 72 (3.4) - 
N/A = not applicable (eligibility criteria not applicable to that study group). 
HIV: Human Immunodeficiency Virus; AIR: Acute Infection of the Respiratory tract Study. 
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Figure 6-3: Symptoms at presentation for all recruited cases 
SOB: shortness of breath; HIV: Human Immunodeficiency Virus. 
Blood culture results were available for 400 (93.4%) of all recruited cases. Of these, 27 (6.8%) were 
positive (11 (40.7%) Salmonella species, 5 (18.5%) Streptococcus pneumoniae, 3 (11.1%) Escherichia coli, 
2 (7.41%) Staphylococcus aureus and 2 (7.41%) Cryptococcus neoformans. BinaxNOW Streptococcus 
pneumoniae urinary antigen results were available for 386 (90.2%) recruited cases. Of the 82 (21.2%) 
with a positive urinary antigen result, 8 (9.8%) also had a positive blood culture result (although only 2 
of these cultured Streptococcus pneumoniae). Three individuals with Streptococcus pneumoniae 
identified in their blood culture had a negative BinaxNOW Streptococcus pneumoniae urinary antigen 
result. 
At least one form of tuberculosis diagnostic result was available for 323 (75.5%) of recruited cases. Of 
these 300 (92.88),282 (87.3%), 266 (82.4%), 13 (4.0%) and 12 (3.7%) had a sputum GeneXpert® result, 
sputum smear, sputum culture, pleural fluid culture and pleural fluid smear result available, 
respectively. Of these 323 individuals, 67 (20.7%) had a positive Mycobacterium tuberculosis result and 8 
(2.48%) had a non-tuberculous Mycobacterium identified (and were therefore excluded as cases from 
the AIR Study). A fifth (94, 21.9%) of all recruited cases were commenced on tuberculosis treatment 
during their hospital admission (and were therefore excluded as cases from the AIR Study). A further 46 
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(10.7%) of participants were started on tuberculosis treatment following discharge but prior to their 
follow-up appointment. Seven (1.64%) of the recruited cases were known to be started on treatment for 
Pneumocystis jiroveci pneumonia during their hospital admission, 3 of whom died as an in-patient. 
Overall, 349 recruited cases (81.5%) were HIV-positive, with 33 (9.5%) of those being newly diagnosed. 
One hundred and eighty-eight (78.0%) of those previously known to be HIV-positive were taking 
antiretroviral treatment prior to admission. Forty-six (10.7%) patients died prior to hospital discharge 
and a further 18 (5.2%) died following discharge, prior to follow-up. There was no significant difference 
in in-patient mortality rates between HIV-positive (40, 11.5%) and HIV-negative (6, 7.6%) patients 
(Pearson’s chi-square test = 0.92, p=0.337). 
The majority of patients (394 (92.1%)) had a chest x-ray taken; 11 (34.4%) of those without a chest x-ray 
died. Of those with a chest x-ray, 320 (81.2%) had changes considered to be consistent with pneumonia. 
Despite a case definition mandating a symptom duration of 14 days or less, 53 (16.6%) of the 320 
recruited cases with chest x-ray changes had a confirmed diagnosis of tuberculosis (20.7% of those with 
diagnostic results available) and a further 60 (18.8%) were commenced on tuberculosis treatment prior 
to their follow up appointment on the basis of clinical suspicion. The 207 remaining patients (48.4% of 
all recruited cases) were treated as community acquired pneumonia.  
6.3.2.1. Characteristics of confirmed pneumonia cases 
Of the 207 (48.4%) considered to have pneumonia, 126 (60.9%) were male and there was a median age 
of 36 (IQR 30-45)). HIV prevalence was 81.6% (169 HIV-positive individuals). Median baseline CD4 count 
amongst this group was 109.5 cells/µl (IQR 43-207) and 67 (39.6%) were not on ART. Of the patients 
treated as pneumonia, 50 (24.2%) had confirmed pneumococcal pneumonia (47 positive BinaxNOW 
Streptococcus pneumoniae urinary antigen results, 4 positive blood cultures). Overall mortality in this 
group was 14.0% (15 (7.25%) died as an in-patient and a further 14 (6.8%) subsequently died before 
follow up).   
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6.3.2.2. Comparison of cases who completed follow up and those who did not 
Comparisons between cases who completed follow-up (confirmed pneumonia) and those who did not 
(predominantly due to ineligibility (see Figure 6-1): a mixture of individuals with non-pneumonia 
respiratory infections, tuberculosis and pneumonia) were made to explore evidence of potential 
selection bias (Table 6-3). Vital signs were broadly similar between the two groups. Cases who 
completed follow-up were older (mean age 36 years vs 35 years, p = 0.040), and had a statistically 
significant shorter duration of symptoms prior to admission (although median symptom duration 7 days 
in both groups), and shorter length of admission (5 days vs 7 days, p = 0.021) compared to those who 
did not complete follow up. Those who completed study follow-up and were HIV-positive were less 
likely to have an existing diagnosis of HIV (64.9% vs 71.1%, p = 0.023) and had a higher admission CD4 
count than those who were not followed up (median 119 cells/l [IQR 47–205] vs. median 86 cells/l 
[IQR 30–185], p = 0.029).  
6.3.3. Characteristics of cases and controls 
Details of demographics, socioeconomic status, household characteristics and health status for cases 
and controls who completed follow up can be found in Table 6-4. Out of all participants, only one (a HIV-
positive case) reported they had received pneumococcal and Haemophilus influenza vaccinations, and 
none had received an influenza vaccination. 
In the HIV-positive sub-group, cases and controls had similar ages and were predominantly male (58.1% 
and 55.0%, respectively). Just over half of all HIV-positive cases and controls had never alcohol (53.9% 
and 55.6%, respectively), but cases were more likely to be previous drinkers than controls (39.3% vs 
23.7%) and less likely to be current drinkers than controls (6.8% vs 20.7%). Current smoking was more 
common amongst HIV-positive cases than controls (3.4% vs 11.2%). There was no consistent difference 
in measures of socioeconomic status between HIV-positive cases and controls, and their households had 
similar characteristics. BMI was lower in HIV-positive cases than controls (mean 19.9 kg/m2 (STD 2.5 
kg/m2) vs 21 kg/m2 (STD 3.9 kg/m2). CD4 count was lower in cases than controls (median 129 cells/µl 
(IQR 49-209 cells/µl) vs 355 cells/µl (IQR 236-492 cells/µl), and cases were less likely to be taking 
antiretroviral therapy or co-trimoxazole than controls (58.1% vs 79.9% and 57.3% and 75.2%, 
respectively). Very few individuals had previously been told they have non-respiratory co-morbidities.  
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Table 6-3: Baseline hospital data for all recruited cases. 
 Cases who 
completed follow-
up  
(total n=145) 
Cases who did not 
complete follow-up 
(total n=283) 
P value 
Male, n (%) 91 (62.8) 186 (65.7) 0.543** 
Age (years), median [IQR] 36 [31-45] 35 [30-41] 0.040†† 
Symptom duration (days), median [IQR] * 7 [5–8] 7 [5–10] 0.007†† 
Length of admission (days), median [IQR] * 5 [4–8] 7 [4–12] 0.021†† 
Hospital outcome, n (%) 
Alive 
Dead 
Unknown 
 
145 (100.0) 
0 (0) 
0 (0) 
 
232 (82.0) 
46 (16.3) 
5 (1.8) 
<0.001** 
Pre-hospital antibiotics, n (%) 
Yes 
No 
Unknown 
 
79 (54.5) 
59 (40.7) 
7 (4.8) 
 
158 (55.8) 
111 (39.2) 
14 (4.9) 
0.742** 
Systolic blood pressure (mmHg), mean [STD] * 104.4 [22.5] 112.1 [79.5] 0.263‡‡ 
Diastolic blood pressure (mmHg), mean [STD] * 67.0 [14.5] 75.5 [81.1] 0.223‡‡ 
Heart rate (bpm), mean [STD] * 116.5 [20.0] 116.5 [22.6] 0.995‡‡ 
Respiratory rate (bpm), median [IQR] * 28 [23–36] 28 [24–34] 0.748†† 
Oxygen saturation (%),  median [IQR] * 95 [91–97] 95 [90–98] 0.344†† 
Temperature (C), median [IQR] 38.2 [37.1–39.0] 37.8 [36.7–38.7] 0.023†† 
HIV-positive, n (%) 117 (80.7) 232 (82.0) 0.745** 
Diagnosis of HIV, n (%)† 
Previously known 
New diagnosis 
Unknown 
 
76 (64.9) 
17 (14.5) 
24 (20.5) 
 
165 (71.1) 
16 (6.9) 
51 (22.0) 
0.071** 
CD4 (cells/µl), median [IQR] †* 119 [47-205] 86 [30-185] 0.029†† 
Pre-hospital antiretroviral treatment, n (%)‡ 60 (79.0) 128 (77.6) 0.767** 
Pre-hospital co-trimoxazole prophylaxis, n 
(%)‡ 
59 (77.6) 120 (72.7) 0.418** 
Continued overleaf 
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Table 6-3 continued Cases who 
completed follow-
up  
(total n=145) 
Cases who did not 
complete follow-up 
(total n=283) 
P value 
Chest X-ray changes consistent with 
pneumonia, n (%)* 
145 (100) 190 (73.4) <0.001** 
Confirmed diagnosis of tuberculosis, n (%)* 0 (0) 67 (33.0) <0.001** 
In-hospital commencement of tuberculosis 
treatment, n (%)* 
0 (0) 94 (33.7) <0.001** 
Positive malaria rapid diagnostic test, n (%)* 4 (3.0) 5 (1.9) 0.511** 
Positive blood culture, n (%)* 7 (5.3) 20 (7.5) 0.403** 
Positive BinaxNOW Streptococcus 
pneumoniae urinary antigen, n (%)* 
34 (25.2) 48 (19.1) 0.165** 
*Missing data was not imputed; †of those who are HIV-positive; ‡of those who were previously known to be HIV-positive; ** 
compared using Pearson’s Chi-squared test; ††compared using Mann-Whitney U tests; ‡‡compared using Independent t-
tests. 
IQR: interquartile range; mmHg: millimetres of mercury; STD: standard deviation; bpm: beats/breaths per minute; HIV: 
Human Immunodeficiency Virus.  
 
In the HIV-negative sub-group, cases were slightly older than controls (median 39 years (IQR 30-64 
years) vs 35 years (IQR 26-42 years), and males were more common amongst cases than controls (82.1 
% vs 64.3%). Fewer HIV-negative cases had never drunk alcohol or never smoked than controls (39.3% vs 
61.9% and 26.4% vs 81%, respectively). Cases were more commonly in the lowest socioeconomic status 
quintile than controls (35.7 vs 13.1%), and they had poorer quality roofing and flooring in their homes. 
Similarly to the HIV-positive sub-group, cases in the HIV-negative sub-group had a lower BMI than 
controls, but average values were higher in the HIV-negative sub-groups compared to the HIV-positive 
sub-groups. 
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Table 6-4: Participant characteristics for HIV-positive and HIV-negative cases and controls, and univariate analysis of the association between 
exposures and pneumonia. 
 HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Participant characteristics 
Age (years), median [IQR] 36 [31-43] 36 [32-44] -- -- 39 [30-64] 35 [26-42] -- -- 
Gender, n (%) 
Male 
Female 
 
68 (58.1) 
49 (41.9) 
 
93 (55.0) 
76 (45.0) 
-- --  
23 (82.1) 
5 (17.9) 
 
54 (64.3) 
30 (35.7) 
-- -- 
Civil status, n (%) 
Married  
Widowed 
Divorced 
Separated  
Single 
 
68 (58.1) 
11 (9.4) 
14 (12.0) 
7 (6.0) 
17 (14.5) 
 
121 (71.6) 
18 (10.7) 
11 (6.5) 
2 (1.2) 
17 (10.1) 
 
1 
1.09 (0.49-2.44) 
2.26 (0.97-5.26) 
6.23 (1.25-30.83) 
1.78 (0.85-3.71) 
 
-- 
0.839 
0.058 
0.025 
0.124 
 
20 (71.4) 
2 (7.1) 
3 (10.7) 
0 (0) 
3 (10.7 
 
54 (64.3) 
4 (4.8) 
2 (2.4) 
3 (3.6) 
21 (25.0) 
 
1 
1.35 (0.23-7.95) 
4.05 (0.63-26.05) 
1 
0.39 (0.22-0.62) 
 
-- 
0.740 
0.141 
-- 
<0.001 
Smoking status (all forms), n (%)  
Never smoked  
Ex-smoker 
Current smoker 
 
85 (72.7) 
28 (23.9) 
4 (3.4) 
 
123 (72.8) 
27 (16.0) 
19 (11.2) 
 
1 
1.50 (0.83-2.73) 
0.30 (0.10-0.93) 
 
-- 
0.182 
0.036 
 
13 (26.4) 
10 (35.7) 
5 (17.9) 
 
68 (81.0) 
7 (8.3) 
9 (10.7) 
 
1 
7.47 (2.41-12.2) 
2.9 1 (0.84-10.08) 
 
-- 
0.001 
0.093 
Passive tobacco smoke exposure, n (%) 
No  
Yes 
 
65 (55.6) 
42 (44.4) 
 
90 (53.3) 
79 (46.8) 
 
1 
0.91 (0.57-1.47) 
 
-- 
0.701 
 
13 (46.4) 
15 (53.6) 
 
54 (64.3) 
30 (35.7) 
 
1 
2.08 (0.87-4.94) 
 
-- 
0.098 
 
Continued overleaf 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Alcohol intake, n (%) 
Never  
Previous drinker 
Current drinker 
 
63 (53.9) 
46 (39.3) 
8 (6.8) 
 
94 (55.6) 
40 (23.7) 
35 (20.7) 
 
1 
1.72 (1.01-2.92) 
0.34 (0.15-0.78) 
 
-- 
0.046 
0.011 
 
11 (39.3) 
13 (46.4) 
4 (14.3) 
 
52 (61.9) 
15 (17.9) 
17 (20.2) 
 
1 
4.10 (1.53-11.00) 
1.11 (0.31-3.96) 
 
-- 
0.005 
0.869 
Carer for person with chronic illness, n 
(%) 
No  
Yes 
 
 
77 (65.8) 
40 (34.2) 
 
 
97 (57.4) 
72 (42.6) 
 
 
1 
0.70 (0.43-1.14) 
 
 
-- 
0.137 
 
 
22 (78.6) 
6 (21.4) 
 
 
58 (69.1) 
26 (31.0) 
 
 
1 
0.61 (0.22-1.68) 
 
 
-- 
0.337 
Socioeconomic factors 
Socioeconomic status quintile, n (%) 
Highest  
High 
Middle 
Low  
Lowest 
 
19 (16.2) 
25 (21.4) 
26 (22.2) 
22 (18.8) 
25 (21.4) 
 
26 (15.4) 
40 (23.7) 
33 (19.5) 
37 (21.9) 
33 (19.5) 
 
1 
 0.86 (0.39-1.86) 
1.08 (0.49-2.36) 
0.81 (0.37-1.80) 
1.04 (0.48-2.28) 
 
-- 
0.692 
0.851 
0.610 
0.929 
 
6 (21.4) 
2 (7.1) 
7 (25.0) 
3 (10.7) 
10 (35.7) 
 
28 (33.3) 
14 (16.7) 
15 (17.9) 
16 (19.1) 
11 (13.1) 
 
1 
0.67 (0.12-3.74) 
2.18 (0.62-7.66) 
0.86 (0.19-3.98) 
4.24 (1.24-14.50) 
 
-- 
0.645 
0.225 
0.863 
0.021 
Household member has bank account, 
n (%)§ 
No 
Yes 
 
 
71 (60.7) 
46 (39.3) 
 
 
99 (58.6) 
70 (41.4) 
 
 
1 
0.92 (0.56-1.48) 
 
 
-- 
0.722 
 
 
20 (71.4) 
8 (28.6) 
 
 
39 (46.4) 
45 (53.6) 
 
 
1 
0.35 (0.14-0.87) 
 
 
-- 
0.025 
 
Continued overleaf 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Education level, n (%) 
Higher education§ 
Secondary only§ 
Primary only 
None 
Unknown 
 
7 (6.0) 
45 (38.5) 
59 (50.4) 
6 (5.1) 
0 (0) 
 
12 (7.1) 
59 (35.1) 
90 (53.8) 
7 (4.2) 
0 (0) 
 
1 
1.31 (0.48-3.59) 
1.12 (0.41-3.02) 
1.47 (0.35-6.17) 
-- 
 
-- 
0.603 
0.817 
0.599 
-- 
 
2 (7.1) 
4 (14.3) 
18 (64.3) 
4 (14.3) 
0 (0) 
 
12 (14.3) 
33 (39.3) 
33 (39.3) 
5 (6.0) 
1 (1.2) 
 
1 
0.73 (0.12-4.50) 
3.27 (0.66-16.26) 
4.8 (0.65-35.20) 
-- 
 
-- 
0.732 
0.147 
0.123 
-- 
Number of school years completed, 
median [IQR]* 
8 [5-12] 8 [6-11] -- -- 6 [3-8] 10 [7-12] -- -- 
Current occupation, n (%)  
Paid employee 
Paid domestic worker 
Self-employed 
Unemployed 
Unpaid family worker 
Student 
 
40 (34.2) 
2 (1.7) 
40 (34.2) 
32 (27.4) 
1 (0.9) 
2 (1.7) 
 
47 (27.8) 
2 (1.2) 
37 (21.9) 
78 (46.2) 
0 (0) 
5 (3.0) 
 
1 
1.18 (0.16-8.72) 
1.27 (0.69-2.35) 
0.48 (0.27-0.87) 
1 
0.47 (0.09-2.56) 
 
-- 
0.875 
0.445 
0.015 
-- 
0.382 
 
12 (42.9) 
0 (0) 
7 (25.0) 
9 (32.1) 
0 (0) 
0 (0) 
 
29 (34.5) 
3 (3.6) 
16 (19.1) 
30 (35.7) 
0 (0) 
6 (7.1) 
 
1 
1 
1.06 (0.27-1.98) 
0.73 (0.27-1.98) 
-- 
1 
 
-- 
-- 
0.922 
0.530 
-- 
-- 
Not enough money for soap in past 
year, n (%)§ 
No 
Yes 
 
 
95 (81.2) 
22 (18.8) 
 
 
131 (77.5) 
38 (22.5) 
 
 
1 
0.80 (0.44-1.44) 
 
 
-- 
0.453 
 
 
20 (71.4) 
8 (28.6) 
 
 
68 (80.1) 
16 (19.9) 
 
 
1 
1.7 (0.64-4.55) 
 
 
-- 
0.291 
 
Continued overleaf 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Household ownership of assets, n (%) 
Electricity§ 
Flush toilet§ 
Television§ 
Telephone 
Mobile telephone§ 
Radio§ 
Refrigerator§ 
Bed with mattress§ 
Car 
Motorbike/moped 
Washing machine 
Home 
Indoor bath or shower§ 
Indoor tap§ 
Outdoor tap§ 
Mosquito net§ 
 
61 (52.1) 
2 (1.7) 
48 (41.0) 
0 
98 (83.8) 
83 (70.9) 
21 (18.0) 
85 (72.7) 
2 (1.7) 
2 (1.7) 
0 
71 (61.2) 
5 (4.3) 
4 (3.4) 
19 (16.2) 
89 (77.4) 
 
76 (45.0) 
9 (5.3) 
62 (36.7) 
3 (1.8) 
144 (85.2) 
116 (68.6) 
32 (18.9) 
132 (78.1) 
7 (4.1) 
0 
0 
109 (64.9) 
10 (5.9) 
10 (5.9) 
35 (20.7) 
138 (81.7) 
-- --  
11 (39.3) 
3 (10.7) 
10 (35.7) 
1 (3.6) 
23 (82.1) 
23 (82.1) 
6 (21.4) 
17 (60.7) 
1 (3.6) 
1 (3.6) 
0 
14 (50.0) 
3 (10.7) 
3 (10.7) 
5 (17.9) 
19 (67.9) 
 
49 (58.3) 
11 (13.1) 
46 (54.8) 
2 (2.4) 
72 (85.7) 
67 (79.8) 
25 (29.8) 
70 (83.3) 
2 (2.41) 
1 (1.2) 
0 
38 (45.8) 
12 (14.3) 
11 (13.1) 
16 (19.1) 
71 (85.5) 
-- -- 
Animal ownership, n (%)§ 
No animals  
Owns animals 
 
86 (73.5) 
31 (26.5) 
 
111 (65.7) 
58 (34.3) 
 
1 
0.69 (0.41-1.16) 
 
-- 
0.161 
 
13 (46.4) 
15 (53.6) 
 
59 (70.2) 
25 (29.8) 
 
1 
2.72 (1.13-6.55) 
 
-- 
0.025 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Sleeps in same room as animals, n (%) 
No  
Yes 
 
117(100.0) 
0 (0) 
 
167 (98.8) 
2 (1.2) 
 
1 
1 
 
-- 
-- 
 
27 (96.4) 
1 (3.6) 
 
81 (96.4) 
3 (3.6) 
 
1 
1.00 (0.10-10.02) 
 
-- 
1.000 
Household member went hungry for 
lack of money in past year, n (%) 
Most days§ 
Certain times of year 
Occasionally 
Never 
 
 
2 (1.7) 
41 (35.3) 
7 (6.0) 
66 (56.9) 
 
 
5 (3.0) 
62 (36.9) 
9 (5.4) 
92 (54.8) 
-- --  
 
0 
11 (40.7) 
1 (3.7) 
15 (55.6) 
 
 
2 (2.4) 
24 (28.6) 
1 (1.2) 
57 (67.9) 
-- -- 
Household member went hungry for 
lack of money when age 5, n (%) 
Most days 
Certain times of year 
Occasionally 
Never 
 
 
2 (1.7) 
51 (43.6) 
10 (8.6) 
54 (46.2) 
 
 
6 (3.6) 
73 (43.2) 
15 (8.9) 
73 (43.2) 
-- --  
 
1 (3.6) 
16 (57.1) 
3 (10.7) 
8 (28.6) 
 
 
7 (8.3) 
33 (39.3) 
1 (1.2) 
43 (51.2) 
-- -- 
Household characteristics 
Roofing material, n (%)§ 
Finished  
Rudimentary 
Natural 
 
112 (95.7) 
0 (0) 
5 (4.3) 
 
164 (97.0) 
0 (0) 
5 (3.0) 
 
1 
-- 
1.46 (0.41-5.18) 
 
-- 
-- 
0.554 
 
25 (89.3) 
0 (0) 
3 (10.7) 
 
82 (97.6) 
0 (0) 
2 (2.4) 
 
1 
-- 
4.92 (0.78-31.11) 
 
-- 
-- 
0.090 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Wall material, n (%)§ 
Finished  
Rudimentary 
Natural 
 
79 (67.5) 
34 (29.1) 
4 (3.4) 
 
98 (58.0) 
71 (42.0) 
0 (0) 
 
1 
0.59 (0.35-0.98) 
1 
 
-- 
0.043 
-- 
 
19 (67.9) 
8 (28.6) 
1 (3.6) 
 
57 (67.9) 
26 (31.0) 
1 (1.2) 
 
1 
0.92 (0.36-2.38) 
3.00 (0.18-50.33) 
 
-- 
0.868 
0.445 
Floor material, n (%)§ 
Finished  
Rudimentary 
Natural 
 
93 (79.5) 
0 (0) 
24 (20.5) 
 
134 (79.3) 
0 (0) 
35 (20.7) 
 
1 
-- 
0.99 (0.55-1.77) 
 
-- 
-- 
0.968 
 
20 (71.4) 
0 (0) 
8 (28.6) 
 
72 (85.7) 
0 (0) 
12 (14.3) 
 
1 
-- 
2.40 (0.86-6.67) 
 
-- 
-- 
0.093 
Number of people per room in 
household, median [IQR] 
1.5 [1.0-
2.0] 
1.5 (1.0-
2.0) 
1.09 (0.79-1.51)† 0.604 1.7 [1.0-
2.0] 
1.5 [1.0-
2.0] 
1.15 (0.66-1.99) † 0.625 
Contact with children, n (%) 
Does not live with children  
Lives with children 
 
15 (12.8) 
102 (87.2) 
 
27 (16.0) 
142 (84.0) 
 
1 
1.29 (0.65-2.55) 
 
-- 
0.459 
 
2 (7.1) 
26 (92.9) 
 
14 (16.8) 
70 (83.3) 
 
1 
2.60 (0.55-12.23) 
 
-- 
0.226 
Population density (1000 people/ km2), 
median [IQR] 
4.2 [2.2- 
8.0] 
4.2 (2.4-
9.9) 
0.98 (0.92-1.02) † 0.256 3.9 [2.2-
7.1] 
3.9 [2.2-
9.9] 
0.96 (0.88-1.06) † 0.447 
Participant health characteristics 
Body mass index (kg/m2), mean [STD] 19.9 [2.5] 21.6 [3.9] 0.85 (0.78-0.92) † < 0.001 20.9 [3.8] 23.2 [4.9] 0.84 (0.72-0.98)† 0.023 
CD4 count (cells/µl), median [IQR] 129 [49-
209] 
355 (236-
492) 
0.99 (0.99-0.99) † < 0.001 -- -- -- -- 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
ART, n (%) 
No  
Yes 
 
49 (41.9) 
68 (58.1) 
 
39 (23.1) 
130 (76.9) 
 
1 
0.42 (0.25-0.70) 
 
-- 
0.001 
-- -- -- -- 
Co-trimoxazole prophylaxis, n (%) 
No  
Yes 
 
50 (42.7) 
67 (57.3) 
 
42 (24.9) 
127 (75.2) 
 
1 
0.44 (0.27-0.73) 
 
-- 
0.002 
-- -- -- -- 
Ever been told has, n (%): 
Heart disease* 
Heart failure 
Hypertension 
Diabetes 
Lung cancer 
Stroke* 
Cancer* 
Chronic kidney disease* 
Chronic liver disease* 
Epilepsy* 
Dementia* 
 
2 (1.7) 
3 (2.6) 
1 (0.9) 
0 
1 (0.9) 
2 (1.7) 
2 (1.8) 
0 
0 
0 
0 
 
2 (1.2) 
0 
7 (4.1) 
1 (0.6) 
0 
3 (1.8) 
2 (1.2) 
1 (0.6) 
0 
2 (1.2) 
1 (0.6) 
-- --  
4 (14.3) 
4 (14.3 
4 (14.3) 
1 (3.6) 
0 
2 (7.1) 
0 
0 
0 
0 
0 
 
0 
0 
1 (1.2) 
0 
0 
0 
0 
0 
0 
0 
0 
-- -- 
Pregnant (females only), n (%)* 1 (2.2) 3 (3.9) -- -- 0 3 (10.7) -- -- 
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Table 6-4 continued HIV-positive sub-group HIV-negative sub-group 
Exposures Cases 
(n=117)  
Controls 
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases 
(n=28)  
Controls 
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Hospitalised as a child for malnutrition, 
n (%) 
Yes 
No 
Don’t know 
 
 
4 (3.4) 
99 (84.6) 
14 (12.0) 
 
 
7 (4.1) 
156 (92.3) 
6 (3.6) 
-- --  
 
2 (7.1) 
23 (82.1) 
3 (10.7) 
 
 
2 (2.4) 
79 (94.1) 
3 (3.6) 
-- -- 
Vaccinated, n (%)* 
Pneumococcal vaccine 
Haemophilus influenza vaccine 
Influenza vaccine 
 
1 (0.9) 
1 (0.9) 
0 
 
0 
0 
0 
-- --  
0 
0 
0 
 
0 
0 
0 
-- -- 
Current medication other than ART/co-
trimoxazole or for respiratory 
problems, n (%)* 
11 (9.6) 21 (12.9) -- -- 9 (32.1) 11 (13.4) -- -- 
Duration of ART, n (%)*‡ 
Less than 3 months 
3-12 months 
More than 12 months 
Don’t know 
 
6 (8.8) 
11 (16.2) 
38 (55.9) 
13 (19.1) 
 
5 (4.1) 
14 (11.4) 
104 (84.6) 
7 (5.4) 
-- -- -- -- -- -- 
*Missing data not imputed; †per unit change; ‡ for those taking ART; § variable included in the principal components analysis for socioeconomic status score.  
HIV; Human Immunodeficiency Virus; OR: odds ratio; CI: confidence interval; IQR: interquartile range; STD: standard deviation; ART: antiretroviral therapy 
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6.3.4. Air pollution exposure 
6.3.4.1. Air pollution monitoring 
Ambulatory PM2.5 exposure data was available for 379 (95.2%) of participants who completed follow-up, 
while ambulatory CO, household PM2.5, and household CO exposure data were available for 388 (97.5%), 
258 (64.8%), and 375 (94.2%) of participants, respectively. Data were missing because of technical faults 
with the pollution monitoring devices.  
Ambulatory readings were taken every 9 seconds, with an average of 47 hours 53 minutes data per 
participant. Household CO readings were taking every 30 seconds for 222 (59.2%) participants and every 
10 seconds for 153 (40.8%) participants, with an average of 47 hours 46 minutes data per participant. 
Household PM2.5 readings were taken every 1 minute, with an average of 44 hours 16 minutes data per 
participant.  
Median duration between recruitment and ambulatory monitoring was 11 days (IQR 6-24) for controls 
and 65 days (IQR 57-83) for cases. Median duration between recruitment and household monitoring 
was 11 days (IQR 6-23) for controls and 64 days (IQR 57-78) for cases.  
6.3.4.2. Measured air pollution exposures 
Ambulatory and household exposures to PM2.5 and CO are shown in Table 6-5. In the HIV-positive sub-
group, ambulatory PM2.5 and CO mean exposures were higher in the cases than the controls, but not 
significantly so. In the HIV-negative sub-group, mean ambulatory PM2.5 was higher, but CO was lower, 
for cases than controls. For household measurements PM2.5 mean exposures were lower and CO mean 
exposures were higher for cases than controls in the HIV-positive sub-group, but the reverse was true in 
the HIV-negative sub-group. 
Ambulatory exposure to CO was significantly higher in women than in men (median mean CO exposure 
5.9 ppm (women) vs 4.3 (men), p = 0.0035). There was no significant difference between ambulatory 
PM2.5 exposures, although there was a trend towards men having higher exposures (median mean PM2.5 
exposure 57.5 (women) vs 61.2 (men), p = 0.575). 
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Table 6-5: Measured ambulatory and household air pollution exposures in HIV-positive and HIV-negative cases and controls, and univariate 
analysis of the association between measured air pollution exposures and pneumonia. 
Exposures HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117)  
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28)  
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Ambulatory exposures 
Mean ambulatory PM2.5 
exposure (µg/m3), 
median [IQR]  
60.4 [41.0-
103.0] 
55.2 [34.6-89.1] 1.00 (1.00-1.00) † 0.145 70.7 [50.3-
109.4] 
56.7 [41.3-
92.3] 
1.00 (1.00-1.01) † 0.410 
Mean ambulatory CO 
exposure (ppm), median 
[IQR]  
6.0 [2.7-
11.3 
4.5 [2.5-9.2] 1.03 (1.00-1.07) † 0.047 3.1 [1.2-
7.4] 
4.7 [1.0-
11.5] 
0.93 (0.85-1.01) † 0.079 
Peak ambulatory PM2.5 
exposure (µg/m3), 
median [IQR]* 
5749.5 
[2732.1 – 
13816.0] 
5226.6 [2221.0 – 
15190.1] 
1.00 (1.00-1.00) † 0.975 19617.73 
[4252.3 – 
53123.5] 
5294.5 
[2501.5 – 
14898.2] 
1.00 (1.00-1.00) † 0.013 
Peak ambulatory CO 
exposure (ppm), median 
[IQR]*  
130.4 
[77.5-
203.8] 
137.5 [69.6 – 
237.6] 
1.00 (1.00-1.00) † 0.352 121.9 [44.5 
– 216.5] 
137.3 [48.5 
– 237.2] 
1.00 (1.00-1.00) † 0.466 
Highest ambulatory 15 
min average PM2.5 
exposure (µg/m3), 
median [IQR]* 
953 [582.7 
– 2134.8] 
804.9 [425.9 – 
1627.7] 
1.00 (1.00-1.00) † 0.538 1267.3 
[697.8 – 
2444.2] 
906.2 
[436.4 – 
2190.8] 
1.00 (1.00-1.00) † 0.807 
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Table 6-5 continued 
Exposures 
HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117)  
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28)  
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Highest ambulatory 15 
min average CO exposure 
(ppm), median [IQR]* 
97.4 
[146.4 – 
35.8] 
73.3 [40.0 – 
135.5] 
1.00 (1.00-1.00) † 0.562 55.1 [21.3 
– 111.6] 
85.7 [33.3 
– 143.2] 
1.00 (0.99-1.00) † 0.186 
Highest ambulatory 60 
min average PM2.5 
exposure (µg/m3), 
median [IQR]* 
473.4 
[292.4 – 
1174.8] 
382.0 [207.1 – 
780.1] 
1.00 (1.00-1.00) † 0.309 544.4 
[347.5 – 
937.7] 
397.0 
[243.6 – 
919.3] 
1.00 (1.00-1.00) † 0.877 
Highest ambulatory 60 
min average CO exposure 
(ppm), median [IQR]* 
67.4 [25.9 
– 102.6] 
54.7 [29.5 – 93.8] 1.00 (1.00-1.00) † 0.327 40.3 [8.3 – 
76.1] 
46.0 [21.5 
– 106.4] 
1.00 (0.99-1.00) † 0.186 
Household exposures 
Mean household PM2.5 
exposure (µg/m3), 
median [IQR]*  
125.2 
[77.4-
254.9] 
167.1 [90.6-
311.9] 
1.00 (1.00-1.00) † 0.559 189.5 
[132.4-
344.3] 
132.4 
[69.5-
292.1] 
1.00 (1.00-1.00) † 0.074 
Mean household CO 
exposure (ppm), median 
[IQR]  
6.9 [2.8-
13.6] 
5.4 [2.9-11.8] 1.02 (1.00-1.04) † 0.109 4.5 [2.4-
8.7] 
7.5 [3.6-
16.1] 
0.96 (0.90-1.01) † 0.121 
Peak household PM2.5 
exposure (µg/m3), 
median [IQR]* 
3417.4 
[1925.4 – 
11669.6] 
6170.5 [2248.2 – 
16019.7] 
0.99 (0.98-1.01) † 0.308 13144.8 
[5992.2- 
32884.2] 
5362.2 
[2353.7 – 
16210.1] 
1.01 (1.00-1.02) † 0.162 
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Table 6-5 continued 
Exposures 
HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117)  
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28)  
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Peak household CO 
exposure (ppm), median 
[IQR]* 
133.5 
[58.3 – 
262.8] 
115.0 [62.5 – 
207.5] 
1.00 (1.00-1.00) † 0.131 130 [76.5-
226] 
155 [91.0 – 
287.5] 
1.00 (0.99-1.00) † 0.210 
Highest household 15 min 
average PM2.5 exposure 
(µg/m3), median [IQR]* 
1789.2 
[831.5 – 
3522.6] 
2224.3 [828.8 – 
5259.5] 
1.00 (1.00-1.00) † 0.500 3678.0 
[1679.7 – 
14205.2] 
1545.1 
[706.1 – 
4814.7] 
1.00 (1.00-1.00) † 0.134 
*Missing data not imputed; †per unit change. HIV: Human Immunodeficiency Virus; OR: odds ratio; CI: confidence interval; IQR: interquartile range; PM2.5: particulate 
matter <2.5µm; CO: carbon monoxide; ppm: parts per million. 
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6.3.4.3. Self-reported air pollution exposures 
Self-reported exposures to pollutants in the home and workplace are reported in Table 6-6. Almost all -   
395 (99.2%) - participants reported that their household had frequently used at least one form of solid 
fuel for a period of at least six months at some point in their lifetime.  
In the HIV-positive sub-group, controls tended to cook with solid fuels more frequently than cases, 
although only around 10% of both groups reported cooking “often” or “frequently”.  Type of solid fuel 
used was very similar between HIV-positive cases and controls, with charcoal being by far the most 
commonly used fuel for cooking. Most households use a portable clay cookstove. Most households did 
not use any form of heating, and candles and electricity were the two most common forms of lighting 
for households in both cases and control groups. Approximately a quarter of both cases and controls in 
the HIV-positive sub-group report cooking for commercial purposes and burning mosquito coils inside 
the home. 
In the HIV-negative sub-group, cooking, heating and lighting habits of cases and controls were similar to 
that of the HIV-positive sub-group, although cases were less likely to use charcoal than controls (64.3% 
vs 81.0%) and more likely to use wood (28.6% vs 7.1%) as their primary cooking fuel. 
Women reported cooking much more frequently than men (p <0.001) but there were no differences 
between type of cooking fuel used between genders. There was no difference between men and women 
in heating and lighting use. Women were more likely to report smoke exposure from beer brewing (6.2% 
vs 1.3%, p = 0.006) and commercial cooking (30.4% vs 11.4%, p <0.001) but men reported exposures 
from brick making and women did not (17.7% vs 0%, p <0.001). Men were also more likely to report 
occupational past or current occupational exposures to smoke or dust than women (81.5% vs 63.4%, p = 
<0.001).  
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Table 6-6: Self-reported exposure to air pollutants in HIV-positive and HIV-negative cases and controls, and univariate analysis of the 
association between self-reported air pollution exposures and pneumonia. 
 HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Household cooking 
Cooking with solid fuel frequency, n (%) 
Cooks rarely  
Cooks occasionally 
Cooks sometimes 
Cooks often 
Cooks frequently 
 
29 (24.8) 
36 (30.8) 
40 (34.2) 
12 (10.3) 
0 (0) 
 
22 (13.0) 
53 (31.4) 
73 (43.2) 
20 (11.8) 
1 (0.6) 
 
1 
0.52 (0.26-1.03) 
0.42 (0.21-0.82) 
0.46 (0.18-1.13) 
1 
 
-- 
0.062 
0.011 
0.088 
-- 
 
4 (14.3) 
16 (57.1) 
8 (28.6) 
0 (0) 
0 (0) 
 
16 (19.1) 
23 (27.4) 
34 (40.5) 
10 (11.9) 
1 (1.2) 
 
1 
2.78 (0.78-9.89) 
0.94 (0.25-3.59) 
1 
1 
 
-- 
0.114 
0.929 
-- 
-- 
Types of stove used for cooking, n (%) 
Open 3-stone fire 
Permanent clay cookstove 
Portable clay cookstove 
Metal cookstove 
Electric cooker 
 
45 (38.5) 
12 (10.3) 
96 (82.1) 
1 (0.9) 
12 (10.3) 
 
78 (46.2) 
28 (16.6) 
132 (78.1) 
0 
26 (15.4) 
-- --  
15 (53.6) 
3 (10.7) 
21 (75.0) 
0 
3 (10.7) 
 
33 (39.3) 
19 (22.6) 
62 (73.8) 
0 
16 (19.1) 
-- -- 
Primary cooking fuel, n (%) 
Electricity  
Wood  
Charcoal 
Plastic Bottles 
 
9 (7.7) 
17 (14.5) 
130 (76.5) 
0 (0) 
 
13 (7.7) 
26 (15.4) 
130 (76.9) 
0 (0) 
 
1 
0.94 (0.33-2.69) 
1.01 (0.41-2.46) 
-- 
 
-- 
0.915 
0.981 
-- 
 
1 (3.6) 
8 (28.6) 
18 (64.3) 
1 (3.6) 
 
10 (11.9) 
6 (7.1) 
68 (81.0) 
0 (0) 
 
1 
13.33 (1.32-134.61) 
2.65 (0.32-22.06) 
1 
 
-- 
0.028 
0.368 
-- 
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Table 6-6 continued HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Fuels used for cooking, n (%) 
Wood 
Charcoal 
Electricity 
Plant matter / crop residue 
Kerosene 
Gas 
Wood shavings 
Plastic bottles 
 
44 (37.6) 
107 (91.5) 
12 (10.3) 
2 (1.7) 
1 (0.9) 
1 (0.9) 
0 
0 
 
78 (46.2) 
160 (94.7) 
26 (15.4) 
0 
0 
1 (0.6) 
0 
0 
-- --  
15 (53.6) 
24 (85.7) 
3 (10.7) 
0 
0 
0 
0 
1 (3.6) 
 
34 (40.5) 
80 (95.2) 
16 (19.1) 
1 (1.2) 
0 
0 
1 (1.2) 
1 (1.2) 
-- -- 
Ventilation whilst cooking, n (%) 
Mainly cooks outside or only uses 
electricity  
Mainly cooks inside with ventilation 
Mainly cooks inside without ventilation 
 
22 (18.8) 
 
73 (62.4) 
22 (18.8) 
 
28 (16.6) 
 
107 (63.3) 
34 (20.1) 
 
1 
 
0.86 (0.46-1.63) 
0.82 (0.38-1.79) 
 
-- 
 
0.662 
0.623 
 
2 (7.14) 
 
19 (67.9) 
7 (25.0) 
 
14 (16.7) 
 
66 (78.6) 
4 (4.8) 
 
1 
 
2.02 (0.42-9.66) 
12.25 (1.79-83.95) 
 
1 
 
0.381 
0.011 
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Table 6-6 continued HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Types of fuel used regularly for at least 
6 months in lifetime, n (%)  
Wood 
Charcoal 
Electricity 
Plant matter / crop residue 
Kerosene 
Gas 
Wood shavings 
Animal dung 
 
 
112 (95.7) 
98 (83.8) 
11 (9.4) 
57 (48.7) 
4 (3.4) 
0 
12 (10.3) 
1 (0.9) 
 
 
169 (99.4) 
157 (92.9) 
12 (7.1) 
95 (56.2) 
4 (2.7) 
3 (1.8) 
29 (17.2) 
3 (1.8) 
-- --  
 
28 (100.0) 
22 (78.6) 
1 (3.6) 
15 (53.6) 
0 
0 
5 (17.9) 
0 
 
 
79 (94.1) 
66 (78.6) 
6 (7.1) 
37 (44.1) 
1 (1.2) 
0 
9 (10.7) 
2 (2.4) 
-- -- 
Household heating and lighting 
Uses solid fuel for heat/light, n (%) 
No 
Yes 
 
105 (89.7) 
12 (10.3) 
 
154 (91.1) 
15 (8.9) 
 
1 
1.17 (0.53-2.61) 
 
-- 
0.695 
 
23 (82.1) 
5 (17.9) 
 
78 (92.9) 
6 (7.1) 
 
1 
2.83 (0.79-10.11) 
 
-- 
0.110 
Fuels used for heating, n (%)* 
Wood 
Charcoal 
Electric 
Doesn’t use heating 
 
2 (1.7) 
2 (1.7) 
0 
115 (98.3) 
 
1 (0.6) 
4 (2.4) 
2 (1.2) 
162 (95.9) 
-- --  
1 (3.6) 
0 
0 
27 (96.4) 
 
1 (1.2) 
0 
0 
83 (98.8) 
-- -- 
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Table 6-6 continued HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Types of lighting, n (%) 
Battery operated torch 
Simple paraffin lamp 
Hurricane lamp 
Candles 
Electricity 
Solar light 
Mobile phone torch 
 
25 (21.4) 
6 (5.1) 
3 (3.4) 
95 (81.2) 
57 (48.7) 
0 
0 
 
34 (20.1) 
1 (0.6) 
8 (4.7) 
135 (79.9) 
76 (45.0) 
5 (2.9) 
4 (2.4) 
-- --  
8 (28.6) 
0 
4 (14.3) 
19 (67.9) 
11 (39.3) 
1 (3.6) 
0 
 
17 (20.2) 
1 (1.2) 
3 (3.6) 
67 (79.8) 
47 (56.0) 
1 (1.2) 
1 (1.2) 
-- -- 
Other exposures 
Work related dust/smoke exposure, n 
(%) 
Never exposed  
Previous exposure 
Current exposure 
 
 
32 (27.4) 
44 (37.6) 
41 (35.0) 
 
 
33 (19.5) 
66 (39.1) 
70 (41.4) 
 
 
1 
0.69 (0.37-1.28) 
0.60 (0.32-1.12) 
 
 
-- 
0.235 
0.111 
 
 
6 (21.4) 
13 (46.4) 
9 (32.1) 
 
 
32 (38.1) 
23 (27.4) 
29 (34.5) 
 
 
1 
3.01 (1.00-9.11) 
1.66 (0.52-5.22) 
 
 
-- 
0.050 
0.390 
Number of years working in a 
dusty/smoky environment, median 
[IQR]* 
5 [2-14] 5 [2-12] -- -- 10 [3-15] 4 [2-9.5] -- -- 
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Table 6-6 continued HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Other smoke exposures, n (%)* 
Burning rubbish 
Brewing beer 
Commercial cooking 
Making bricks 
Burning mosquito coils 
Other 
 
2 (1.7) 
3 (2.6) 
27 (23.1) 
10 (8.6) 
31 (26.5) 
3 (2.6) 
 
3 (1.8) 
6 (3.6) 
36 (21.3) 
16 (9.5) 
46 (27.2) 
3 (1.8 
-- --  
1 (3.6) 
1 (3.6) 
3 (10.7) 
5 (17.9) 
6 (21.4) 
1 (3.6) 
 
1 (1.2) 
3 (3.6) 
10 (11.9) 
11 (13.1) 
18 (21.4) 
3 (3.6) 
-- -- 
*Missing data not imputed 
HIV: Human Immunodeficiency Virus; OR: odds ratio; CI: confidence interval; IQR: interquartile range; STD: standard deviation. 
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6.3.4.4. Exhaled carbon monoxide 
eCO was measured in all 145 cases and 251 (99.2%) of controls. In the HIV-positive sub-group, median 
eCO was 4 (IQR 2-6) and 4 (IQR 3-6) in the cases and controls, respectively. In the HIV-negative sub-
group, eCO was 4 (IQR 3-6) and 3 (IQR 2-6) in the cases and controls, respectively. There was no 
association between eCO and pneumonia risk in either HIV-positive or HIV-negative sub-groups (OR 0.98 
(95% CI 0.93-1.03, p=0.430) and OR 1.02 (95% CI 0.96-1.10, p=0.479), respectively). There was a weak 
but statistically significant association between eCO and mean ambulatory CO exposure (Spearman’s 
coefficient, rs 0.113, p=0.025). There was no association between eCO and mean ambulatory PM2.5 
exposure (rs 0.061, p=0.223), mean household CO exposure (rs 0.076, p=0.119) or mean household 
PM2.5 exposure (rs -0.003, p=0.968). 
6.3.5. Chronic respiratory disease 
Table 6-7 details the respiratory symptoms, previous respiratory diagnoses and respiratory medication 
use reported by cases and controls. CRD (composite definition) was more common in cases than 
controls (138 (95%) vs 97 (38.3%)) (Table 6-7), and amongst controls, was more common in HIV-positive 
individuals than HIV-negative individuals (80 (47.3%) vs 17 (20.2%)). Emphysema was the most 
commonly reported respiratory diagnosis, and this was more common in cases than controls in both 
HIV-positive and HIV-negative sub-groups. Very few HIV-positive or HIV-negative individuals had taken 
medications for respiratory problems in the preceding 12 months, but this was slightly more common in 
cases than controls for both sub-groups. Cases more commonly reported chronic respiratory symptoms 
than controls in both sub-groups, but symptoms were more common in HIV-positive controls than HIV-
negative controls (45.6% vs 17.9). 
Only four (12.9%) of the controls who reported chronic cough attended for sputum induction, and 
GeneXpert® was negative in all of these individuals. 
Measured air pollution exposures were not associated with the presence of CRD (data not shown). 
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Table 6-7: Chronic respiratory diagnoses, medications and symptoms in HIV-positive and HIV-negative cases and controls, and univariate 
analysis of the association between past respiratory health and pneumonia. 
 HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Respiratory diagnosis history and medications 
Chronic respiratory disease, n (%) 
No  
Yes 
 
6 (5.13) 
111 (94.9) 
 
89 (52.4) 
80 (47.3) 
 
1 
20.58 (8.58-49.38) 
 
-- 
< 0.001 
 
1 (3.6) 
27 (96.4) 
 
67 (79.8) 
17 (20.2) 
 
1 
106.41 (13.49-
839.66) 
 
-- 
< 0.001 
Previous respiratory diagnosis, n (%) 
No  
Yes 
 
14 (12.0) 
103 (88.0) 
 
103 (60.6) 
67 (39.4) 
 
1 
11.48 (6.07-21.73) 
 
-- 
< 0.001 
 
2 (7.1) 
26 (92.9) 
 
31 (86.9) 
11 (13.1) 
 
1 
86.27 (17.92-
415.40) 
 
-- 
< 0.001 
Ever been told has, n (%): 
Tuberculosis (in past) 
Pneumonia (as adult, in past) 
Emphysema* 
Asthma / Allergic bronchitis* 
Chronic bronchitis* 
COPD* 
 
30 (25.6) 
37 (31.6) 
100 (86.2) 
14 (12.2) 
0 
0 
 
36 (21.3) 
40 (23.8) 
50 (29.9) 
5 (3.0) 
0 
2 (1.2) 
-- --  
4 (14.3) 
9 (32.1) 
24 (85.7) 
3 (10.7) 
0 
0 
 
1 (1.2) 
3 (3.6) 
9 (10.7) 
4 (4.8) 
0 
0 
-- -- 
Medication for respiratory problems 
in past 12 months, n (%)* 
5 (4.4) 1 (0.6) -- -- 2 (7.4) 2 (2.5)   
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Table 6-7 continued HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls  
(n=169)  
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls  
(n=84)  
Unadjusted OR 
(95% CI) 
P 
value 
Hospitalised for breathing problems 
before age of 10, n (%)* 
Yes 
No 
Don’t know 
 
 
7 (6.0) 
88 (75.9) 
21 (18.1) 
 
 
6 (3.6) 
145 (85.8) 
18 (10.7) 
-- --  
 
2 (7.1) 
19 (67.9) 
7 (25.0) 
 
 
2 (2.4) 
73 (88.0) 
8 (9.6) 
-- -- 
Self-reported chronic symptoms 
Previous chronic respiratory 
symptoms, n (%) 
No  
Yes  
 
 
8 (6.8) 
109 (93.2) 
 
 
92 (54.4) 
77 (45.6) 
 
 
1 
16.28 (7.49-35.01) 
 
 
-- 
< 0.001 
 
 
1 (3.6) 
27 (96.4) 
 
 
69 (82.1) 
15 (17.9) 
 
 
1 
124.20 (15.63-986) 
 
 
-- 
< 0.001 
Usually has cough when doesn’t 
have a cold 
21 (18.0) 24 (14.2) -- -- 6 (21.4) 7 (8.3) -- -- 
Short of breath when hurrying on a 
level or walking up a slight hill* 
15 (14.2) 20 (12.1) -- -- 3 (13.6) 3 (3.8) -- -- 
Usually has phlegm on chest when 
doesn’t have a cold 
11 (9.4) 20 (11.8) -- -- 2 (7.1) 2 (2.4) -- -- 
Wheeze during past 12 months 9 (7.7) 12 (7.1) -- -- 6 (21.4) 4 (4.8) -- -- 
Breathing problems which have 
interfered with usual daily activities 
in the past 12 months 
106 (90.6) 57(33.7) -- -- 27 (96.4) 6 (7.1) -- -- 
*Missing data not imputed. 
HIV: Human Immunodeficiency Virus; OR: odds ratio; CI: confidence interval; IQR: interquartile range; COPD: chronic obstructive pulmonary disease. 
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6.3.5.1. Spirometry 
Two independent reviewers deemed the spirometry data as usable per ATS standards in 349 (87.7%) 
participants who completed follow-up. The two reviewers agreed on the spirometry interpretation for 
99.1% of participants. Of the 91 (72.8%) cases that had abnormal spirometry at their initial follow-up 
appointment, it was only possible to repeat spirometry in 13 (14.3%) a minimum of 4 months after their 
pneumonia episode to determine their final spirometry status: spirometry remained abnormal in all 
these individuals.  
Pre-bronchodilator percentage of predicted FEV1 and FVC were lower in cases than in controls in both 
the HIV-positive and HIV-negative sub-groups (Table 6-8). Abnormal spirometry was identified in 91 
(72.8%) cases compared to 111 (49.3%) controls. In all groups, restrictive abnormalities were more 
common than obstructive abnormalities: overall 150 (43.0%) individuals had restrictive spirometry 
compared to 52 (14.9%) with obstructive spirometry. Of those with restrictive disease, 34 (22.7%), 50 
(33.3%), 54 (36.0%) and 12 (8.0%) had mild, moderate, moderately severe and severe disease, 
respectively. Of those with obstructive disease, 2 (3.9%), 7 (13.5%), 13 (25.0%), 20 (38.5%) and 10 
(19.2%) had mild, moderate, moderately severe, severe and very severe disease, respectively.    
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Table 6-8: Spirometry findings in HIV-positive and HIV-negative cases and controls, and univariate analysis of the association between 
spirometry findings and pneumonia. 
 HIV-positive sub-group HIV-negative sub-group 
Cases  
(n=117) 
Controls 
(n=169) 
Unadjusted OR 
(95% CI) 
P 
value 
Cases  
(n=28) 
Controls 
(n=84) 
Unadjusted OR 
(95% CI) 
P 
value 
Spirometry (using Caucasian reference ranges) 
FEV1 % of predicted (per 1% change), 
median [IQR] * 
60.2 [54.2-
73.3] 
70.3 [62.0-
81.0] 
0.98 (0.96-0.99) † 0.006 57.0 [41.7-
66.0] 
71.4 [61.6-
79.7] 
0.93 (0.90-0.97) † < 0.001 
FVC % of predicted (per 1% change), 
median [IQR] * 
74.7 [65.4-
82.6] 
81.5 [71.7-
88.6] 
0.97 (0.95-0.99) † 0.001 73.0 [64.6-
80.4] 
82.2 [73.1-
89.6] 
0.93 (0.89-0.97) † 0.002 
Spirometric classification, n (%)* 
Normal  
Obstructive  
Restrictive  
 
28 (27.5) 
17 (16.7) 
57 (55.8) 
 
76 (51.7) 
17 (11.6) 
54 (36.7) 
 
1 
2.71 (1.22-6.04) 
2.87 (1.61 – 5.07) 
 
-- 
0.014 
<0.001 
 
6 (26.1) 
8 (34.8) 
9 (39.1) 
 
37 (48.1) 
10 (13.0) 
30 (39.0) 
 
1 
4.93 (1.39-17.54) 
1.85 (0.59-5.78) 
 
-- 
0.014 
0.290 
Spirometry (using African-American reference ranges) 
FEV1 % of predicted (per 1% change), 
median [IQR] * 
87.7 [75.7 
– 101.9] 
95.9 [85.1 
– 108.0] 
-- -- 82.0 [69.8 
– 99.6] 
97.9 [ 88.8 
– 110.4] 
-- -- 
FVC % of predicted (per 1% change), 
median [IQR] * 
93.3 [82.4 
– 105.2] 
101.4 [89.3 
– 110.7] 
-- -- 86.2 [81.6 
-101.1] 
103.3 [88.9 
– 111.4] 
-- -- 
Spirometric classification, n (%)* 
Normal  
Obstructive  
Restrictive  
 
10 (68.6) 
16 (15.7) 
16 (15.7) 
 
120 (81.1) 
17 (11.5) 
11 (7.4) 
-- --  
13 (56.5) 
8 (34.8) 
2 (8.7) 
 
63 (81.8) 
10 (13.0) 
4 (5.2) 
-- -- 
*Missing data not imputed; †per unit change. 
HIV: Human Immunodeficiency Virus; OR; odds ratio; CI: confidence interval; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; IQR: interquartile range 
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Using Caucasian reference ranges, abnormal spirometry was associated with the presence of CRD 
(composite definition) in the HIV-positive sub-group (Pearson’s chi-square test= 15.22, p<0.001) but not 
in the HIV-negative sub-group (1.93, p=0.165). Abnormal spirometry was not associated with CRD in the 
control population (3.34, p=0.068). Similar findings were noted between abnormal spirometry and 
chronic respiratory symptoms.  
Use of African-American reference ranges resulted in a higher FVC % of predicted result compared to 
using Caucasian reference ranges, and therefore the prevalence of restrictive airways disease was lower. 
Using African-American reference ranges, abnormal spirometry was associated with the presence of 
CRD in the HIV-positive sub-group (Pearson’s chi-square test= 9.92, p=0.002) but not in the HIV-negative 
sub-group (3.50, p=0.061). An association was found between CRD and abnormal spirometry in the 
control population, if African-American reference ranges were used (6.46, p=0.011). 
In the control group, there were no significant associations found between either restrictive or 
obstructive airways disease and BMI, socioeconomic status or ambulatory PM2.5 and CO mean exposures 
(data not shown) in univariate analysis or after adjustment for age and gender.   
In the control group, BMI was associated with pre-bronchodilator % of predicted FEV1 (p < 0.001) and % 
of predicted FVC (p = 0.001) but there were no associations between socioeconomic status and pre-
bronchodilator % of predicted FEV1 value or % of predicted FVC value (p = 0.185 and p=0.094, 
respectively). There were no associations between mean PM2.5 or CO exposures and spirometry findings 
in the control group.   
6.3.6. Univariate analysis of potential risk factors 
Findings were consistent for pollution assessment modalities in both HIV-positive and HIV-negative sub-
groups: exposure to ambulatory and household PM2.5 and CO had no effect on pneumonia risk with 
unadjusted ORs of approximately one for all measures of mean and peak exposures (Table 6-5). In the 
HIV-positive sub-group, there were no consistent findings related to frequency of cooking with solid 
fuels and no significant findings relating to fuel use, household ventilation, or other reported forms of 
pollution exposure (Table 6-6). In the HIV-negative sub-group, cooking with wood (OR 13.33 [95% CI 
1.32–134.61, p=0.028]) and cooking inside without ventilation (OR 12.25 [95% CI 1.79–83.95, p=0.011]) 
were both associated with an increased risk of pneumonia. 
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CRD was associated with an increased risk of pneumonia in both study groups (HIV-positive: OR 20.58 
[95% CI 8.58–49.38], p<0.001; and HIV-negative: OR 106.41 [95% CI 13.49–839.66, p<0.001]) (Table 6-7). 
Restrictive spirometry was a risk factor for pneumonia in the HIV-positive sub-group only (OR 2.87 [95% 
1.61–5.07, p<0.001]) whereas obstructive spirometry was predictive of pneumonia in both sub-groups 
(HIV-positive: OR 2.71 [95% CI 1.22–6.04, p=0.014]; and HIV-negative: OR 4.93 [95% CI 1.39-17.54, 
p=0.014]) (Table 6-8). Similar results were found in univariate analysis of spirometric findings using 
African-American reference ranges (data not shown).  
Factors associated with a reduced risk were taking antiretroviral treatment (OR 0.42 [95% CI 0.25–0.70, 
p=0.001]), increasing BMI (HIV-positive: OR 0.85 [95% CI 0.78–0.92, p<0.001]; HIV-negative: 0.84 [95% CI 
0.72–0.98, p=0.023]) and increasing CD4 count (cells/µl) (OR 0.99 [95% CI 0.99–0.99, p<0.001]) (Table 
6-4). In the HIV-positive sub-group, socioeconomic status was not associated with pneumonia (OR 1.00 
[95% CI 0.85–1.20, p=0.943]), but there was an increased risk of pneumonia with decreasing 
socioeconomic status in the HIV-negative sub-group (OR 1.38 [95% CI 1.02–1.85, p=0.034]). Other 
potential risk factors and confounding factors are reported in Tables 6-4 to 6-8.   
6.3.7. Multivariate analysis of potential risk factors 
After adjustment for confounders, mean ambulatory and household PM2.5 and CO exposures were not 
associated with pneumonia in the HIV-positive or HIV-negative sub-groups ( 
Table 6-9). CRD had a substantial effect on pneumonia risk in both HIV-positive and HIV-negative sub-
groups (aOR 28.07 [95% CI 9.28–84.83 p<0.001] and aOR 104.27 [95% CI 12.86–852.35, p<0.001], 
respectively). Factors associated with a reduced risk of pneumonia after adjustment for confounders in 
the HIV-positive sub-group included BMI (HIV-positive: aOR 0.84 [95% CI 0.74–0.95, p=0.005]), 
increasing CD4 count (aOR 0.99 [95% CI 0.99–0.99, p<0.001]) and antiretroviral therapy (aOR 0.24 [95% 
CI 0.09–0.61, p=0.003]). In the HIV-negative sub-group, after adjustment for age and sex, being an ex-
smoker (aOR 5.92 [95% CI 1.69–20.79, p=0.006]) and cooking inside without ventilation (aOR 9.32 [95% 
CI 1.24–69.81, p=0.030]) were associated with an increased risk of pneumonia. Increasing BMI (aOR 0.84 
[95% CI 0.72–0.99, p=0.036]) was found to be protective against pneumonia in the HIV-negative sub-
group. We did not find evidence of spatial clustering in pneumonia risk, with all p-values for the test on 
the presence of residual spatial effects being well above 10%. 
142 
 
 
Table 6-9: Multivariate analysis of the effects of household air pollution exposure and chronic 
respiratory disease on pneumonia risk for HIV-positive and HIV-negative sub-groups. 
Exposures Adjusted OR (95% CI) P value 
HIV-positive sub-group 
Mean ambulatory PM2.5 exposure (µg/m3)* 1.00 (1.00–1.01)** 0.141 
Mean ambulatory CO exposure (ppm)* 1.07 (1.00–1.14)** 0.052 
Mean household PM2.5 exposure (µg/m3) †§ 
 
1.00  (1.00–1.00) ** 0.608 
Mean household CO exposure (ppm)* 1.03 (1.00–1.07) ** 0.081 
Chronic respiratory disease* 28.07 (9.29–84.83) < 0.001 
HIV-negative sub-group 
Mean ambulatory PM2.5 exposure (µg/m3) ‡ 1.00 (0.99–1.01) ** 0.872 
Mean ambulatory CO exposure (ppm)‡ 0.95 (0.87–1.03) ** 0.219 
Mean household PM2.5 exposure (µg/m3)‡ § 1.00 (1.00–1.00) ** 0.307 
Mean household CO exposure (ppm)‡ 0.96 (0.91–1.02) ** 0.206 
Chronic respiratory disease‡ 104.27 (12.86–852.35) <0.001 
*Adjusted for age, sex, CD4, chronic respiratory disease, antiretroviral treatment, body mass index, occupational status and 
alcohol intake; †adjusted for age, sex, CD4, chronic respiratory disease and antiretroviral treatment; ‡adjusted for age and 
sex; §Missing household PM2.5 data were not imputed; therefore, analyses were restricted to 169 and 79 observations in the 
HIV–positive and HIV–negative sub-groups, respectively; **per unit change. 
OR: odds ratio; CI: confidence interval; HIV: Human Immunodeficiency Virus; PM2.5: particulate matter <2.5µm; CO: carbon 
monoxide; ppm: parts per million. 
 
6.4. Discussion 
6.4.1. Recruitment and participant characteristics 
The AIR study aimed to recruit a cohort of pneumonia patients, representative of those presenting with 
community acquired pneumonia to a large tertiary referral centre in urban sub-Saharan Africa, alongside 
a cohort of healthy controls, randomly selected from the same population that the pneumonia patients 
came from.  
Recruitment was slower than anticipated for both cohorts. For both cases and controls, recruitment was 
particularly slow during the time of the two natural disasters affecting Malawi during the time of the 
study (floods and drought). This was presumed to be due to difficulties accessing healthcare (and 
143 
 
therefore a lower than usual attendance rate at the hospital) and lack of time to devote to study 
activities whilst dealing with the consequences of the disaster. It was also more difficult to locate 
participants at their households after the floods, as many patients had been forced to relocate.   
Many of the screened respiratory patients were ineligible for the study due to their duration of 
symptoms being longer than 14 days (913, 42.5%). This possibly reflects the high prevalence of 
tuberculosis in this population, but may also be due to the high prevalence of CRD and difficulties in 
distinguishing between acute and chronic symptoms at presentation. If patients with chronic respiratory 
symptoms who had an acute respiratory exacerbation were mistakenly deemed ineligible, this may have 
biased our CRD findings towards the null; despite this a strong association between CRD and pneumonia 
was found. Delayed presentation, which may be related to the fact we were recruiting from a tertiary 
referral hospital or health-seeking behaviours, may have also contributed the high number of people 
excluded due to prolonged symptom duration. This may have impacted on the demography of the 
cohort and the severity of their pneumonia. Although efforts were made to screen all adults presenting 
to QECH with respiratory problems in order to capture a wide spectrum of pneumonia patients, it is 
likely that those with the mildest form of community acquired pneumonia (who did not warrant referral 
to the tertiary centre), and those with the most severe disease (who did not survive until arriving at 
QECH) were not recruited. Of those recruited, those with the most severe disease and poorest outcome 
(i.e. death) were not included in the final analysis because they were unable to complete follow up. 
However, there was little difference between those who completed the study and those who did not in 
terms of baseline vital signs (Table 6-3). 
404 (18.8%) respiratory patients lived outside of Blantyre or moved outside of Blantyre during the 
course of the study and so were ineligible, as the study aimed to evaluate the effect of air pollution in an 
urban setting.  A higher than anticipated number of recruited cases either died or were started on 
tuberculosis treatment prior to follow-up (179, 41.8%), resulting in a smaller case sample size than 
planned.  
Control recruitment was challenging due to the strict quotas required to ensure that consistent numbers 
of individuals were recruited to each age/gender/HIV strata across the time period of study recruitment: 
676 (45.3%) potential controls were ineligible as they didn’t meet the requirements for stratified 
recruitment. This was ameliorated by introducing recruitment from antiretroviral therapy clinics at 
health centres, but still resulted in slower than anticipated control recruitment. In particular, it was 
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difficult to find young HIV-positive males as they tended to not be at home during the daytime and did 
not regularly attend antiretroviral therapy clinics. 
Several measures were taken to ensure that the controls were recruited at random from the same 
population from which the cases were derived. Although these measures made recruitment more 
challenging, and likely resulted in a smaller sample size, this reduced the risk of bias in the control 
population. Both cases and controls were restricted to the same geographical area (Blantyre city) and 
Figure 6-2 demonstrates that a good geographical spread across the city was achieved. Control 
recruitment locations were selected at random (weighted by population density), and individuals were 
selected at random from all eligible household members (including those not home at the time of the 
visit), ensuring that every inhabitant of Blantyre city had an equal chance of being approached for 
screening. However, individuals who were unavailable to complete the screening process were more 
likely to be male than female (86.2% vs 13.8%) and therefore the recruited male control cohort is at 
more risk of bias than the female control cohort.     
Reluctance to participate was relatively low in both cases and controls, with 52 (2.4%) and 64 (4.6%) of 
potential cases and controls, respectively, either declining to consent or withdrawing consent.  Controls 
were more likely to withdraw consent if they were HIV-positive (6.7%) than HIV-negative (2.2%), 
perhaps reflecting reluctance to participate following positive HIV test result, although the impact of this 
was small.   
6.4.2. Pneumonia patient characteristics 
The characteristics of patients who had pneumonia were broadly similar to those studied in other 
pneumonia cohorts from sub-Saharan Africa. Approximately half of recruited cases in the AIR study were 
considered to have pneumonia as they had confirmed chest x-ray changes and were not started on 
tuberculosis treatment. There was a preponderance of male gender in those with confirmed 
pneumonia, which is consistent with pneumonia cohorts in other settings (6, 208, 209, 218, 287, 288). A 
median age of 36 (IQR 30-45) in the pneumonia cohort is also similar to that seen in other pneumonia 
studies in sub-Saharan Africa (6, 24, 218, 231, 241, 289), but younger than seen in well-resourced 
settings (208, 209, 288).  
HIV prevalence amongst the hospitalised pneumonia patients (81.6%) was comparable to other to 
studies of pneumonia in sub-Saharan Africa (6, 218, 231, 289). Median baseline CD4 count was low and 
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almost 40% were not on ART: this highlights an important opportunity for reducing pneumonia burden 
in this population, as pneumonia risk increases with decreasing CD4 count (24).  
There were high rates of confirmed tuberculosis and clinically suspected tuberculosis amongst recruited 
cases, despite a case definition mandating a symptom duration of 14 days or less, similar rates to that 
identified by the MARISO study (218). We found a higher rate of tuberculosis than seen in a Kenyan 
study of patients with a similar case definition (9% confirmed diagnosis) (6). This is possibly explained by 
the additional use of GeneXpert® MTB/RIF assays in the AIR and MARISO studies. A substantial burden of 
Mycobacterium tuberculosis has been found in several community acquired pneumonia studies in sub-
Saharan Africa (6, 218, 231, 289), and this high prevalence of tuberculosis amongst acutely unwell 
patients is an important finding which highlights the need for early clinical suspicion of pulmonary 
tuberculosis in high prevalence areas even in those with an acute presentation. In the MARISO study, 
detection of M. tuberculosis was associated with treatment failure at 72 hours, delayed clinical stability 
and increased 30-day mortality(218). This has implications for guidelines regarding empirical treatment 
for community acquired pneumonia patients, including the avoidance of single agent use of 
fluoroquinolones which may propagate resistance in Mycobacterium tuberculosis (290). Pragmatic WHO 
guidelines recommend the addition anti-tuberculosis medication in community acquire pneumonia 
patients who have not responded to 3-5 days  of broad spectrum antibiotic treatment (291),  although 
this may not be an adequate strategy as it may miss 15% of patients with culture positive tuberculosis 
(292). This is concerning considering the high rates of early mortality seen in tuberculosis patients (293). 
Improvements in rapid diagnostics for M. tuberculosis - such as GeneXpert® MTB/RIF assay or the Alere 
Determine tuberculosis lipoarabinomannan (LAM) urinary antigen assay (292, 294-296) - may help, but 
further randomised controlled trials regarding how to clinically manage this population are warranted 
(297, 298).  
In all recruited cases, Streptococcus pneumoniae was the second most commonly detected pathogen 
(85, 20.1% of those with either a blood culture result or a BinaxNOW® Streptococcus pneumoniae 
urinary antigen result). Pneumococcal bacteraemia was seen in 1.3%. Streptococcus pneumoniae was 
detected in 67 (21.2%) of the participants with chest x-ray changes and microbiological diagnostic 
results, and 50 (24.5%) of the 204 participants with pneumonia and available microbiological diagnostic 
results. The prevalence of pneumococcal pneumonia is similar to that detected in the MARISO study 
(218), but lower than other studies in sub-Saharan Africa in which intensive microbiological diagnostics 
were performed (including high rates of pleural fluid aspiration culture by Scott et al) (6, 231). The low 
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bacteraemia rate may in part be due to a high proportion of patients having reported receiving 
antibiotic treatment prior to presentation at QECH, but may also reflect inadequate microbiological 
diagnostics (individuals who had already had a blood culture taken by the clinical team prior to their 
recruitment did not have this repeated, and the clinical result was recorded where possible) (299). 
Indirect effects of the widespread uptake of the infant pneumococcal vaccine may have resulted in a 
shift towards less-invasive non-vaccine type pneumococcal serotypes, which may also explain low 
bacteraemia detection rates (300).  
Overall hospital mortality of recruited cases was 10.7%, but was lower if limited to pneumonia patients 
(7.25%), which is comparable to other studies of unselected community-acquired pneumonia patients in 
both well and poor-resourced settings (6, 205, 218, 288). There was no difference in in-patient mortality 
according to HIV status which is consistent with other studies (6, 218). Death prior to follow up occurred 
in 64 (14.9%) of respiratory cases (29 (14.0%) of confirmed pneumonia cases) but this is likely to be an 
underestimate as death following discharge was not recorded for individuals who had already been 
excluded for other reasons.  
6.4.3. Air pollution exposure 
Air pollution monitoring was conducted for all 399 participants who completed the study. For almost all 
participants, data were available for ambulatory PM2.5 and CO exposures and household CO exposures 
but, despite multiple attempts at monitoring, we were unable to collect household PM2.5 exposure data 
for 35% of participants due to technical difficulties: the UCB-PATS monitors were frequently found to be 
faulty, and often provided only intermittent data across a 48 hours period.  
While there is no gold standard method for air pollution monitoring, measuring both ambulatory and 
household levels of two different major components of air pollution (PM2.5 and CO) is likely to capture a 
representative picture of an individual’s total exposure. Mean household PM2.5 levels detected (all 
homes: median 149.5 µg/m3, IQR 85.0–289.0 µg/m3) and mean household CO levels (all homes: median 
6.4 ppm, IQR 2.9–12.6ppm) were comparable to those detected in a previous study of urban Malawian 
homes (mean 150 µg/m3, standard deviation 360 µg/m3 and mean 6.14 ppm, respectively) (3).  
The detected levels of exposure greatly exceed the levels considered safe: WHO Air Quality Guidelines 
recommend not exceeding 24hour-mean PM2.5 levels of 25 µg/m3 (196). Mean ambulatory PM2.5 levels 
detected (all participants: median 59.4 µg/m3, IQR 39.6–96.1 µg/m3) equate to a 2.5%–5% increased risk 
of short-term mortality according to these guidelines. For CO exposure, the WHO recommends not 
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exceeding 24hour-mean levels of 7mg/m3 (equivalent 5.68 ppm) (301): mean 48-hour ambulatory CO 
levels detected in this study were above this level for 45% of participants with available data. Mean CO 
concentrations over 1 hour should not exceed 35 mg/m3 (equivalent 28.4ppm) yet median highest 
ambulatory 60 min average CO exposures were 53.5pm (IQR 23.6-100.8). Furthermore, mean CO 
concentrations over 15 minutes should not exceed 100 mg/m3 (equivalent 81.1ppm), but highest 
ambulatory 15 min average CO exposures were greater than this for 53% of those with available data 
(median 80.7ppm (IQR 34.4-135.8)). 
Cooking was the predominant source of pollution exposure reported in this study, with only a minority 
of participants reporting exposures from heating, lighting, current occupational exposures, current 
tobacco smoke exposure or other sources. Almost all participants reported that their household had 
frequently used at least one form of solid fuel for a period of at least six months at some point in their 
lifetime. Higher ambulatory CO exposures in women compared to men is consistent with the fact 
women cooked more frequently than men (p<0.001) and the most commonly used fuel was charcoal, 
which emits relatively large amounts of CO when burned. Although not statistically significant, higher 
PM2.5 exposures in men compared to women may be a result of their increased exposures from 
occupational sources. Brick making, which typically uses petrol for fuel resulting in CO emissions, was 
only reported by men. Burning of mosquito coils, reported by both men and women, can result in high 
PM2.5 and carcinogenic polycyclic aromatic hydrocarbons associated with respiratory symptoms (58).  
These high levels of exposure, well in excess of international safety standards, highlight the need to 
address air pollution levels in Malawi. Whilst it is not possible from our ambulatory data to distinguish 
between indoor and outdoor exposures, the high PM2.5 and CO levels detected in households suggests 
that household air pollution is a significant contributor to this problem. With almost all households 
reporting use of solid fuels for cooking, but only a minority of household using heating or lighting, it is 
cooking practices that offer the biggest opportunity for addressing household air pollution.  
6.4.4. Exhaled carbon monoxide 
The need for a biomarker of exposure was discussed in Chapters 4 and 5. eCO was proposed as a 
potentially feasible biomarker to be used in the field in resource-poor settings. eCO measurement was 
well tolerated and easy to perform in this study. However, with only a very weak association between 
eCO and ambulatory CO exposure, and no association with the other measured pollutants parameters, 
there is no evidence from this study to support eCO as a biomarker of household air pollution exposure. 
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6.4.5. Chronic respiratory disease 
A large proportion of individuals reported chronic respiratory symptoms or previous diagnoses, and so 
met our composite definition of CRD. The very high rate of reported symptoms in cases (93.2% of HIV-
positive and 96.4% of HIV-negative) may reflect recall bias as individuals who have recently had 
pneumonia may be more likely to respond positively to symptom questions (although cases were asked 
to recall the period in the months prior to their pneumonia episode). However, the substantial rate of 
chronic respiratory symptoms in the HIV-positive controls (46%), suggests that there is a significant 
background level of respiratory problems in this population. The results for the composite definitions of 
chronic respiratory symptom and CRD were largely driven by individuals who reported episodes of 
respiratory problems interfering with their daily activities in the past 12 months (up to 7 episodes) which 
may be the result of acute episodes rather than chronic problems. If this is removed from the composite 
definition, both CRD and chronic respiratory symptoms remain strongly associated with pneumonia in 
both HIV-positive and HIV-negative sub-groups (CRD: HIV-positive OR 10.8 (95% CI 5.5-21.1, p <0.001) 
and HIV-negative OR 38.3 (95% CI 10.2 – 143.7, p <0.001); chronic respiratory symptoms: HIV-positive 
OR 1.6 (95% CI 1.0-2.8, p = 0.045) and HIV-negative OR 8.5 (95% CI 3.2-23.1, p <0.001)). 
Chronic cough was the most commonly reported symptom, which, as noted elsewhere, may reflect 
undiagnosed tuberculosis (41). However, tuberculosis diagnostics were negative in 120 (82.8%) of cases 
and in all four of the controls with chronic cough who attended for sputum induction. It was not possible 
to exclude tuberculosis in 87% of the controls with a chronic cough who did not attend for sputum 
induction despite multiple invitations.  
Emphysema was the most commonly reported previous respiratory diagnosis, whereas COPD was only 
reported by very few. This may reflect the terminology used by health care professionals in Malawi, or 
may be related to the translation of these diagnoses into Chichewa. The translated Chichewa 
questionnaires used to determine air pollution exposures and respiratory history and symptoms were 
approved by the BOLD study, to ensure that high quality translations were used and also to allow 
comparability with the BOLD multinational studies. However, by choosing to use externally approved 
translations, this prevented the opportunity to test and adapt the questionnaires locally to ensure that 
terminology was correctly understood by the study population, which may have impacted on our 
questionnaire findings and may partly explain the high prevalence of CRD identified. 
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For the primary analysis, spirometry was interpreted using NHANES III Caucasian reference ranges in 
accordance with BOLD study standards, to allow comparison of data with the multinational BOLD 
studies (121). When using spirometry reference ranges derived from African-American populations, the 
rates of restrictive disease were much lower compared to standards for Caucasian populations. This is 
consistent with the BOLD study from Nigeria, in which the prevalence of restriction was 70.4% and 
72.8% in men and women, respectively, using NHANES III Caucasian reference ranges, compared to 
17.8% and 14.4% using NHANES III African-American reference ranges, and <4% in both men and 
women using locally derived reference ranges (302). The previous BOLD study from Blantyre also found 
a prevalence reduction from 38.6% to 9% when using locally derived reference ranges compared to 
NHANES III Caucasian reference ranges (41). Although neither of these locally derived reference ranges 
have been externally validated, these findings support existing evidence that sub-Saharan Africa 
populations have smaller lungs than Caucasian populations (303), possibly due to the life course effects 
on lung health discussed below. Although genetic differences in body shape related to ethnicity are 
known to play a role in lung function, environmental factors are also important making choice of 
appropriate reference range for any given population a controversial issue (303, 304). Burney and 
Hooper conclude from a study of 4000 white and African-American adults in the USA that although 
there are differences in ventilatory function between ethnic groups, there is no evidence that there is 
any difference in mortality between ethnic groups for any given FVC and therefore ethnically adjusted 
reference ranges should not be used when assessing prognosis (305).  
Using NHANES III Caucasian reference ranges, the AIR study and an earlier BOLD study in Malawi both 
found a high prevalence of restrictive lung disease, rather than obstructive lung disease (41). This is in 
keeping with other studies in sub-Saharan Africa (306) and other resource poor settings (307, 308). Low 
FVC has been shown to be associated with poverty (measured by Gross National Income and using proxy 
indicators for socioeconomic status, such as education level) (302, 307, 309). There is also evidence for 
an association between low  BMI and reduced FVC (41, 302, 310), although the association may be non-
linear and influenced by percentage body fat (311). Early life course events, such as low birthweight, 
childhood malnutrition and childhood respiratory infections may affect lung growth resulting in reduced 
adult lung function (312-316). However, a recent study from Blantyre found no association between 
severe acute malnutrition in early childhood and subsequent reduced lung function (317). In the AIR 
study, an association was found between BMI and lung function in the controls (unadjusted for 
confounders) and but there was no association between socioeconomic status and lung function. In 
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keeping with findings from Nigeria, we found no association between household air pollution and low 
FVC (302). 
Low FVC is associated with increased mortality in other settings, even in the absence of respiratory 
symptoms (307, 318). Restrictive airways disease predicts mortality better than obstructive disease, and 
restrictive disease is associated with COPD mortality, indicating that many “COPD” deaths may in fact be 
due to underlying, undiagnosed restrictive disease (307). The relationship identified by AIR between 
airways restriction and pneumonia is potentially relevant to our understanding of this increased 
mortality. The underlying aetiology, pathology, epidemiology and prognosis of this low FVC 
phenomenon requires further investigation. 
Previous studies found an association between biomass exposure and reduced FEV1 and FVC, resulting in 
obstructive lung disease (319), but recent studies in sub-Saharan Africa have not found an association 
(41, 306, 320). In our study, no association was found between ambulatory mean PM2.5  and CO 
exposures and % predicted FEV1 or FVC; this is consistent with a study from Guatemala in which there 
was no association between 48 hour ambulatory CO exposure and lung function (321).   
Lung function was not consistently associated with our CRD or respiratory symptoms, which may reflect 
our composite definitions for CRD and chronic respiratory symptoms. For example, breathlessness may 
be explained by cardiac dysfunction rather than respiratory disease. Inaccurate recall of symptoms or 
diagnoses may have also contributed to inaccurate exposure classification. The lack of association may 
also be explained by the true presence of abnormal lung function in the absence of respiratory 
symptoms, and vice-versa (322).   
6.4.6. Risk factors for pneumonia 
We found no association between household air pollution exposure, measured using ambulatory and 
household monitoring of pollutants, and radiologically confirmed pneumonia in urban Malawian adults. 
This was consistent across both HIV-positive and HIV-negative individuals and when measuring PM2.5 
and CO. In contrast, we found a strong association between CRD, as defined by participant-reported 
symptoms and diagnoses, and pneumonia in this setting. This was supported by an association between 
pneumonia and both restrictive (in the HIV-positive sub-group only) and obstructive lung disease, 
diagnosed by spirometry testing. As no association was detected between measured air pollution 
exposures and abnormal lung function or CRD, there is no evidence from this study that household air 
pollution is indirectly associated with pneumonia as a result of increased pneumonia risk from CRD.  
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It seems likely that socioeconomic factors explain the unexpected findings of reduced risk of pneumonia 
in current smokers and consumers of alcohol, as in the context of urban Malawi, the poorest individuals 
cannot afford cigarettes and alcohol (323). The low prevalence of smoking in this setting means that 
smoking is not a major driver of pneumonia risk in multivariate analysis, unlike in higher resourced 
countries (208). 
Reduced BMI, an indicator for malnutrition (324), was a strong predictor for pneumonia in both sub-
groups, even after adjustment for age, gender, CRD and CD4 in the HIV-positive sub-group: malnutrition 
may play a role in pneumonia risk, as has been shown in children (325). Further research into nutritional 
status in this population and possible interventions is warranted.  
The lack of association between household air pollution and ALRI in adults identified in this study may 
be explained by the overwhelming effect of other major risk factors (such as CRD, HIV-associated factors 
and BMI), in this setting. This could explain why an association is evident in children but not adults, in 
whom lifelong exposure to other factors plays a more important role (12). Alternatively, it is possible 
that we have not detected a true association between household air pollution and ALRI in adults owing 
to methodological limitations, in particular with exposure assessments. 
6.4.7. Strengths and weaknesses 
The AIR study is the only study of household air pollution and pneumonia in adults to have used multiple 
measurements of air pollution exposure with radiologically confirmed hospitalised pneumonia cases. 
Although the largest and most detailed study of household air pollution and ALRI in adults to date, it has 
a number of limitations.  
We were unable to evaluate HIV-positive and HIV-negative individuals together due to a lack of 
statistical power, but our findings were broadly consistent across both groups. The original sample size 
was not met because recruitment was slower than anticipated leading to lower power to detect an 
effect. However, in the HIV-positive group, we were able to detect an OR greater than 1.0003 per unit 
change for ambulatory PM2.5 exposure (our primary exposure of interest) with 80% power. The decision 
to stop recruitment (at the end of the planned study period, but with a smaller than planned sample 
size) was made on the basis of the results of an interim analysis. There are risks of undertaking an 
interim analysis, especially if this has not been pre-specified in the original protocol. Firstly, the interim 
analysis makes the assumption that all subsequent data collected will be similar to that in the existing 
dataset. If future data collected differs significantly from the initial dataset, either due to systemic bias 
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or chance, then the predictions of the interim analysis will be inaccurate for the final analysis. Interim 
analysis introduces the risk of bias to the study as, for example, participant selection or exposure and 
outcome measurements may be influenced by the knowledge of the interim analysis findings if the 
study team is not blinded. There are also risks associated with repeated significance testing or multiple 
comparisons, which increases the probability of a Type I error. Finally, if the same rigour of data cleaning 
and statistical methodology is not applied at the interim analysis as compared with the final analysis, 
then the interim analysis will have poor predictive capabilities for determining the likely final outcome. 
The interim analysis for the AIR study was undertaken despite these known risks due to practical and 
logistical reasons: it was not possible to extend the planned recruitment period (due to financial and 
time constraints) unless there was a good scientific basis for doing so. The interim analysis had 
determined a high likelihood of detecting an association between pneumonia and CRD and ambulatory 
mean CO exposure at final analysis, but no association between pneumonia and ambulatory mean CO 
exposure was found. Reasons for the difference between the interim and final analysis findings could be 
that there was a difference between the initial and final datasets, or because the data used in the 
interim analysis had not been cleaned using the same methods as the final dataset. Given the smaller 
than originally planned sample size, this raises the possibility of a Type 2 error, which is the major 
weakness of this study. 
Due to the case-control design of the study, assessment of exposures was conducted after the 
occurrence of the pneumonia. This resulted in the most severe cases of pneumonia (patients with the 
highest mortality risk) not being included in the final analysis, as they did not survive until follow-up. The 
potential effect of this selection bias is to bias the findings towards the null. However, we found minimal 
difference in baseline vital sign observations (which may indiciate the severity of illness at presentation) 
between cases who completed follow up and those who didn’t, suggesting there were not major 
differences in disease severity between the two groups. In addition, our study design precluded the 
inclusion of individuals with milder disease, as we only recruited individuals who were admitted to 
QECH. We did not include individuals who may have pneumonia who did not seek healthcare, who only 
attended district/community health centres or who were well enough to be discharged from QECH 
emergency room. The potential effect of this may have been to bias the findings away from the null. This 
effect could have been mitigated by also recruiting from community health centres, but this was not 
possible due to resource contraints, such as lack of availability of x-ray machines. 
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Potential risk factors were assessed after the episode of pneumonia, and so questionnaire assessments 
may have been subject to recall bias. In particular, our composite assessment of CRD may have been 
vulnerable to recall bias, as cases may have been more likely to report respiratory symptoms and 
diagnoses than controls due to their recent illness. Spirometry results provide objective evidence of an 
association between CRD and pneumonia but abnormal lung function in the cases may have been a 
result of their acute illness rather than chronic disease (although lung function should have recovered 2 
months following the acute episode). Attempts were made to account for this by repeating spirometry 
at least another 2 months later (and no significant changes between these two measurements were 
noted), but this was only possible in 14% of cases with abnormal spirometry.  
Objective measurements of air pollution exposures were made, but these may not be representative of 
pre-pneumonia exposures, although 138/142 (97.2%) cases reported that they had returned to normal 
levels of function. A sensitivity analysis, in which cases without reported full functional recovery were 
excluded, also found no effects of mean ambulatory PM2.5 exposure (unadjusted OR 1.00 [95% CI 1.00–
1.00, p=0.113] and unadjusted OR 1.00 [95% CI 1.00–1.01, p=0.359] in the HIV-positive and HIV-negative 
sub-groups, respectively). In addition, our exposure monitoring does not account for differences in 
exposure over the course of a lifetime. The ambulatory pollutant monitoring is unable to distinguish 
between outdoor and indoor exposures although since our findings are consistent across ambulatory, 
household, and questionnaire assessments, we argue that our findings are reflective of the effects of 
household air pollution.   
As this was an observational study, the associations we have found between exposures and pneumonia 
cannot be attributed as causal. Larger studies, to confirm these associations explore the role of CRD and 
reduced BMI in pneumonia risk in sub-Saharan Africa are warranted. 
6.4.8. Conclusions 
The latest Global Burden of Disease Study (2013) estimates for the burden of adult ALRI caused by 
household air pollution are based on data extrapolated from evidence for tobacco smoke and outdoor 
air pollution (9). The systematic review presented in Chapter 3 concluded that there was insufficient 
evidence for an association between household air pollution and pneumonia. Our findings in the AIR 
study are inconsistent with evidence presented by Ezzati et al. who demonstrated a dose-dependent 
relationship between household air pollution exposure and ALRI (265). This study from rural Kenya 
conducted household monitoring prospectively over a 2-year period (12 hours per day) but did not use 
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radiologically confirmed pneumonia, did not account for HIV status, and their cohort included children 
over the age of 5 years. 
Pneumonia is a major health burden in sub-Saharan Africa (9). Although there are compelling reasons 
for tackling household air pollution (2), other issues need to be addressed to reduce the burden of 
pneumonia in adults. Evidence from this study can be used to establish global estimates for the 
contribution of household air pollution exposure to the burden of disease, to ensure the limited 
available resources for public health interventions are appropriately directed. Risk factors associated 
with pneumonia in this study, such as HIV and BMI, are typically associated with socioeconomic status, 
indicating that poverty is an important driver of pneumonia in urban African adults. To reduce the 
burden of pneumonia, further research into the effects of CRD and the underlying aetiologies in this 
setting are required. Prenatal and childhood malnutrition may play a role. Targeted evidence-based 
strategies to reduce the high burden of CRD seen in young adults are needed and may help to tackle the 
high morbidity and mortality caused by pneumonia.  
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7. Discussion 
7.1. Thesis summary 
Pneumonia causes a large burden of disease worldwide (almost 300 million cases of lower respiratory 
tract infection globally per year (16)), and in sub-Saharan Africa there are 200,000 deaths in adults from 
pneumonia annually (19). Whilst risk factors for pneumonia in developed countries are well understood, 
this is not the case in sub-Saharan Africa. Despite the high burden of pneumonia, little research on the 
topic has been conducted. Household air pollution exposure, which many individuals living in poverty 
worldwide face on a daily basis, is thought to cause half a million pneumonia deaths in children each 
year (12). In adults, estimates of attributable risk of ALRI (including pneumonia) from household air 
pollution exposure in the Global Burden of Disease Study rely on data extrapolated from studies of 
tobacco smoke and outdoor air pollution (7, 11). This thesis explores the role that household air 
pollution and other potential risk factors play in adult pneumonia in resource-poor settings such as 
Malawi, while addressing methodological challenges related to conducting household air pollution 
research. 
After a general review of the literature (Chapter 2), I presented the findings of a systematic review of 
the literature, summarising the existing evidence for an association between household air pollution and 
ALRI in adults (Chapter 3) (283). Following systematic searches of 10 databases and other sources, which 
identified nearly 5000 records, only 8 studies examining the relationship between domestic use of solid 
fuels and ALRI in adults were found reflecting a limited body of research on the topic given the high 
disease burden estimated by the Global Burden of Disease Study. The heterogeneity in methods in the 
studies identified precluded meta-analysis and the majority of studies identified had major 
methodological flaws resulting in substantial risk of bias. We concluded that there was limited evidence 
in the existing literature for an association between household air pollution and ALRI risk in adults.  
In light of the significant methodological challenges identified by the systematic review, particularly 
regarding exposure assessment, this thesis sought to develop tools to facilitate household air pollution 
research. In pilot work conducted in the UK and Malawi, two potential biomarkers of household air 
pollution exposure were evaluated. Firstly, using induced sputum samples collected from patients with 
chronic respiratory diseases in the UK, we evaluated the feasibility of using AMPL as a biomarker of 
exposure (Chapter 4) (326). Comparison of two digital analysis software packages for quantifying AMPL 
revealed that neither technique provides a suitable method for determining exposure in resource-poor 
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settings, due to demand on resources, expertise involved, unreliability of the automated estimates and 
time required. Although we were unable to comment on the accuracy of AMPL as a biomarker of 
exposure, we recommended that resources instead be directed towards developing a biomarker that 
can easily be deployed in resource-poor settings, to enable household air pollution researchers to 
improve exposure assessment. The second potential biomarker of exposure evaluated in this thesis was 
eCO. Unlike AMPL, eCO proved to be easy to employ – for both researchers and participants – when 
used in both rural and urban settings in Malawi (Chapters 5 & 6) (279).  When eCO levels were 
measured in conjunction with 48 hours of detailed exposure monitoring in 397 participants of a case-
control study, we found only a weak association between eCO and ambulatory CO exposure, and no 
association with household CO, ambulatory PM2.5 or household PM2.5 exposures. We therefore 
concluded that there is insufficient evidence to support eCO as a biomarker of exposure to household 
air pollution. Similar exploration of other potential biomarkers should be undertaken, until this 
methodological limitation of household air pollution research has been addressed.  
To further address the evidence gap identified through the systematic review described in Chapter 3, 
this thesis went on to present the findings of a case-control study evaluating the risk factors for 
pneumonia in Malawian adults, with a particular focus on the role of household air pollution (Chapter 
6). Hospitalised patients with radiologically-confirmed pneumonia and community controls underwent 
48 hours of ambulatory and household PM2.5 and CO exposure monitoring. In addition, participants 
completed questionnaires and spirometry assessments, to detect the presence of CRD. Multivariate 
logistic regression, stratified by HIV infection status, explored associations between these and other 
potential risk factors with pneumonia. Follow up was completed by 145 (117 HIV-positive; 28 HIV-
negative) cases and 254 (170 HIV-positive; 84 HIV-negative) controls. Although we did not reach our 
intended sample size, which increases the risk of a type II error, the actual sample size was sufficient to 
detect an OR greater than 1.0003 per µg/m3 change for ambulatory PM2.5 exposure (our primary 
exposure of interest) with 80% power (this equates to an ability to detect an OR of 1.01 for a 20µg/m3 
increase for ambulatory PM2.5 exposure with 80% power). Exposure to high levels of household air 
pollution, well above WHO recommended levels, was widespread. However, we found no association 
between household air pollution and pneumonia in this population. This finding is in contrast to the 
results of the cohort study conducted by Ezzati et al. in Kenya (265), identified by our systematic review 
as being the highest quality existing evidence from sub-Saharan Africa. This may be because household 
air pollution exposures are different in urban Blantyre compared to rural Kenya, where multiple Maasai 
people may live inside the same hut alongside a continually smouldering fire. Furthermore, ALRI 
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diagnosis in the Kenyan study did not include radiological confirmation of pneumonia and so perhaps 
included alternative diagnoses and milder disease compared to the AIR study. However, there are 
several reasons why the null finding in the AIR study may be inaccurate, in particular: exposure 
assessments may have been biased as they were conducted after the episode of pneumonia in cases; 
exposure assessments were relatively short in the context of a lifetime of household air pollution 
exposure; and due to widespread high exposures (with relatively little variation in exposure between 
individuals) it is difficult to detect a difference between cases and controls with a small sample size. 
Several of the study design limitations resulted from the case-control design of the study, including 
retrospective exposure assessment and exclusion of cases in whom pneumonia was fatal. These 
limitations could be avoided in the future by using a cohort study design, although this would require 
substantial financial resource to allow for sufficient sample size and length of follow up. Given the high 
prevalence of household air pollution exposure and pneumonia in settings like Malawi, and therefore 
the potentially high attributable risk of household air pollution for pneumonia, investment of resources 
in cohort studies to clarify this association is warranted.  
In contrast to the air pollution findings, CRD was strongly associated with pneumonia risk. Contrary to 
previous widely accepted views of CRD in sub-Saharan Africa, our study supports findings from other 
recent studies in Malawi that restrictive airways disease, rather than obstructive airways disease, is the 
predominant issue (when using the NHANES III Caucasian or locally derived reference ranges) (41). Low 
FVC is known to be associated with poverty and low BMI, and it is possible that early life insults such as 
malnutrition (including in utero) result in restricted lung growth in sub-Saharan African (302, 307, 310, 
312), but there are few data regarding the aetiology, pathogenesis or prognosis of restrictive airways 
disease in this setting. In other settings, low FVC is known to be associated with early mortality (307, 
318). If the same is true in sub-Saharan Africa, the identified association with pneumonia may partly 
account for this. Further research to understand the aetiology and risk factors for restrictive airways 
disease in sub-Saharan Africa may help to reduce the mortality burden in this setting.    
7.2. Conclusions 
The evidence presented in this thesis does not support an association between household air pollution 
and pneumonia in adults. Nevertheless, household air pollution and pneumonia both remain significant 
challenges in many of the poorest countries of the world. We found that pneumonia results in 
significant mortality in a young population in Malawi (16% of suspected pneumonia cases died prior to 
follow up), and that there is an underlying association with chronic respiratory illness even in this young 
158 
 
population. We also found that household air pollution levels are well above recommended guidelines 
in the homes of many ordinary Malawians, and this is associated with a wide range of health, economic, 
environmental and social problems as discussed in Chapter 2. This thesis has highlighted many of the 
methodological challenges associated with researching the effects of household air pollution in resource 
poor settings. To ensure that accurate conclusions are drawn from future research, and hence public 
health resources are appropriately allocated, it is essential that sufficient attention is given to the 
methodological design of household air pollution studies. In particular, accurate exposure assessment 
should be a priority and in settings where exposure to household air pollution is almost universally high, 
the sample size must be adequate to detect small changes in exposure. Two previously proposed 
biomarkers of exposure have been deemed unsuitable by pilot studies presented in this thesis: currently 
there is no adequate biomarker of exposure suitable for use in resource poor settings. Building on the 
findings of this thesis, recommendations for future research are outlined below. 
7.3. Future research priorities 
Conclusions from this thesis give rise to important questions which should be addressed by the scientific 
community. In this section, I outline some of the factors for consideration with regards to the following 
questions: 
7.3.1. What is the burden of disease in adults caused by household air pollution exposure, 
and how can this be reduced? 
The findings of the AIR study do not support the Global Burden of Disease estimates regarding the 
increased risk of pneumonia in adults resulting from household air pollution. Due to the methodological 
limitations of the AIR study that have been discussed, as well as the inconclusive evidence detailed in 
the systematic review, further research should be undertaken to clarify these global disease burden 
estimates. Robust prospective studies, including case-control studies but ideally large cohort studies, 
examining this association should be conducted in other locations, such as south Asia and Latin America, 
as the findings of the AIR study may not be generalizable to other settings where air pollution exposures 
and risk factor profiles (including HIV prevalence) are different. Investment in cohort studies is 
warranted given the potentially large burden of disease attributable to household air pollution, and data 
obtained from cohort studies will play an important role in achieving several of the United Nation’s 
Sustainable Development Goals (in particular good health and well being, affordable and clean energy, 
reduced inequalities and climate action) (327). Furthermore, the widely accepted association between 
household air pollution and COPD has been challenged by recent evidence, including that from the AIR 
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Study. This must be clarified to ensure that burden of disease estimates are accurate and resources are 
appropriately allocated. 
To enable such research to be undertaken to an adequate standard, attention must be focused on the 
methodological challenges identified in this thesis. Identification of an accurate and feasible biomarker 
would help improve exposure assessments, and more pilot studies of alternative potential biomarkers 
should be conducted before testing in larger studies is undertaken. 
Efforts should continue to identify suitable interventions that are not only able to significantly reduce 
exposures, but that are also appropriate for the context in which they are being implemented. Recent 
evidence has suggested that the scientific community should broaden its focus from cookstoves, and 
explore other possible solutions such as fuel diversification or community level interventions (143).  
7.3.2. How can the burden of pneumonia in sub-Saharan Africa be reduced? 
HIV-associated factors, and other poverty-linked risk factors identified in this study (such as CRD and 
malnutrition), should be incorporated into the research agenda towards reducing the burden of 
pneumonia in sub-Saharan Africa. The role of CRD and malnutrition requires further clarification, using 
robust studies with validated exposure measures, and larger studies of household air pollution should 
be conducted to confirm or refute the findings of AIR study. RCTs of multi-faceted interventions - for 
example, nutritional supplements, treatment of underlying CRD, and pollution reduction measures - 
should be conducted to establish the most effective way of reducing exposure to confirmed risk factors, 
with the aim of reducing pneumonia incidence. A major challenge faced is how to address the life-
course effect of multiple exposures within the context of time-limited research studies.  
7.3.3. What is the impact of chronic respiratory disease in sub-Saharan Africa? 
A major finding of this thesis is the important role that CRD plays in pneumonia risk in Malawian adults. 
Emerging evidence, from the AIR Study and other sub-Saharan African studies, suggests that restrictive 
disease is more prevalent than obstructive airways disease in this setting (41, 302). Although known to 
be associated with poverty (307), and data from Nigeria shows an association with age, gender, height, 
and extremes of BMI (302), little work has been done to explore low FVC in sub-Saharan Africa. 
Prospective longitudinal work to understand and describe the epidemiology, pathology, underlying 
aetiologies, burden and prognosis are required. It is likely that multiple insults throughout the life course 
- including maternal malnutrition, childhood respiratory infections and HIV - are implicated.  
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7.4. Public health and policy implications 
This thesis provides data to address identified gaps in the evidence. Previously, due to lack of available 
data for the direct effects of household air pollution on pneumonia in adults, global estimates were 
based on extrapolated data from ambient air pollution and tobacco smoke exposure studies. These 
analyses can now be updated to improve the accuracy of disease burden estimates, and the attribution 
of risk factors. This will allow decision makers in low- and middle-income countries, where funds and 
infrastructure are scarce, to develop policies to allow the appropriate allocation of resources to tackle 
morbidity and mortality. In the AIR Study, CRD was strongly associated with pneumonia, with an OR of 
almost 30 in HIV-positive individuals and over 100 in HIV-negative individuals. This highlights the 
important role that the increasing burden of non-communicable diseases has on infectious diseases in 
vulnerable populations where HIV prevalence is high. Strategies need to be developed to tackle the 
epidemic of CRD in sub-Saharan Africa, but perhaps with a shift in focus towards restrictive rather than 
obstructive airways disease. Understanding and addressing the risk factors for low FVC has the potential 
to have a substantial impact on both the direct burden of disease caused by restrictive airways disease, 
and the subsequent risk of pneumonia. Reducing this disease burden would benefit some of the world’s 
most vulnerable populations, a step towards tackling global health inequality. 
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9. Appendix 1 – Liverpool Quality Assessment Tool 
STUDY ID  
EXTRACTED 
BY 
 
EXTRACTION 
DATE 
DD MM YY 
   
 
METHODOLOGICAL QUALITY APPRAISAL 
 
Exposure to Indoor Air Pollution and Pneumonia: A systematic review and meta-analysis 
 
CROSS SECTIONAL STUDIES 
PART A: Study Sample  
QUALITY 1 – SELECTION BIAS          QUALITY 2 – RESPONSE BIAS 
Is there evidence of selection bias?  Is there evidence of response bias? 
Yes   Yes  
Possible   Possible  
No *  No * 
If Yes/possible, provide details: 
 
 
 
 If Yes/possible, provide details: 
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PART B: Exposure Assessment 
QUALITY 3 – Indirect Exposure          QUALITY 4 – Direct exposure 
Ranking of exposure measurement?  Ranking of exposure measurement? 
Poor (Uncertain 
discrimination) 
  No direct measurement  
Adequate   Indoor pollution * 
Good (clearly described, good 
discrimination) 
*  Personal child exposure ** 
   
 
 
fuel, stove, structural, behavioural  personal, room, calibration, how? 
 
QUALITY 5 – RECALL BIAS                 QUALITY 6 – MEASUREMENT BIAS 
Is there evidence of recall bias?  Is there evidence of measurement bias? 
Yes   Yes  
Possible   Possible  
No  *   No * 
If Yes/possible, provide details: 
 
 If Yes/possible, provide details: 
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PART C: Outcome Assessment 
QUALITY 6 – Assessment of pneumonia        QUALITY 7 – BIAS IN ASCERTAINMENT 
Ranking of outcome assessment?  Is there evidence of ascertainment bias? 
Parent recall   Yes  
Fieldworker assessed *  Possible  
Physician assessed **  No * 
Radiological ***    
  If Yes/possible, provide details: 
  
 
Objective to subjective    
 
PART D: Analysis of Results 
QUALITY 8 – ADJUSTMENT FOR CONFOUNDING   
Is there adjustment for confounding? 
No Limited or no adjustment for confounding. 
Yes - adequate The main confounders adjusted for         (*)   
Yes - good Majority of known confounders in model (**)  
 
 
 
 
PART E: Qualifying comments 
QUALITY 8: indicate overall assessment and specific issues that you would like to draw 
attention to: 
Total Stars   /13 
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STUDY ID  
EXTRACTED 
BY 
 
EXTRACTION 
DATE 
DD MM YY 
   
 
METHODOLOGICAL QUALITY APPRAISAL 
Exposure to Indoor Air Pollution and Pneumonia: A systematic review and meta-analysis 
CASE-CONTROL STUDIES 
PART A: Study Sample  
QUALITY 1 – CASE SELECTION BIAS      QUALITY 2 – CONTROL SELECTION BIAS 
Is there evidence of selection bias?  Is there evidence of response bias? 
Yes   Yes  
Possible   Possible  
No  *  No * 
If Yes/possible, provide details: 
 
 
 If Yes/possible, provide details: 
  
 
 
PART B: Exposure Assessment 
QUALITY 3 – Indirect Exposure          QUALITY 4 – Direct exposure 
Ranking of exposure measurement?  Ranking of exposure measurement? 
Poor (Uncertain 
discrimination) 
  No direct measurement  
Adequate   Indoor pollution * 
Good (clearly described, good 
discrimination) 
*  Personal child exposure ** 
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QUALITY 5 – RECALL BIAS                 QUALITY 6 – MEASUREMENT BIAS 
Is there evidence of recall bias?  Is there evidence of measurement bias? 
Yes   Yes  
Possible   Possible  
No *  No * 
If Yes/possible, provide details: 
 
 
 Not applicable  
 If Yes/possible, provide details: 
  
 
PART C: Outcome Assessment 
QUALITY 6 – Assessment of pneumonia         
Ranking of outcome assessment? 
Parent recall  
Fieldworker assessed * 
Physician assessed **  
Radiological *** 
 
 
PART D: Analysis of Results 
QUALITY 7 – ADJUSTMENT FOR CONFOUNDING   
(Including matching at design stage) 
Is there adjustment for confounding? 
No Limited or no adjustment for confounding. 
Yes - adequate The main confounders adjusted for         (*) 
Yes - good Majority of known confounders in model (**)  
 
 
Appendix 1 – Liverpool Quality Assessment Tool 
185 
 
 
 
 
PART E: Qualifying comments 
QUALITY 8: indicate overall assessment and specific issues that you would like to draw 
attention to: 
Total Stars /13 
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STUDY ID  
EXTRACTED 
BY 
 
EXTRACTION 
DATE 
DD MM YY 
   
 
METHODOLOGICAL QUALITY APPRAISAL 
Exposure to Indoor Air Pollution and Pneumonia: A systematic review and meta-analysis 
COHORT STUDIES 
PART A: Study Sample  
QUALITY 1 – SELECTION BIAS          QUALITY 2 – RESPONSE BIAS 
Is there evidence of selection bias?  Is there evidence of response bias? 
Yes   Yes  
Possible   Possible  
No *  No * 
If Yes/possible, provide details: 
 
 
 
 If Yes/possible, provide details: 
 
 
 
QUALITY 3 – BIAS IN FOLLOW-UP  
        Is there evidence of bias in follow up? 
Yes  
Possible  
No * 
If Yes/possible, provide details: 
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PART B: Exposure Assessment 
QUALITY 4 – Indirect Exposure          QUALITY 5 – Direct exposure 
Ranking of exposure measurement?  Ranking of exposure measurement? 
Poor (Uncertain 
discrimination) 
  No direct measurement  
Adequate   Indoor pollution * 
Good (clearly described, good 
discrimination) 
*  Personal child exposure ** 
   
 
 
 
QUALITY 6 – MEASUREMENT BIAS 
Is there evidence of measurement bias? 
Yes  
Possible  
No * 
Not applicable  
If Yes/possible, provide details: 
 
 
 
 
PART C: Outcome Assessment 
QUALITY 6 – PNEUMONIA ASSESSMENT    QUALITY 7 – BIAS IN ASCERTAINMENT 
Ranking of outcome assessment?  Is there evidence of ascertainment bias? 
Parent recall   Yes  
Fieldworker assessed *  Possible  
Physician assessed **  No * 
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Radiological ***    
  If Yes/possible, provide details: 
 
 
 
PART D: Analysis of Results 
QUALITY 8 – ADJUSTMENT FOR CONFOUNDING   
Is there adjustment for confounding? 
No Limited or no adjustment for confounding. 
Yes - adequate The main confounders adjusted for         (*) 
Yes - good Majority of known confounders in model (**)  
 
 
 
PART E: Qualifying comments 
QUALITY 9: indicate overall assessment and specific issues that you would like to draw 
attention to: 
Total Stars   /13 
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STUDY ID  
EXTRACTED 
BY 
 
EXTRACTION 
DATE 
DD MM YY 
   
 
METHODOLOGICAL QUALITY APPRAISAL 
Exposure to Indoor Air Pollution and Pneumonia: A systematic review and meta-analysis 
INTERVENTION STUDIES/ TRIALS 
PART A: Study Sample  
QUALITY 1 – SELECTION BIAS          QUALITY 2 – RESPONSE BIAS 
Is there evidence of selection bias?  Is there evidence of response bias? 
Yes   Yes  
Possible   Possible  
No *  No * 
If Yes/possible, provide details: 
 
 
 
 If Yes/possible, provide details: 
 
 
 
QUALITY 3 – Allocation of Intervention        QUALITY 4 – FOLLOW-UP BIAS 
       Is there evidence of bias in allocation 
of intervention? 
 Is there evidence of follow-up bias? 
Yes   Yes  
Possible   Possible  
No (but quasi-random) *  No * 
No (randomised) **    
If Yes/possible, provide details: 
 
 
 
 If Yes/possible, provide details: 
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PART B: Exposure Assessment (for intervention) 
QUALITY 4 – Indirect Exposure          QUALITY 5 – Direct exposure 
Ranking of exposure measurement?  Ranking of exposure measurement? 
Poor (Uncertain 
discrimination) 
  No direct measurement  
Adequate   Indoor pollution * 
Good (clearly described, good 
discrimination) 
*  Personal child exposure ** 
   
 
 
 
PART C: Outcome Assessment 
QUALITY 6 – PNEUMONIA ASSESSMENT    QUALITY 7 – BIAS IN ASCERTAINMENT 
Ranking of outcome assessment?  Is there evidence of ascertainment bias? 
Parent recall   Yes  
Fieldworker assessed *  Possible  
Physician assessed **  No * 
Radiological ***    
  If Yes/possible, provide details: 
 
 
 
PART D: Analysis of Results 
QUALITY 8 – ADJUSTMENT FOR CONFOUNDING (Balance of randomisation)  
Are confounders balanced/ Is there adjustment for confounding? 
No Confounders not assessed (for randomisation success) or adjusted for 
if not balanced. 
Yes - adequate The main confounders balanced/ adjusted for   (*) 
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Yes - good Majority of known confounders balanced/ adjusted for in model (**)  
 
 
 
PART E: Qualifying comments 
QUALITY 9: indicate overall assessment and specific issues that you would like to draw 
attention to: 
Total Stars   /13 (14 if randomised design = 2 STARS) 
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STUDY ID  
EXTRACTED 
BY 
 
EXTRACTION 
DATE 
DD MM YY 
   
 
SHORT FORM: METHODOLOGICAL QUALITY APPRAISAL 
Exposure to Indoor Air Pollution and adult ALRI: A systematic review and meta-analysis 
CASE-CONTROL STUDIES 
 WEAK MODERATE  STRONG REASON & IMPLICATION 
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